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1 Summary 
1.1 English Summary 
In metazoans the regulation of transcription commonly relies on multiple types of 
regulatory elements. Often these elements are separated from their target promoters 
by great genomic distance and can even have other genes in between. Current 
models propose the chromosomes to be folded following a specific topology in order 
to allow these long-range interactions to occur. In addition to the locus topology, 
chromatin environment and DNA accessibility play an important role to determine 
the activity of regulatory elements. 
Thanks to genome-wide studies these layers of regulation have been shown to 
correlate with gene expression to different extents, however it is still not clear how 
chromatin, DNA topology and genetic components integrate in order to carry out 
this process. With this project we aim to understand basic mechanisms organizing 
promoter–regulatory elements communication in a defined model locus. 
A previous project from the laboratory used chromosomal deletions and in vivo 
reporter assays to identify and characterize regulatory elements in c-Myc locus. This 
study, performed by Veli Uslu showed that during mouse embryonic development, at 
11.5 days of gestation, different enhancers coordinate c-Myc transcription in the 
facial tissues and embryonic liver. We analyzed the distribution inside c-Myc locus of 
histone modifications enriched at enhancer sites, restricting to few smaller putative 
regions the genetic position of facial and liver enhancers. We also assessed the 
occupancy of the architectural protein CTCF, enriched at sites involved in long-
range interactions and on insulators, finding both tissue-invariant and tissue-specific 
binding sites at different parts of the locus. 
To study if the topology of the locus influences enhancer promoter 
communication and how it does this, we created three lines of mice carrying 
different chromosomal inversions. Each of which reshuffles the relative positions of 
the different genetic elements: c-Myc promoter, enhancers and CTCF binding sites. 
The observed effects of the genetic engineering include significant reductions of 
c-Myc expression in the facial tissues and redirection of regulatory activity to other 
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genes. In the liver we saw instead milder and non-significant effects of the inversions 
on c-Myc regulation. 
We investigated the occupancy of CTCF and the Cohesin complex subunit 
RAD21 (another architectural protein) in the facial mesenchyme and liver, on the 
engineered lines, detecting in c-Myc locus just some minor changes compared to the 
Wt. 
Our data suggest that the architecture of the loci may have a functional role in 
organizing promoters-regulatory elements interactions, and, if altered, can lead to 
genes misexpression. In case architectural proteins are involved in this process, our 
data suggests that their binding to the genome, not significantly altered by genetic 
reshuffling, may be mostly determined by the DNA sequence (genetics). On the 
other hand, it is possible that the long-range interactions engaged by these proteins 
may be influenced more by their working context. 
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1.2 Deutsche Zusammenfassung 
Bei vielzelligen Tieren stützt sich die Regulierung der Transkription häufig auf 
mehreren regulativen Elementen. Oft besteht zwischen diesen Elementen und ihren 
Zielpromotoren ein großer genetischer Abstand und es können sich auch andere 
Gene zwischen ihnen befinden. Die aktuellen Modelle sehen vor, dass die 
Chromosomen nach einer bestimmten Topologie gefaltet sind, um das Entstehen 
dieser long-range interactions zu ermöglichen. Zusätzlich zu der Locus Topologie 
spielen die Chromatin-Umgebung und die DNA Zugänglichkeit eine wichtige 
Rolle, um die Aktivität der regulativen Elemente zu bestimmen. 
Dank genomweiter Studien wurde bewiesen, dass diese Schichten der 
Regulierung mit der Genexpression unterschiedlichen Ausmaßes korreliert sind. Es 
ist jedoch noch nicht klar, wie Chromatin, DNA-Topologie und genetische 
Komponenten interagieren, um diesen Vorgang durchzuführen. Mit diesem Projekt 
zielen wir darauf ab, die grundlegenden Mechanismen der Organisation bei der 
Kommunikation von Promotor-Regulationselementen in einem definierten Locus- 
Modell zu verstehen. 
In einem vorherigen Projekt des Labors wurden chromosomale Deletionen und 
in-vivo Reporter-Assays verwendet, um die regulatorischen Elemente in c-Myc Locus 
zu identifizieren und charakterisieren. Diese Studie, durchgeführt von Veli Uslu, 
zeigte, dass während der Embryonalentwicklung von Mäusen, bei 11,5 Tagen 
Trächtigkeit, verschiedene Transkriptionsverstärker die c-Myc-Transkription im 
Gesichts-Mesenchym mit der embryonalen Leber koordinieren. 
Wir untersuchten die Verteilung innerhalb des c-Myc-Locus von an den 
Enhancer Sites angereicherten Histon-Modifikationen, um die genetische Position 
der Gesichts- und Leber Enhancer auf kleinere putative Regionen zu beschränken. 
Wir untersuchten auch die Belegung der Isolatoren als auch des architektonischen 
Proteins CTCF‘s, an den Standorten, die in die weitreichenden Wechselwirkungen 
involviert sind. Folglich fanden wir sowohl Gewebe-Invarianten als auch 
gewebespezifische Bindungsstellen in verschiedenen Teilen des Locus. 
Wir betrachteten die Rolle der Locus Topologie in der Beeinflussung der 
Promoter-Enhancer-Kommunikation mit der Schaffung von drei ausgeglichenen 
chromosomalen Inversionen innerhalb des Locus. Jede dieser Inversionen soll die 
Positionen der c-Myc-Promotoren und die Langstrecken-Enhancer, sowie CTCF 
Bindungsstellen auf spezifische Weise neu vermischen. Wir beobachteten 
Umleitungen von Regulierungstätigkeiten (anhand der in-vivo-Reporter-Assays) 
und signifikante Reduktion von c-Myc Expression im Gesichts-Mesenchym. In der 
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Leber hingegen beobachteten wir eine leichtere und nicht erhebliche Auswirkung 
der Inversionen auf die c-Myc-Regulierung. 
Wir untersuchten die Belegung von CTCF und der Untereinheit vom Cohesin 
komplexen RAD21 (ein weiteres architektonisches Protein) im Gesichts-
Mesenchym und in der Leber, auf den technischen Linien, mit Erfassung im c-Myc 
Locus von nur einigen kleineren Veränderungen im Vergleich zu dem Wt.   
Unsere Daten suggerieren, dass die Architektur der Loci eine funktionelle Rolle 
in der Organisation der regulativen Promotor-Elemente haben kann. Wenn diese 
verändert werden, kann dies zur Gen-Fehlexpression führen. Die 
gewebespezifischen Auswirkungen der Gentechnik, die wir am c-Myc-Locus 
beobachten konnten, könnte die Tatsache widerspiegeln, dass verschiedene Gewebe 
unterschiedlich lokalisierte Topologien implementieren, um spezifische, 
weitreichende Wechselwirkungen zu fördern. Wenn architektonische Proteine an 
diesem Prozess beteiligt sind, weisen unsere Daten darauf hin, dass deren Bindung 
zum Genom, das nicht signifikant durch genetische Umordnung verändert ist, vor 
allem durch die DNA-Sequenz (Genetik) bestimmt werden kann. Es ist jedoch 
möglich, dass die weitreichenden Wechselwirkungen, die sie durchleben, stärker 
durch den Kontext beeinflusst werden, in dem sie eingesetzt sind. 
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2 Introduction 
2.1 Transcriptional Control of Gene Expression in 
Metazoans 
In multicellular organisms, every cell needs to execute cell-type specific functions, 
maintain its lineage identity, respond to cell signaling and be able to tune its 
physiology according to fluctuations of chemical and physical parameters. The 
completion of these activities is ensured by the control of gene expression.  
The flow of genetic information from DNA to protein is controlled at several 
levels: transcription, splicing, transcript export and localization, transcript 
degradation, translation, post-translational-modifications and protein degradation. 
Although not clearly demonstrated, one possible reason for having so many points of 
control is to confer robustness to the system, for example, in case one point of 
control is not working properly. Additionally, this redundancy can also provide 
flexibility to the system in terms of adaptation timing. In this last case, some changes 
require a fast and transient response, for example the production and release of 
specific hormones in dangerous situations. Other stimuli instead require a more 
stable and not necessarily fast response, for example the specification of cell fate in 
metazoans. 
DNA transcription is controlled at the level of initiation, elongation and 
termination, (reviewed in Levine, 2011; Porrua & Libri, 2015). Transcriptional 
initiation is dependent on the assembly on the promoter of the pre-initiation 
complex (PIC). PIC is constituted by the RNA polymerase II (RNA Pol II) and the 
general transcription factors (GTF) (TFIIA, TFIIB, TFIID, TFIIE, TFIIF, 
TFIIH), which recognize the promoter and load it with the RNA Pol II (T. K. Kim, 
Ebright, & Reinberg, 2000). This complex allows the transcription of approximately 
the first 10 nucleotides. At this step the polymerase can either stall, or continue in 
the main gene body (Hirose & Ohkuma, 2007). Some studies revealed that 10–30% 
of the inactive promoters are loaded with RNA Pol II (Core, Waterfall, & Lis, 2008; 
Jonkers & Lis, 2015; Levine, 2011). However, in this case, RNA Pol II stalls and 
fails to proceed in the main gene body. Until a short time ago it was believed that the 
initiation step was the only limitation of transcription. Recent data, mostly due to 
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the great development in sequencing technologies (next generation sequencing, 
NGS), has started challenging this model. There are now protocols available to 
assess in a genome wide fashion RNA Pol II occupancy (RNA Pol II ChIP-seq), 
nascent transcripts (GRO-seq) (Core et al., 2008), unstable transcripts (GRO-cap) 
(Core et al., 2014a), as well as transcriptional elongation speed (4sUDRB-seq) 
(Fuchs et al., 2015). The quantity of data obtained by these methods support the 
idea that the control of pause/release of the RNA Pol II could be a further point of 
transcriptional regulation, yet it is still not completely clear what regulates the 
balance between transcriptional initiation and elongation (Zeitlinger et al., 2007). 
Once the RNA Pol II overcomes the promoter-proximity and enters the gene-
body, the transcriptional speed can differ as much as three fold between different 
genes (Danko et al., 2013; Fuchs et al., 2014; Jonkers, Kwak, & Lis, 2014; Veloso et 
al., 2014). There are important differences in transcriptional speed even inside the 
gene-body: the beginning (within ~ 15Kbp from the promoter) is the slowest phase, 
characterized by an elongation of 0.5Kbp/minute, while the rest of the gene is 
transcribed at 2–5Kbp/minute (figure 1) (Danko et al., 2013; Fuchs et al., 2014; 
Jonkers et al., 2014; Veloso et al., 2014). The increment of RNA Pol II speed likely 
occurs due to a progressive maturation of the transcriptional machinery while it is 
elongating, which includes the phosphorylation of the serine 2 of the RNA Pol II 
carboxy terminal domain (CTD), the removal of pausing factors (if present) and the 
recruitment of other subunits (such as splicing factors) (Cheng et al., 2012; 
Heidemann, Hintermair, Voß, & Eick, 2013; Jishage et al., 2012). In addition, it is 
possible that chromatin and histone modifications can affect the RNA Pol II 
advancement. Transcribed gene bodies are enriched for H2B ubiquitylation, 
H3H36me3, H3K56ac and H3K79me2, which can directly increase the DNA 
accessibility, or function as a scaffold for histone chaperones that can evict 
nucleosomes or alter their turnover (Bintu et al., 2012; Venkatesh & Workman, 
2015; Zentner & Henikoff, 2013). Even inside the fast-transcribed zone, there can 
be RNA Pol II slowdowns, typically, they occur at exons, or at cleavage and 
polyadenylation sequences (Gromak, West, & Proudfoot, 2006; Kwak, Fuda, Core, 
& Lis, 2013). It is possible that splicing events—which can take 20–30 seconds in 
vivo—may be the cause for the transcriptional slowdown observed on exonic 
sequences (Alexander, Innocente, Barrass, & Beggs, 2010; Jonkers et al., 2014; 
Kwak et al., 2013; Veloso et al., 2014). 
After the gene is fully transcribed, the polymerase has to dissociate from the 
DNA, in a process known as transcription termination. In yeast (and similarly in 
metazoans) the cleavage and polyadenylation factor-cleavage factor (CPF–CF) 
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complex recognizes termination signals in the 3’ UTR of the nascent mRNA as well 
as the phosphorylated serine 2 of the RNA Pol II CTD. The CPF-CF complex 
recognizes and cleaves the mRNA on the poly(A) site and adds ATP nucleotides on 
the 3’ end of the transcript thereby producing the poly(A)-tail, typical of the mRNA 
(Kuehner, Pearson, & Moore, 2011). It is still nonetheless debated how the RNA 
Pol II slips off the DNA, ending the transcription process (M. Kim et al., 2004; 
Richard & Manley, 2009). 
 
Figure 1 | Transcription elongation speed. Adapted from (Jonkers & Lis, 2015). The 
figure shows a hypothetical gene. The density of RNA Pol II and the speed of transcription 
across the gene are not constant. The factors that are thought to affect the transcriptional 
speed at specific parts of the gene are listed below the gene model. 
2.1.1 Genetic Elements of Transcriptional Regulation 
2.1.1.1 Promoters 
The promoter is defined as the sequence encompassing the transcription start site 
(TSS) of a gene, necessary to initiate its transcription. 
In mammals the definition of promoter includes the core promoter, extending 
for about 30bp upstream and downstream of the TSS (commonly referred to as 
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promoter), and the proximal promoter, within a few hundreds of base pairs (bp) 
upstream of the TSS, which comprises binding sites for TFs.  
One distinction in promoter classes is done according to their sequence 
composition at the proximal promoter: high and low CG content or high and low 
CpG dinucleotide frequency (Carninci et al., 2006; Yamashita, Suzuki, Sugano, & 
Nakai, 2005). This distinction partially overlaps with the function of the genes. 
Promoters with high CG content tend to be found at broadly expressed genes and 
also, developmentally regulated ones (Carninci et al., 2006). In total, they represent 
about 60% of the human genes. They are characterized by having multiple TSSs 
close to each other and by having CpG-islands on the proximal promoter. Promoters 
with low CG content, are mostly found on tissue specific genes, which tend to have 
a single TSS (Maston, Evans, & Green, 2006; Ponjavic et al., 2006; Venter et al., 
2001).  
Promoters can also be classified based on the motifs found at the core promoter. 
These notably include the TFIIB recognition element (BRE), typically starting from 
37 bp upstream of the TSS, the TATA box, 31 bp upstream of the TSS, the Motif 
Ten Element (MTE), 18 bp downstream of the TSS, and, the Downstream 
Promoter Element (DPE), just after the MTE (Maston et al., 2006). Of these, DPE 
and BRE are the most common, present in 25% of the human core promoters, and 
the TATA box, present in 13% of the human core promoters (Maston et al., 2006).  
Another important criteria of classifying promoters, other than the ones based 
on DNA sequence, is represented by the epigenetic status of the promoter, namely, 
histone and DNA modifications (treated in more detail in the next sections) which 
reflect the activity of the promoter in different cell types. Tissue specific expressed 
genes usually carry the active H3K4me3 and H3K27ac histone modifications only 
downstream of the TSS whereas broadly expressed genes such as housekeeping 
genes, carry these marks throughout the promoter (Ernst & Kellis, 2010). In 
particular the H3K4me3 usually spans the entire CpG island (Deaton & Bird, 
2011). 
2.1.1.2 Regulatory Elements 
It is well established in the literature that regulatory elements (RE(s)) are responsible 
for mediating transcriptional regulation, acting probably on every transcriptional 
phase. These regulatory elements are DNA sequences capable of recruiting TF(s). 
They are usually a few hundreds of bp long and carry specific DNA motifs 
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recognized by the TFs (reviewed in Spitz & Furlong, 2012). Other than sequence 
(motifs), indirect binding and DNA accessibility affect the recruitment of TFs to 
regulatory elements.  
One example of indirect binding is given by the co-activator p300–CREB, 
which is in general, recruited to the DNA by other TFs, through protein–protein 
interactions (Merika, Williams, Chen, Collins, & Thanos, 1998).  
TFs accessibility to motifs is affected by the presence of nucleosomes or because 
of unsuitable DNA shape. In these cases, remodeling complexes like SWI/SNF or 
architectural proteins like HMGA1 can respectively slide the nucleosomes away 
from the binding site or unbend the DNA, in both cases the result is the 
improvement of the binding of the TF to the RE (Voss & Hager, 2014; Yie, 
Merika, Munshi, Chen, & Thanos, 1999). ChIP-seq analysis showed that TFs bind 
only a fraction of the available motifs in the genome, supporting the idea that 
chromatin context, accessibility and DNA shape represent altogether a major 
determinant for TF recruitment (Arvey, Agius, Noble, & Leslie, 2012; John et al., 
2011a; X.-Y. Li et al., 2011; Tsai, Shiu, & Tsai, 2015). 
Regarding the function of REs instead, it is possible that a significant fraction of 
the TFs binding is non functional, and probably, just have to do with the fact that 
the DNA in those locations is accessible enough (John et al., 2011b).  
Conversely, the binding of TFs to the DNA can have functional implications in 
transcription, promoting or inhibiting it. In these cases the REs are respectively 
called enhancers and silencers. TFs can affect transcription by recruiting other co-
activators/co-repressors or nucleosome-remodeling complexes. TFs can also act 
more directly, by promoting the recruitment of the GTF (in case of enhancers), or 
by targeting their assembly (in case of silencers) (Koch et al., 2011). Lastly, TFs can 
also recruit DNA and histone modifying enzymes, like for the case of the protein 
complexes Trithorax and Polycomb (reviewed in Schuettengruber, Martinez, Iovino, 
& Cavalli, 2011; Steffen & Ringrose, 2014). The post-translational modification of 
the histones (most often on the histone tails, protruding outside the nucleosome) can 
in turn have many consequences (discussed in more detail in the chromatin section). 
They can directly affect the progression of the RNA Pol II on the gene body. 
Alternatively, they can recruit other TFs, which specifically recognize the histone 
modification. Finally, they can recruit other proteins that alter the chromatin 
compaction. 
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2.1.1.2.1 Enhancers 
2.1.1.2.1.1 Enhancers Characterization 
Enhancers are defined as DNA sequences that can activate transcription through the 
binding of TFs (activators). 
Enhancers were originally discovered in the simian virus 40 (SV40) genome, 
already in the early eighties (Conrad & Botchan, 1982; de Villiers, Olson, Tyndall, 
& Schaffner, 1982). Soon after their description in the SV40 system, enhancers were 
described also in a few other loci, including the Immunoglobulin heavy chain (IgH) 
genes (Banerji, Olson, & Schaffner, 1983; Gillies, Morrison, Oi, & Tonegawa, 
1983). 
Later on, the development of the enhancer-trap allowed the discovery of several 
enhancers and became a standard technique (used for long time) for their 
identification in many systems, ranging from mammals to Drosophila and Arabidopsis 
(Dornan, Gailey, & Goodwin, 2005; Engineer, Fitzsimmons, Schmuke, Dotson, & 
Kranz, 2005; Korn et al., 1992; Weber, de Villiers, & Schaffner, 1984).  
Nowadays, two main different approaches are being used for the identification 
of enhancers on a genome-wide scale.  
The first approach is based on the use of NGS technologies. One method 
exploits the fact that enhancers tend to lie on accessible DNA regions; techniques 
such as DNaseI-seq and FAIRE-seq aim to map on the genome these regions 
(Giresi et al., 2007; Gross & Garrard, 1988; M. Liu et al., 2015; Stalder et al., 
1980). Alternatively, histone modifications such as H3K4me1 and H3K27ac, or the 
coactivator p300, all enriched at enhancer sites, can be mapped on the genome by 
ChIP-seq (Creyghton et al., 2010a; Heintzman et al., 2007; Rada-Iglesias et al., 
2011; Visel, 2009; Zentner, Tesar, & Scacheri, 2011).  
The second approach is based on high throughput reporter assays, which allow 
testing the enhancer potential of thousands of sequences in parallel (W. Akhtar et 
al., 2013; Arnold et al., 2013; Melnikov et al., 2012; Mogno, Kwasnieski, & Cohen, 
2013). One example of this approach is given by the STARR-seq method, firstly 
applied in Drosophila cells, which allowed the identification of thousands of cell-
type-specific enhancers (Arnold et al., 2013). 
2.1.1.2.1.2 Enhancers Mechanisms of Action 
Enhancers were shown to affect every step of transcriptional regulation. 
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Regarding the transcription initiation, enhancers can promote the assembly of 
the PIC at genes promoters. It is believed that in most of the cases the way this is 
achieved occurs through the recruitment of the Mediator protein complex, rather 
than by a direct targeting. According to this view, enhancers-bound-activator(s) 
interact with the Mediator and form an active hub where the signals of one or more 
regulatory elements converge (reviewed in Malik & Roeder, 2010). The Mediator 
complex, in turn, promotes the formation of the PIC (Esnault et al., 2008; Pavri et 
al., 2005). 
Enhancers can also promote the RNA Pol II release from stalled promoters, 
improving the elongation step (Hargreaves, Horng, & Medzhitov, 2009; K. Lee, 
Hsiung, Huang, Raj, & Blobel, 2015; Lokody, 2014; Zippo et al., 2009). 
An important feature of enhancers concerns their compatibility with the 
different promoters. Some reports showed that not any enhancer could act on any 
promoter.  
In Drosophila, one study identified that the motifs at the core promoter confer 
the specificity to the interaction. In this study the capability of a set of known 
enhancers to activate (in vivo) the expression of a reporter gene having either the 
DPE or TATA motifs at the core promoter was assessed. It was shown that certain 
enhancers activate only one of the two types of promoters. Regarding the function of 
the promoter–enhancer specificity, it was speculated that this mechanism could in 
principle be important in cases where enhancers do not lie in the proximal promoter, 
but rather are separated from their target gene(s) by a large distance (as described in 
the next section). Alternatively, this mechanism may be important in the case that 
the enhancers are closer to a non-target gene then the target one. In these situations, 
the compatibility between the two could help in sorting promoter–enhancer 
interactions. On the other hand, in the same study it was also shown that likely this 
is not a universal mechanism, as it was limited to 4 out of the 18 enhancers tested 
(Butler & Kadonaga, 2001).  
More recent reports performed in a genome-wide fashion suggested a slightly 
different scenario. In one study the responsiveness of a housekeeping and a 
developmental gene promoter to all the 11364 candidate enhancers in Drosophila S2 
cells was analyzed. It was reported that in 32% of the cases, enhancers did not have a 
preference for either of the promoters (Zabidi et al., 2014). 
In the next sections other mechanisms for organizing promoter–enhancer 
communication will be mainly considered. 
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2.1.1.2.2 Silencers 
Silencers are defined as DNA sequences bound by TFs (repressors) capable of 
repressing transcription. 
Compared to enhancers, the identification of silencers is complicated by the fact 
that there are no hallmarks available for their high-throughput identification. In 
addition, the fact that as from definition, silencers repress transcription, makes the 
reporter assays a less suited method (compared to enhancers) for their discovery and 
validation. Repressors, namely the TFs that bind silencers and exert the repressing 
effects, were mostly described. For these reasons, repressors are treated in more 
detail in this section. 
Similarly to activators, repressors were shown to impair transcription in different 
ways.  
The dorsal switch protein (DSP1) in Drosophila was shown to repress the 
Zerknullt (Zen) gene by binding TBP and removing TFIIA from the DNA. As a 
consequence, DSP1 targets the assembly of the pre-initiation complex and prevent 
the loading of RNA Pol II to the promoter (Doyle, Kraut, & Levine, 1989; Kirov, 
Lieberman, & Rushlow, 1996). Similarly, in mouse the repressor Mohawk binds the 
pre-initiation complex proteins TBP, TFIIA1 and TFIIB, as well as co-repressors 
histone deacetylases enzymes (Anderson, Beres, Wilson-Rawls, & Rawls, 2009). 
Other studies showed that repressors can target transcription initiation by binding to 
the Mediator (reviewed in Malik & Roeder, 2010). 
Another mechanism of transcriptional silencing involves the pausing of the 
RNA Pol II. A few proteins—including the negative elongation factor (NELF) and 
DRB sensitivity-inducing factor (DSIF)—in both mammals and Drosophila were 
shown to increase the RNA Pol II stalling on the promoter-proximal region (20–
60bp away from the TSS) (Missra & Gilmour, 2010; Natarajan et al., 2013; 
Yamaguchi, Shibata, & Handa, 2013). In one study, the transcription factor SP3 was 
shown to inhibit the transcriptional elongation at the p21CIP gene. The depletion of 
SP3 led to increase p21CIP mRNA levels, and, was accompanied by an increment of 
H3K36me3 (histone modification associated with transcriptional elongation) and by 
a reduced NELF occupancy at the p21CIP promoter (Valin, Ouyang, & Gill, 2013). 
Similarly, the SNAIL repressor in Drosophila was shown to inhibit the release of the 
RNA Pol II from the genes promoters (Bothma, Magliocco, & Levine, 2011). 
Often repressors recruit on silencer elements other co-repressors, commonly 
histone deacetylases. One example of this mechanism is given by the repressor 
RUNX2, which suppresses transcription at the rDNA in a HDAC1 (histone 
deacetylase) dependent manner (Ali et al., 2012). 
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Finally, some repressors such as Polycomb group proteins affect transcription by 
chemically modifying histone tails. Their activities influence the properties of the 
chromatin, and hence, are described in more detail in the chromatin section. 
2.1.1.2.3 Short-Range and Long-Range Regulatory Elements in 
Metazoans 
The regulation of gene expression at transcriptional level exists in all living 
organisms from bacteria to eukaryotes. However there are a few fundamental 
differences between these two taxa. 
In bacteria the process is fairly simple, it is based on regulatory sequences 
located very close to, or even at the very promoter. These sequences are bound by 
TFs that can either help recruit the RNA polymerase, or, occupy the promoter, in 
this way preventing the RNA polymerase binding it. A famous example of this 
mechanism is given by the Lactose operon discovered by Francois Jacob, Andre´ 
Lwoff and Jacques Lucien Monod (awarded the Nobel prize in physiology or 
medicine, in 1965).  
In metazoans, the spatial relationship between regulatory elements and 
promoters is more complicated; regulatory elements lie both upstream and 
downstream of the target gene, as well as inside gene introns (Ott et al., 2009). The 
distance between them also varies, ranging from hundreds of bp to hundreds of Kbp 
(respectively, short and long-range regulatory elements). For example in mammals, 
in erythroid cells, the expression of the β-globin genes depends on regulatory 
sequences located 20–30Kbp upstream of the gene cluster (figure 2) (Curtin, Liu, 
Liu, Chang, & Kan, 1989; Hardison et al., 1997; Moon & Ley, 1990).  
The most accepted model—explaining how long-range regulatory sequences 
influence their target promoters—proposes that the DNA molecule is flexible and 
can allow the formation of looped structures (Bulger & Groudine, 1999). The 
validity of the “looping” model is thought to extend to all the eukaryotes, from yeast 
to mammals (Petrascheck et al., 2005). 
It is still not clear how many regulatory sequences act on a given gene at any 
time, and the physiological meaning of having both short and long-range regulatory 
elements. Recent studies performed with adaptations of the 3C and Hi-C methods 
(Capture-C and HiCap) were particularly useful in order to map interactions 
between distal regulatory elements and promoters (Hughes et al., 2014; Sahlén et al., 
2015).  
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Figure 2 | Igf2-H19 and Hbb locus topology. Adapted from (Ribeiro de Almeida, 
Stadhouders, Thongjuea, Soler, & Hendriks, 2012). A) The Igf2-H19 locus is subjected to 
differential methylation (DMR) on paternal and maternal alleles. In the maternal allele CTCF 
binds the imprinting control region (ICR) and mediates DNA looping, important for 
preventing the endodermal enhancer (Ee) and the mesodermal enhancer (Em) to act on Igf2 
(leading to Igf2 silencing and to the expression of H19). In the paternal allele, CTCF is 
unable to bind the methylated ICR, and as a result, the enhancers reach Igf2 and activate its 
expression (Bell & Felsenfeld, 2000; Hark et al., 2000). B) The β-globin genes (Hbb locus) 
lie within the olfactory receptor (OR) gene-cluster. CTCF binds four DNaseI hypersensitive 
sites (HS) scattered throughout the region, one of them in the locus control region (LCR). 
CTCF-mediated looping is important to condensate the OR gene-cluster. This compaction 
brings several regulatory sequences into proximity, and as a result, it forms at the LCR an 
“active chromatin hub”. During cells maturation only certain β-globin genes interact with the 
LCR while others stick out of the loop and remain silent. In eryhroid progenitor cells, the ϵy 
and βh1 globin genes are expressed; on differentiated erythroid cells, ϵy and βh1 become 
silenced, and the adult genes β-major (βmaj) and β-minor (βmin) gain expression. 
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The HiCap method performed in mESC, showed that distal interactions often 
occur within 100Kbp, and that distal regions interact most often with just one 
promoter whereas promoters on average interact with approximately 6 distal regions 
(Sahlén et al., 2015). Interestingly, this study also showed that 65% of the total 
interactions occur between a given element and the closest promoter. This evidence 
suggests that in a significant proportion of the cases promoter–distal element 
interactions can skip gene(s) and argues against some old models present in the 
literature, proposing that promoter–enhancer interactions are uniquely based on 
proximity. 
2.1.1.3 Insulators 
In eukaryotes genetic insulators have been described in many taxa, ranging from 
yeast, to Drosophila and mammals (Kirkland, Raab, & Kamakaka; Vogelmann, 
Valeri, Guillou, Cuvier, & Nollmann). The physiological importance of insulators is 
particularly evident in metazoan genomes, where the long-distance activity of REs 
may (in principle) not be confined only to their target genes, but also extend to 
others, leading to ectopic expression of the latter, with potential detrimental 
consequences. Insulators were therefore proposed to limit the range of action of REs. 
The definition of insulator encompasses two different genetic mechanisms. The 
first category, “enhancer-blocking” represents DNA sequences capable of disrupting 
the communication between a regulatory element and a promoter when placed in 
between (Conte, Dastugue, & Vaury, 2002; Geyer & Corces, 1992). The second 
category is represented by DNA sequences capable of containing repressive effects, 
notably the spreading of heterochromatin. This function is carried out by insulators 
with a “barrier” activity (Gaszner & Felsenfeld, 2006; Valenzuela & Kamakaka, 
2006).  
Despite the fact that some insulators behave either as enhancer blockers or as 
barriers, some others can act as both. Examples of the last category are the short 
interspersed element (SINE) in mouse and the gypsy insulator in Drosophila (Gdula, 
Gerasimova, & Corces, 1996; Tatiana I Gerasimova, Lei, Bushey, & Corces, 2007; 
Lunyak et al., 2007; Román, González-Rico, & Fernández-Salguero, 2011). 
In both mouse and yeast it was observed that the tRNA gene promoters have a 
barrier function, blocking the spread of repressive heterochromatin into actively 
transcribed domains. The barrier activity is not dependent on RNA Pol III 
transcription and is carried out by the general transcription factors (for the RNA Pol 
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III) TFIIIB and TFIIIC (Noma, Cam, Maraia, & Grewal, 2006; Valenzuela, 
Dhillon, & Kamakaka, 2009). Another mechanism of barriers is observed at the β-
globin locus. In chicken cells this locus is insulated from an adjacent heterochromatic 
domain by the HS4 insulator. In this case the barrier activity requires the proteins 
CTCF, USF1 and VEZF1. The subsequent recruitment of histone modifying 
enzymes bring active modifications that counteract the heterochromatin spreading 
(Dickson et al., 2010).  
Regarding the enhancer-blocking insulators, reporter assays in Drosophila 
allowed the identification of several sequences that possess this property (Parnell & 
Geyer, 2000). In mammals, an example of enhancer-blocking insulator is the 
imprinting control region (ICR) located between the Igf2 promoter and its enhancer 
(figure 2). In the maternal allele, the binding of CTCF to the ICR is essential to 
maintain the insulating properties of this sequence and does not allow the enhancer 
to act on the Igf2 promoter, keeping the gene silenced (Kurukuti et al., 2006), 
(reviewed in P. Singh, Lee, & Szabó, 2012).  
Two independent models can describe the mechanisms of the enhancer-
blocking insulators. One proposes that the enhancer does not reach the promoter 
because it is physically sequestered by the enhancer-blocking insulator (Nolis et al., 
2009). Another model proposes that enhancer-blockers and perhaps, insulators in 
general, are bound by architectural proteins and interact with each other via DNA 
loops between them, affecting the 3D architecture of the loci. As a consequence, this 
would constrain one enhancer in one loop, preventing it reaching other promoters (T 
I Gerasimova & Corces, 2001). According to this view, several recent evidence 
support the idea that enhancer-blocking insulators do not work autonomously. 
Rather, their activity seems to be largely influenced by the surrounding sequence, 
showing significant differences according to the context in which the insulators are 
placed (reviewed in Chetverina, Aoki, Erokhin, Georgiev, & Schedl, 2014). For 
example, in Drosophila, if the enhancer-blocker su(Hw) is placed between a promoter 
and its enhancer, as defined, it can block the activity of the enhancer. However, this 
activity is lost if two copies of su(Hw) are used instead of one (Muravyova, 2001). 
Supporting the context-dependency model, other observations showed that 
enhancer-blockers can indeed impair the communication between enhancer and 
promoter if arranged as described above, but can also improve enhancer-promoter 
interactions in other configurations. For example, both insulators yellow-1A2 and 
white-WARI in Drosophila lead to reporter activation if placed downstream of a 
reporter and Gal4 motif construct (reviewed in Chetverina et al., 2014). 
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In Drosophila, several proteins are enriched at enhancer-blocking sequences, 
amongst them are CTCF, the boundary element associated factor (BEAF) and the 
GAGA factor (Van Bortle et al., 2014). In human, CTCF is enriched between 
adjacent genes with low correlation in expression level, compared to sites where the 
flanking genes have similar expression levels (Xie et al., 2007). In Drosophila similar 
findings were obtained for the protein BEAF and in a few cases, CTCF was also 
shown to act as enhancer blocker (Bell, West, & Felsenfeld, 1999; Wood et al., 
2011; Yang, Ramos, & Corces, 2012; Yusufzai, Tagami, Nakatani, & Felsenfeld, 
2004). Despite these few reported cases, the role of these TFs in mediating 
insulating effects, and their precise mechanism of action remain to be clarified. 
2.1.1.4 Tethering Systems 
The evidence that the physical interaction between long-range regulatory elements 
and promoters occur due to DNA-loops between them, leads to the consideration 
that some regulatory elements may have evolved just to carry out the function of 
mediating the formation of DNA-loops.  
One example of such a system is given by the Antennapedia gene complex in 
Drosophila (Calhoun, Stathopoulos, & Levine, 2002; Ohtsuki, Levine, & Cai, 1998). 
The Antennapedia is one of the most important Hox gene-clusters in Drosophila. 
Misexpression of these Hox genes during development impairs the correct embryonic 
segmentation, causing homeotic transformation, and in some cases, death. The 
expression of the Src gene, in different tissues of the parasegment-2, is dependent on 
the T1 enhancer. T1 lies 25Kbp telomeric to the gene promoter and in between the 
two there is another gene, Ftz. Interestingly, the T1 enhancer does not activate Ftz 
(which in addition to being the closest, has a stronger promoter than Src). Somehow 
T1 skips Ftz and activates Src. This phenomenon seems to be mediated by the 
tethering element Src450 located just upstream of the Src promoter. Remarkably, if 
the Src450 sequence is placed upstream of the Ftz promoter, Ftz acquires expression 
in the same tissues as Src as a result of the recruitment of the T1 enhancer.  
The molecular mechanisms and the TFs responsible for this behavior are 
unknown. In human erythroid cells, in the globin gene-cluster, it is speculated that 
GATA1–AP1/NF-E2 interactions are serving a similar purpose (Gong & Dean, 
1993; Gourdon et al., 1992). 
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2.1.2 Topological Component of Transcriptional Regulation: 
From Chromosome Territories to DNA Loops 
2.1.2.1 Nuclear Compartments 
As recently as the late 1970s, with the development of DNA–FISH protocols for 
“chromosome painting”, it was observed that chromosomes tend to have ordered 
arrangements inside the nucleus—termed chromosome territories (CT(s)). In 
particular, larger chromosomes tend to stay at the periphery, while smaller ones are 
mostly at the interior (Sun, Shen, & Yokota, 2000). Correlations between gene 
activity and nuclear positioning were also described. Active genes and gene-rich 
chromosomal regions are preferentially located towards the interior of the nucleus, 
while inactive genes and gene-poor chromosomal regions tend to stay at periphery 
(Bolzer et al., 2005; Croft et al., 1999). 
Regarding the dynamicity of the DNA movements inside the nucleus, in vitro 
studies performed in mammalian cells, showed that during interphase, DNA 
sequences are constrained in a volume of about 1% of the total volume of the 
nucleus, corresponding to a radius of 1µm (Edelmann, Bornfleth, Zink, Cremer, & 
Cremer, 2001). The early G1 phase is characterized by movements greater than 2µm 
and represents the only phase of the cell cycle where important DNA repositioning 
is observed. After that, chromosomal segments seem to be more constrained within 
their CTs (Walter, Schermelleh, Cremer, Tashiro, & Cremer, 2003). 
2.1.2.2 Lamina Associated Regions 
One mechanism presumably important for organizing the CTs (and the topology of 
the chromosomes) may be the tethering of DNA segments to the nuclear periphery. 
The nuclear-lamina has been hypothesized to mediate this interaction.  
The nuclear-lamina is composed of a network of V-intermediate-filaments 
(lamins) attached to the nuclear membrane by lamin-associated membrane proteins 
(LAP) (reviewed in Georgatos, Meier, & Simos, 1994; Gruenbaum et al., 2003). 
Lamins are split into two groups: type A and type B, both able to bind a class of 
DNA sequences called matrix attachment regions (MARs) (Dijkwel & Hamlin, 
1988; Forrester, van Genderen, Jenuwein, & Grosschedl, 1994; Loc & Strätling, 
1988; Ludérus et al., 1992). These are typically 100–300bp long, with a high content 
of A/T nucleotides. It was also shown that lamins can bind the core histones in a 
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MARs independent manner (Goldberg et al., 1999; Taniura, Glass, & Gerace, 
1995). 
From a physiological perspective, lamins deficiencies cause several diseases 
termed “laminophaties” that range from muscular dystrophies to neurophaties 
(Camozzi et al., 2014). It was described that human fibroblasts carrying dominant-
negative mutations on the lamin-A gene had genome-wide perturbations in DNA–
lamin interactions, which as consequences, led to the loss of definition of CTs and 
loss of peripheral heterochromatin (McCord et al., 2013). Similarly, other studies 
performed in mouse fibroblasts, suggested that lamins deficiencies have 
consequences at the level of CTs, for example, with the relocation of chr18 towards 
the nucleus interior (Malhas, Lee, Sanders, Saunders, & Vaux, 2007). On the other 
hand, other studies on mESC showed that the knockout of lamin-A and lamin-B 
did not cause any significant change of interaction between the DNA and nuclear-
lamina. As suggested by the authors, other nuclear-lamina components could be 
involved in the process (Amendola & van Steensel, 2015). For example, it was 
observed that the lamin-B receptor is important for anchoring heterochromatic 
regions to the nuclear envelope (Solovei et al., 2013). Other screenings in human 
fibroblasts showed that several nuclear envelope trans-membrane proteins promote 
DNA localization to the nuclear periphery. In particular, individual proteins were 
shown to affect the nuclear localization of only certain chromosomes or to have an 
effect only on certain cell types (Zuleger et al., 2013).  
Nuclear lamina was shown as an important determinant to organize the 
positioning of heterochromatic regions (McCord et al., 2013). One histone mark 
found in heterochromatin is the H3K9me3, and interestingly, in mammalian cells 
H3K9me2 is enriched at the nuclear periphery. G9a, the methyl-transferase that 
catalyzes this modification, promotes DNA–nuclear-lamina interactions (Kind et al., 
2013). In addition to the G9a enzyme, the modifications H3K9me2/3 themselves 
were also shown in few contexts to be involved in the process (Bian, Khanna, 
Alvikas, & Belmont, 2013). Finally, other repressive chromatin marks, namely 
Polycomb and the histone H1 were proposed to be involved in nuclear-lamina DNA 
localization; however, their roles in the process remain to be clarified (Guelen et al., 
2008; Ikegami, Egelhofer, Strome, & Lieb, 2010; Izzo et al., 2013). 
Because of its role in the maintenance of nuclear architecture, nuclear-lamina 
seems to have some effects on gene expression. Consistent with the idea that 
heterochromatic parts of the genome are located at the nuclear periphery, most genes 
in contact with nuclear-lamina are very lowly expressed (Pickersgill et al., 2006). 
However, correlation between spatial position and expression level does not prove 
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causality. In one study, performed in human cells, with the aim of investigating this 
question, specific chromosomes were tethered to the nuclear periphery by binding to 
a nuclear envelope protein. It was observed that after this perturbation, there was a 
reversible silencing of some, but not all, of the genes involved. This silencing was 
shown to be dependent on the activity of histone deacetylases enzymes. Importantly, 
the observation that several genes did not show significant reductions in gene 
expression, suggests that transcription at the nuclear periphery is possible (Finlan et 
al., 2008). Similarly, more recent studies showed that the selective anchoring of 
active genes to the nuclear-lamina in some but not all the cases can reduce their 
expression level (Towbin, Gonzalez-Sandoval, & Gasser, 2013). The role of nuclear-
lamina in transcriptional regulation is also supported by the observation that during 
mESC differentiation, several genes move towards the nuclear-lamina and become 
silenced, others instead move away from it and gain expression (Peric-Hupkes et al., 
2010). Therefore, it is possible that the DNA interaction with the nuclear-lamina 
could be an important mechanism not only for the maintenance of the 
nuclear/chromosomal architecture, but also for gene silencing. 
It is still debated in the literature what makes the nuclear periphery such a 
repressive environment. One possibility could be that the enrichment of histone 
modifying enzymes like histone deacetylases and the methyl-transferase G9a are 
responsible for the gene silencing (Finlan et al., 2008; Milon et al., 2012). Another 
possibility could be that the higher DNA compaction observed at the periphery 
compared to the nuclear interior presents many obstacles for the TFs to bind their 
motifs (W. Akhtar et al., 2013; Nagano et al., 2013). 
2.1.2.3 Chromatin Conformation 
Next generation sequencing technologies have recently allowed the exploration of 
the genome architecture at a smaller scale than previously possible with the DNA–
FISH (used to map the chromosome territories). The DNA–FISH can also be used 
to determine spatial distances between probed DNA sequences, however the 
throughput is low. With chromosome-capture derived methods it is now possible to 
assess DNA interaction in a genome-wide manner (Barutcu et al., 2015). 
Within nuclear territories, chromosomes are organized into large compartments, 
typically of several Mbp. They are referred to as A and B compartments, 
representing active and inactive chromatin respectively (Lieberman-Aiden et al., 
2009; Simonis et al., 2006). Inside the nucleus, both A and B compartments tend to 
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cluster with other compartments of the same kind (reviewed in Dekker & Heard, 
2015). 
At a smaller scale, Hi-C data revealed that the genomes of eukaryotes are 
arranged in topologically-associated-domains (TAD) (J. R. Dixon et al., 2012). 
TADs are defined as chromosomal regions where DNA sequences have enriched 
contact frequency within the domain, compared to sequences located outside. In the 
mouse genome there are approximately 2200 TADs, with average size of 900Kbp. 
Their position in the chromosomes is relatively constant across different cell types 
and even across different, but related species (J. R. Dixon et al., 2012). In Drosophila 
TADs share most of the characteristics found in mammals except that they are 
smaller (~ 60Kbp), probably due to the higher gene density in this model (reviewed 
in Dekker & Heard, 2015). 
In mammals, TAD-boundaries⎯namely the regions separating adjacent 
TADs⎯are enriched for housekeeping genes, tRNA genes, SINE retrotransposons 
and CTCF motifs. They are instead depleted of tissue specific genes, H3K4me1 and 
H3K9me3 histone modifications (J. R. Dixon et al., 2012). 
It was shown that despite the fairly conserved organization of TADs across 
different cell-types, the specific long-range interactions within them can change 
considerably (Nora et al., 2012). In fact, due to their large size, in mouse, TADs 
contain multiple genes, on average 32 (the median is 19). One early study identified 
9888 dynamic interacting regions in the mouse genome, which in more than 96% of 
cases, occurred inside the same TAD. These regions were enriched for genes 
differentially expressed across different cell-types and contained 20% of all genes 
with expression changes of at least four fold. The authors proposed that the contacts 
inside TADs could be dynamic and engage tissue specific REs (J. R. Dixon et al., 
2012). Therefore it is possible that either TADs do not completely overlap with the 
concept of regulatory domains (RD(s)) (genomic regions within which a given set of 
regulatory elements exerts its activity), or that they contain several regulatory 
domains (Symmons et al., 2014). 
In mammals CTCF and Cohesin complex are thought to be important for 
chromosome architecture. Some early evidence of this comes from the H19-Igf2 
locus. Many of the long-range interactions in this locus depend on the presence of 
CTCF motifs at the H19 imprinting control region (ICR) (figure 2A) (Hark et al., 
2000; Ribeiro de Almeida et al., 2012; Zhao et al., 2006). Similar observations 
regarding the need for CTCF binding sites for maintaining the locus architecture 
were also made for the Hbb locus (figure 2B) (Splinter et al., 2006). Besides these 
locus-based cases, some studies investigated the role of CTCF and Cohesin complex 
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at genomic level using the Hi-C method (Seitan et al., 2013; Sofueva et al., 2013; 
Solovei et al., 2013). Despite these studies leading to slightly different conclusions 
(probably due to the different cellular models used), they agree that in both cases 
when Cohesin or CTCF are depleted, there is a general decrease in intra-TAD 
interactions. In the case of the Cohesin knockout, this relaxation had no effect at the 
level of TAD organization. Instead, for CTCF knockout, the decrement in intra-
TAD interactions was balanced by a slight increase of inter-TADs interactions 
(Zuin et al., 2013). This evidence indicates that although TADs are still present in 
protein knockout experiments, both CTCF and Cohesin complex could play a role 
in TADs definition and in the genome organization. CTCF and Cohesin complex 
probably contribute in different ways to these processes and may not be the only 
factors involved.  
Other data suggest that TFIIIC may also be important to further stabilize long-
range interactions and specify TAD-boundaries (Raab et al., 2012), (reviewed in 
Kirkland, Raab, & Kamakaka, 2013; Van Bortle & Corces, 2012).  
Finally, the Mediator complex was proposed to be important for the formation 
of DNA-loops connecting enhancers to promoters. Firstly, genome-wide data 
showed a highly significant correlation of the binding to the genome of the Mediator 
and NIPBL (Cohesin loading factor) (Kagey et al., 2010). Secondly, knockout 
experiments showed that the MED1 subunit of the Mediator complex is required to 
bring into close proximity the T3 response element to the Crabp1 gene promoter and 
induce its expression (Park et al., 2005). 
2.1.2.4 Chromosome Architecture Factors 
The two factors involved in genome organization discussed here are CTCF and the 
Cohesin complex. 
CTCF, also known as CCCTC-binding-factor is a zinc-finger protein, 
conserved in bilaterian animals (Heger, Marin, Bartkuhn, Schierenberg, & Wiehe, 
2012). It recognizes and binds DNA on the consensus sequence 
CCGCGNGGNGGCAG.  
Cohesin is a protein complex formed by the 4 subunits SMC1, SMC3, 
SCC3/SA and SCC1/RAD21. It is evolutionarily conserved in all eukaryotes. The 
primary function of Cohesin is to keep sister chromatids together during DNA 
replication, G2 and early M phases. More recently this complex was described as 
having a function in interphase, in particular in gene expression. Because of its 
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capability of linking different DNA molecules, observed in G2 and early M phases, 
it was hypothesized that Cohesin plays a role in gene expression by mediating DNA 
looping, important for promoter–regulatory element interactions (Rollins, Morcillo, 
& Dorsett, 1999; West, Gaszner, & Felsenfeld, 2002).  
Chromatin-immunoprecipitation, coupled with high throughput sequencing 
(ChIP-seq) methods, allowed the mapping of the genomic location of both CTCF 
and Cohesin binding sites. In mammalian cells, CTCF binds around 55000 sites, 
most of them conserved across cell types. About half of binding sites occur at 
intergenic regions, while about 15% occur nearby the promoters and about 40% in 
intragenic regions (H. Chen, Tian, Shu, Bo, & Wang, 2012).  
Cohesin binding in the genome is somewhat more variable, ChIP-seq for the 
SMC1 subunit revealed 46000 binding sites in mouse cortex tissue and 32000 in 
mouse pancreatic tissue (Cuadrado, Remeseiro, Graña, Pisano, & Losada, 2015). 
Similar to CTCF, about 12% of the SMC1 binding sites occur nearby annotated 
promoters, while about 45% are found in intragenic and intergenic regions. 
There is an extensive overlap between CTCF and Cohesin occupancy, about 
50–80% of the CTCF binding sites are also bound by Cohesin (Hou, Dale, & Dean, 
2010; Parelho et al., 2008a).  
Regarding the cell-type conservation of the CTCF binding sites, it is shown 
that 20–50% of the them have, at least to some extent, cell-type variability 
(Heintzman et al., 2009; T. H. Kim et al., 2007). It is not completely clear what 
determines CTCF (and perhaps Cohesin) binding at these sites. A first clue is that 
in the CTCF motif there is a CpG dinucleotide, suggesting that differential 
methylation determines which sites can be bound in different cell types. Indeed, one 
study showed that 41% of the tissue specific CTCF binding sites do correlate with 
differential methylation (Wang et al., 2012). The case of the methylation-sensitive 
binding of CTCF at the H19-Igf2 locus, which controls the epigenetic imprinting as 
well as the function of the ICR insulator, is one clear example of this mechanism 
(Guibert et al., 2012). On the other hand, the presence of many cell-type specific 
sites that are not differentially methylated indicates that other mechanisms—in 
addition to DNA methylation—must be involved in the process (Wang et al., 2012). 
One possibility is that the binding of CTCF to the DNA may be stabilized by other 
proteins/cofactors. Few proteins were proven at specific loci to be necessary for 
CTCF function. Amongst these there are NUCLEOPHOSMIN, PARP1, YY1 
and Cohesin (Zlatanova & Caiafa, 2009). However, only Cohesin so far has been 
shown to be important for CTCF activity on a genomic scale (Parelho et al., 2008b; 
Rubio et al., 2008; Wendt et al., 2008; Xiao, Wallace, & Felsenfeld, 2011). 
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In mammals as well as Drosophila, architectural factors binding sites are slightly 
enriched at TAD-boundaries (J. R. Dixon et al., 2012; Van Bortle et al., 2014). 
Genome-wide studies suggest their involvement in maintaining the topological 
organization of the chromosomes and in delineating TADs (Seitan et al., 2013; 
Sofueva et al., 2013; Solovei et al., 2013). In mouse, TADs cover about 90% of the 
genome (excluding centromeres and telomeres) and contain 85% of CTCF binding 
sites. TAD-boundaries instead cover about 10% of the genome (excluding 
centromeres and telomeres) and contain 15% of the CTCF binding sites. 
Importantly, despite a slight increase of CTCF occupancy at TAD-boundaries, the 
majority of CTCF sites still occur intra-TAD (J. R. Dixon et al., 2012). This simple 
evidence, valid also for Cohesin, suggests that architectural factors may be involved 
in other functions (not necessarily architectural) other than TAD specification.  
Among these functions, it is proposed that Cohesin and CTCF could be 
important to mediate promoter–REs long-range interactions on a sub-TAD scale. 
To go deeper into this question, the Hi-C technique, performed with standard 
sequencing depth, does not have the resolution to map intra-TAD topologies. The 
5C method instead, is usually implemented over genomic regions of around 1Mbp 
and can overcome this limitation. In mESC the use of this technique, revealed that 
intra-TADs interactions occur between sites bound by CTCF and/or Cohesin. 
Knockdown of SMC1 and MED12 (subunit of the Mediator complex) had 
consequences at the level of chromosome architecture, and also resulted in the 
downregulation of genes engaging long-range interactions mediated by the Cohesin 
(Phillips-Cremins et al., 2013). 
2.1.3 Chromatin Component of Transcriptional Regulation 
Chromatin has a wide influence on transcription. Firstly, it affects DNA 
accessibility, an important feature for TFs binding. Secondly, through many 
different chemical modifications (mostly on histones and DNA), it labels specific 
sites for recruiting enzymes and proteins (reviewed in V. W. Zhou, Goren, & 
Bernstein, 2011) (figure 3). Lastly, it contributes to maintaining cell identity and the 
transcriptional program across cell divisions. This form of phenotypic inheritance is 
known as “epigenetic” and occurs by passing modified histones to the daughter cells 
in mitosis (Campos, Stafford, & Reinberg, 2014). In this project, only the role of 
chromatin in gene expression and not in epigenetics is considered. 
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Figure 3 | Histone modifications and their context. Adapted from (V. W. Zhou et al., 
2011). 
The binding of TFs to their motifs is typically affected by their accessibility on 
the DNA, which depends on the presence of the nucleosome at these sites as well as 
on higher order of compaction. Except for “pioneer transcription factors”, a class of 
TFs that can bind nucleosomal DNA, most often histones and TFs, compete with 
each other to bind the DNA (reviewed in (Iwafuchi-Doi & Zaret, 2014). DNA 
accessibility is controlled by different mechanisms. These include the nucleosome 
repositioning, done by the remodeling complexes; the replacement of histone 
subunit with histone variants, giving the nucleosome different affinity for the DNA 
and different binding turnover; and the post-translational modifications of the 
histone tails.  
Histones interact with the DNA to a large extent via hydrophobic interactions 
and ionic bonds. Modification of the histones by lysine acetylation removes the 
positive charge on that residue, thereby decreasing the interaction with the negative 
charge of the DNA. This, results in a looser interaction of the histone with the 
DNA. As a consequence, the DNA is more accessible and the remodeling complexes 
can move the whole nucleosome more freely. Acetylated histones are commonly 
found on active gene promoters and gene bodies as well as on active enhancers. 
Proteins that have a bromodomain recognize the acetylated lysines. In higher 
eukaryotes there are 5 bromodomain-extraterminal (BET) proteins: Brd2, Brd3, 
	   26 
Brd4, and Brdt, some of them, subunits of remodeling complexes such as 
SWI/SNF-like and the general transcription factor TFIID (Krogan et al., 2003; 
Matangkasombut, Buratowski, Swilling, & Buratowski, 2000).  
One way of reducing DNA accessibility is via condensation. One important 
factor mediating chromatin compaction is the protein HP1, which binds the 
H3K9me3 histone modification (enriched in heterochromatin), and was shown in 
vivo to mediate large-scale chromatin condensation (Cowell et al., 2002; Mosch, 
Franz, Soeroes, Singh, & Fischle, 2011; Verschure et al., 2005). The histone H1 was 
also shown to mediate chromatin compaction. Unlike the other histones, it binds the 
linker DNA between the nucleosomes and promotes condensation. Rather than a 
general transcriptional repressor, the histone H1 seems to be mainly involved in 
repression of transposable elements and specific sets of genes (Vujatovic et al., 2012). 
In Drosophila H1 seems to be involved in repression of ~ 50% of transposable 
elements and ~ 10% of the protein coding genes (Lu et al., 2013). In mammals, the 
study of the histone H1 is complicated by that presence of five different H1 isoforms 
that can complement each other’s function when single knockout experiments are 
performed (Drabent, Saftig, Bode, & Doenecke, 2000; Sirotkin et al., 1995).  
Despite the large number of chromatin proteins and histone modifications 
described in the literature, an important study in the chromatin field revealed that 
from a functional perspective, there are just few major types of chromatin (Filion et 
al., 2010). 
 In this study, the group of Bas Van Steensel mapped the location of more than 
fifty chromatin proteins in Drosophila cells. Principal component analysis of the 
coverage profiles revealed that altogether; the genome can be divided into five major 
chromatin categories. Using multivariate segmentation algorithms they then 
segmented the genome into five states, characterized by similar protein composition. 
Almost concomitantly other studies reported similar observations in mammals. 
Although the authors did not describe the chromatin types in particular, they found 
similar correlations of DNA binding proteins and histone modifications with the 
different transcriptional activities of the chromatin (Ernst et al., 2011).  
The five main chromatin types found in Drosophila by Filion and colleagues are 
briefly summarized in the next sections.  
2.1.3.1 Transcriptionally Active Chromatin 
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There are two distinct kinds of active chromatin: one is found on genes with tissue 
specific expression, the other, on genes with broad expression across different tissues. 
Both types are characterized by the active histone marks H3K4me3 and H3K27ac at 
the promoter, however, while in the case of broadly active genes these modifications 
span the whole promoter, the tissue-specific genes present them only downstream of 
the TSS (Deaton & Bird, 2011; Ernst & Kellis, 2010).  
The H3K4me3 histone modification is catalyzed by the SET domain present in 
the Trithorax group proteins (TrxG) in Drosophila, and in the myeloid/lymphoid or 
mixed-lineage leukemia (MLL) (ortholog of Trithorax) in mammals (Katsani, 
Arredondo, Kal, & Verrijzer, 2001; Yu, Hanson, Hess, Horning, & Korsmeyer, 
1998). H3K27ac is catalyzed by p300 (Tie et al., 2009). 
The comparison of the transcript levels in broadly active and tissue-specific 
genes shows that there is almost no difference between the two categories. However, 
the chromatin associated with broadly expressed genes is the only chromatin type in 
Drosophila to have the H3K36me3 modification, previously considered a universal 
marker of transcriptional elongation (Rando & Chang, 2009; Sims & Reinberg, 
2009). Consistently, in mammals, H3K36me3 is also enriched at CpG rich 
promoters (M. M. Akhtar, Scala, Cocozza, Miele, & Monticelli, 2013). 
2.1.3.2 Enhancer Associated Chromatin 
The chromatin found at active enhancer sites is an active type of chromatin. Filion 
and colleagues included it in the two types of active chromatin and did not attribute 
it to an independent class (Filion et al., 2010). It shares many common features with 
the chromatin found at active genes, but it also has a few differences.  
Similarly to all the active chromatin types, enhancer-associated chromatin is 
characterized by high DNA accessibility and low nucleosome density, which is an 
important feature for the binding of TFs (Boyle et al., 2008), (reviewed in (Zaret & 
Carroll, 2011).  
On the other hand, while active genes have H3K4me3 and H3K27ac histone 
modifications at the promoter, enhancers do not have the H3K4me3. Instead, they 
often have the H3K4me1 histone mark, and, acquire the H3K27ac only if they are 
active.  
Active enhancers are enriched for the remodeling complex SWI/SNF, for the 
Mediator complex and for the coactivators Brd4 and p300 (Euskirchen et al., 2011; 
Lovén et al., 2013).  
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Inactive enhancers instead can carry the H3K27me3 modification, indicating 
Polycomb repression (Simon & Kingston, 2009). 
One feature of the enhancers-associated chromatin, recently brought to light 
thanks to the improvements of the methods aimed to find unstable transcripts, is 
that there is transcription ongoing at enhancer sites. It is not known with precision 
how common this phenomenon is, nonetheless, in the human genome there are 
thousands of transcribed enhancers (Andersson et al., 2014). The RNA molecules 
thereby produced (eRNA) are short, unspliced RNAs, with small half-lives, 
degraded shortly after they are generated (probably by the exosome complex) and 
therefore invisible using the standard transcriptomics methods (Core et al., 2014a). 
Despite the lack of knowledge regarding its biological function, there is evidence 
suggesting that enhancer transcription may not be just a result of leaking RNA Pol 
II transcription on accessible DNA. Rather, enhancer transcription shares many 
common points with gene transcription, including the presence of core promoters 
motifs and highly positioned nucleosomes flanking the TSS, indicating that 
enhancer transcription may be a defined and regulated process (Core et al., 2014a). 
2.1.3.3 Repressive Chromatin 
In the Drosophila genome, three different kinds of repressive chromatin have been 
described, altogether accounting for almost 3/4 of the entire genome and containing 
almost half of the genes. Genes embedded in repressive chromatin are either not 
expressed or expressed at very low levels.  
One kind of chromatin found in all eukaryotes is the classical heterochromatin, 
positive for the histone modification H3K9me3 and condensed by the protein HP1. 
H3K9me3 modification is catalyzed in multiple steps: first the lysine 9 of the histone 
H3 is mono and di-methylated by the histone-lysine N-methyltransferase G9a, then 
SETDB1 and SUV39H1/H2 catalyze the last methylation (J.-K. Lee & Kim, 2013; 
Schuhmacher, Kudithipudi, Kusevic, Weirich, & Jeltsch, 2015; Shinkai & 
Tachibana, 2011; Vaquero et al., 2007). 
The second kind of repressive chromatin is the Polycomb associated chromatin, 
also present in all eukaryotes. Polycomb group proteins are essential for cell 
differentiation and development (Martinez & Cavalli, 2006; Pasini, Bracken, 
Hansen, Capillo, & Helin, 2007). They are found in two independent complexes 
that have slightly different mechanisms of repression, and catalyze two different 
histone modifications: H3K27me3, and the ubiquitylation of the histone H2A, 
	   29 
H2AK119ub. H3K27me3 modification completely covers promoters and transcribed 
regions of repressed developmental genes (Kalb et al., 2014). This modification 
cannot coexist, in the same residue, with the active histone mark H3K27ac (found at 
the promoter of every transcribed gene). Therefore it is thought that H3K27me3 has 
a repressive effect on transcription by counteracting the deposition of the acetylation 
mark (reviewed in (Schwartz & Pirrotta, 2013). H2AK119ub instead, mediates 
transcriptional repression by interfering with the transcriptional elongation (W. 
Zhou et al., 2008). The chromatin condensation occurs independently of both 
histone modifications and it is likely to be mediated by Polycomb proteins 
themselves (Eskeland et al., 2010). 
The last repressive chromatin type is different from those previously described, 
as it does not contain the heterochromatin markers HP1 and H3K9me3, nor 
Polycomb group proteins and associated modifications. Instead it is enriched for the 
histone H1. Because of the technical challenge to perform histone H1 ChIP-seq in 
mammalian tissues (the few H1-ChIP-seq datasets available were obtained using 
tagged versions of the histone H1, (J.-Y. Li, Patterson, Mikkola, Lowry, & 
Kurdistani, 2012)), this chromatin type has been described mainly in Drosophila. In 
this organism it is the most abundant chromatin type and covers 48% of the genome. 
It seems, like in the case of the other repressive chromatin types, that it actively 
represses transcription and, contains silent genes that are active in only few tissues. 
2.1.4 Genomic Imprinting 
2.1.4.1 Imprinting Functions 
Imprinting is defined as the epigenetic mechanism that causes the mono-allelic 
expression of a gene, dependent on the parental origin of the allele.  
It was first discovered thirty years ago by the observation that in pronuclear 
transplantation experiments, both male and female genomes were necessary for 
correct embryonic development (McGrath & Solter, 1984).  
Imprinting is found only in flowering plants and mammals and has 
independently evolved in these two taxa (Köhler, Wolff, & Spillane, 2012). In 
mammals it probably evolved together with the placenta (125 million years ago).  
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In mouse, 150 genes are imprinted and about half this number in human. 
However, the imprinted genes are not necessarily conserved between these two 
organisms (Prickett & Oakey, 2012). 
More than 80% of the imprinted genes are found in gene clusters, in mouse 
there are 13 of them spread on 8 chromosomes (a complete list can be found at 
www.mousebook.org). Imprinted genes show clear enrichment with specific gene 
ontology categories including metabolism, thermoregulation and embryonic growth 
(Cannon & Nedergaard, 2004; Charalambous, da Rocha, & Ferguson-Smith, 2007; 
M. Chen et al., 2005, 2012; Constância et al., 2002; Guillemot et al., 1995; Kelly et 
al., 2009).  
Its effects are seen predominantly on embryo-nourishing tissues such as 
placenta, adipose tissue and brain (M. Chen et al., 2005; Constância et al., 2002). In 
the latter case, it affects behaviors associated with feeding, for example, the neonatal 
milk suckling (Ball et al., 2013; Plagge et al., 2004). In 72% of the cases, imprinted 
genes are imprinted in multiple tissues, whereas in the remaining 28%, they are 
imprinted in a single tissue (Schulz et al.). In more than half of the cases, tissue-
specific imprinted genes show mono-allelic expression in extra-embryonic structures, 
such as placenta (48%) and yolk sac (9%). In most of the remaining cases, tissue-
specific imprinted genes are imprinted in the whole brain or in specific parts of the 
brain (Schulz et al., 2008). 
The reasons why imprinting evolved are not known. Two hypothetical models 
coexist in the literature, the kinship model and the coadaptation model. 
The kinship model proposes that maternal and paternal genes have different 
“interests” in the use of nutrients while the fetus is dependent on the mother. For the 
paternal genes in order to spread, it is convenient to maximize the intake of nutrient 
by the embryo from the uterus, even though this could be detrimental for the 
mother. Maternal genes instead, benefit from the opposite situation, where the little 
uptake from the fetus guarantees more pregnancies for the mother. According to this 
theory, often, imprinted genes that promote or inhibit growth are expressed from the 
paternal or maternal allele respectively (Isles, Davies, & Wilkinson, 2006).  
The coadaptation model instead, is based on the fact that the fetus develops 
inside the mother and the two of them have a continuous communication/exchange. 
The model proposes that some genes (most of the imprinted genes are involved in 
growth) in the fetus are expressed from the maternal allele because they just fit better 
with the maternal environment (Wilkins, 2014). For example the pregnancy and 
delivery of a larger fetus may be difficult for a smaller mother. 
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2.1.4.2 Mechanisms of Imprinting 
Imprinting is established on the male and female germline via CpG DNA 
methylation on the imprinting control region (ICR) of a gene cluster (Lees-
Murdock & Walsh). These regions are referred to as germline differentially 
methylated regions (gDMRs). Some other allele specific methylation differences are 
acquired after oocyte fertilization, during early embryonic development. These 
regions are termed acquired differentially methylated regions (aDMRs) (S.-P. Lin et 
al., 2003; Peters et al., 1999; Redrup et al., 2009; Thorvaldsen, Duran, & 
Bartolomei, 1998).  
During embryonic development, harsh genomic reprograming events are 
necessary to acquire totipotent traits, among these, the complete DNA 
demethylation of the paternal pronucleus (Iqbal, Jin, Pfeifer, & Szabó, 2011). It is a 
big question in the field what epigenetic signals allow the methylation of the ICRs to 
remain stable throughout development and adulthood despite these reprograming 
events. 
The parent specific DNA methylation at the ICRs is responsible for the local 
establishment of a specific chromatin environment. This is characterized by the 
deposition of repressive histone modifications, among which are H3K9me3 and 
H4K20me3 (Henckel et al., 2009). Consistently, other studies showed that the 
methyl transferase activity of the G9a enzyme (responsible for the mono and di-
methylation of the H3K9) is necessary for the imprinting maintenance on the 
trophoblast (Wagschal et al., 2008). 
Maternal and paternal imprinted gene clusters show important differences. 
Maternal imprinting is seen on ICRs that contain the promoter of a long non-
coding RNA (lncRNA) spanning a protein-coding gene of the cluster, but 
transcribed in antisense direction. As their transcription is mutually exclusive, in the 
paternal chromosome, the lncRNA transcription blocks the transcription of the 
protein-coding genes of the cluster. On the other hand, in the maternal chromosome 
the lncRNA expression is silenced by DNA methylation, allowing the transcription 
of the protein-coding genes of the cluster. This mechanism is supported by the study 
of a few cases, including the Kcnq1 and Ube3a clusters (figure 4A) (Mancini-
Dinardo, Steele, Levorse, Ingram, & Tilghman, 2006; Sleutels, Zwart, & Barlow, 
2002).  
Paternal imprinting also involves lncRNA transcription, however, it tends to 
occur at intergenic regions, probably on insulator elements, without spanning 
protein-coding genes. The Igf2-H19 locus is one example of parental imprinting 
(figure 4B). In this locus, in the maternal chromosome, the binding of CTCF to the 
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ICR prevents an enhancer acting on the promoter of Igf2, which leads to the 
silencing of Igf2. From the ICR there is the transcription of the lncRNA H19, 
which is dispensable, for maintaining the insulating effect of the ICR. In the 
paternal chromosome the methylation of the ICR does not allow CTCF to bind, 
and as a result, the enhancer is able to activate Igf2 transcription (Bell & Felsenfeld, 
2000)(Hark et al., 2000). 
 
Figure 4 | Mechanisms of paternal and maternal imprinting. Adapted from (Plasschaert 
& Bartolomei, 2014). A) Maternal imprinting. At the Kcnq1 locus in the paternal allele the 
antisense transcription of the lncRNA Kcnq1ot1 blocks the transcription of Kcnq1. In the 
maternal allele, the methylation of Kcnq1ot1 promoter keeps Kcnq1ot1 silenced. Kcnq1 and 
other genes of the cluster acquire expression. B) Paternal imprinting. At the Igf2/H19 locus, 
in the maternal allele an enhancer (located downstream H19 transcribed region) activate the 
expression of the non-coding gene H19. The binding of CTCF to the ICR (lying between Igf2 
and H19) confers insulating properties to the ICR. As a consequence, the enhancer is not 
able to activate the expression of Igf2. In the paternal allele, the methylation of the ICR 
prevents the binding of CTCF, and causes the ICR to lose its function as insulator. Because 
of this, the enhancer can activate Igf2. 
	   33 
2.2 c-Myc locus 
2.2.1 MYC Roles as Transcription Factor 
c-Myc gene was discovered more than thirty years ago, from chromosomal 
translocations in Burkitt’s lymphoma cells. The analysis of the translocation 
breakpoint revealed a coding sequence similar to the myelocytomatosis viral 
oncogene v-Myc, and for this reason it was named c-Myc (Bishop, 1982; Sheiness, 
Fanshier, & Bishop, 1978). 
MYC is a basic helix-loop-helix transcription factor, evolutionarily conserved in 
all vertebrates with a considerable amount of sequence similarity (Atchley & Fitch, 
1995). It binds to thousands of promoters in mammalian cells as MYC-MAX 
heterodimer (Blackwood & Eisenman, 1991; C. Y. Lin et al., 2012). In particular it 
binds the motif CACGTG of the enhancer box (E-box) in the core promoter of 
active genes. Depending on the target gene, MYC can act as transcriptional activator 
or repressor, and, can affect transcription at both initiation and elongation steps 
(Rahl et al., 2010).  
MYC mediates the transcriptional response of growth-factors stimulation. 
Importantly, MYC does not only regulate the expression of mRNA(s), it also 
regulates ribosomal and tRNA genes, transcribed by the RNA Pol I and RNA Pol 
III respectively (Campbell & White, 2014; Dai, Sun, & Lu, 2010; Mitchell et al., 
2015). Amongst the major gene ontology categories of protein-coding genes under 
the control of MYC there are: ribosome biogenesis, apoptosis, cell adhesion, cell 
size, angiogenesis and metabolic pathways (Nieminen, Partanen, & Klefstrom, 2007; 
Peterson & Ayer, 2011; A. M. Singh & Dalton, 2009; Uslu et al., 2014; van 
Riggelen, Yetil, & Felsher, 2010).  
Because of its influence on all these processes, MYC was shown early on to have 
a role in both development and cancer. 
2.2.1.1 MYC Roles in Embryonic Development 
c-Myc is essential for proper mouse development. Homozygotes null mutations cause 
lethality between 9.5 and 10.5 days of gestation, most likely due to early 
hematopoietic defects (Davis, Wims, Spotts, Hann, & Bradley, 1993). c-Myc null 
embryos have developmental delays compared to the littermates and are considerably 
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smaller in size. In addition, they also have a few phenotypes at the moment of death, 
including heart and neural tube abnormalities (Davis et al., 1993).  
Heterozygote c-Myc animals are viable, but are smaller and have smaller organs 
than their littermates after birth. In particular, muscle, connective tissue, skin, bones, 
white fat and lymphoid organs are the most affected by the lower c-Myc levels. 
Fibroblast cultures showed that c-Myc heterozygotes cells have increased doubling 
time compared to Wt cells under the same conditions, but have the same size and 
cell cycle distribution, indicating that the reduction in body and organ weight in c-
Myc heterozygote animals is due to reduced cell proliferation (Trumpp et al., 2001).  
In Drosophila decreased c-Myc expression also lead to decreased body and organ 
weight. However, in contrast to mouse, this phenotype is due to reduction in cell 
size, more than cell number (Johnston, Prober, Edgar, Eisenman, & Gallant, 1999). 
It is possible that despite the fact that in both organisms c-Myc is involved in tissue 
and organism growth, there may be substantial differences in the extent Drosophila 
and mouse couple cell growth to cell proliferation (Trumpp et al., 2001). 
2.2.1.2 MYC Roles in Cancer 
The majority of the data in the literature regarding MYC, refers to the important 
role this protein has in cancer rather than in physiological conditions like 
development.  
In contrast to other proto-oncogenes like RAS and BCR, MYC does not need 
to be mutated to promote tumor formation (although some cancers, like Burkitt’s 
lymphoma do have mutated MYC forms) (Land, Parada, & Weinberg; Langdon, 
Harris, Cory, & Adams, 1986). Its only overexpression is a common feature in many 
MYC-driven cancers. About half of the human tumors show MYC overexpression, 
commonly, reaching more than two orders of magnitude compared to the 
physiological level (C. Y. Lin et al., 2012b; Rauen, 2013). Non-transformed cells 
typically enter apoptosis if MYC expression is forced to such levels (Askew, 
Ashmun, Simmons, & Cleveland, 1991). 
The ways in which cancers benefit from such high levels of MYC are numerous, 
the most important probably being the enhanced cell growth and protein synthesis as 
well as the influence on the tumor environment by increasing the production and 
secretion of angiogenic factors (Baudino et al., 2002; Rosenwald, 1996). 
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2.2.2 c-Myc Transcriptional Regulation 
Cell growth and proliferation are proportional to the amount of c-Myc transcripts. In 
vitro, quiescent cells have 10–40 fold less c-Myc mRNA than cycling ones (Facchini 
& Penn, 1998; Souleimani & Asselin, 1993). Removal of growth factors in vitro, 
brings c-Myc transcript to a basal level and has consequences at the level of growth 
and proliferation (Grandori, Cowley, James, & Eisenman, 2000; Henriksson & 
Lüscher, 1996; Lemaitre, Buckle, & Méchali, 1996). 
During embryonic development, higher levels of MYC compared to terminally 
differentiated tissues, sustain the embryo growth and counteract cellular 
differentiation. Several signaling pathways at later stages are involved in the 
downregulation of c-Myc, the most important being TGF-β, WNT and BMP, 
(reviewed in J Liu & Levens, 2006). Amongst the main classes of TFs acting 
downstream of the signals there are LEF-TCF and SMAD(s) (Wierstra & Alves, 
2008). 
In adult tissues, mitogens, growth factors and antiproliferative signals like 
retinoic acid, vitamin-D, estrogen, PDGF, EGF, interferons and interleukins keep 
c-Myc expression under tight control. These pathways relay the signal to several TFs, 
including the estrogen receptor (ER), Stat(s), NFκB, Sp1–3, E2F(s), Rfx(s), 
AP1/FOS-JUN (reviewed in J Liu & Levens, 2006; Wierstra & Alves, 2008). 
2.2.2.1 c-Myc Promoters 
c-Myc is a housekeeping gene, and as commonly seen for this category of genes (and 
developmentally regulated ones), it has a high CpG content promoter, in this 
specific case forming a large CpG island (~ 3Kbp, containing 221 CpG di-
nucleotides). 
c-Myc transcription can start from two independent promoters 160bp apart from 
each other, P1 and P2 (with P2 being downstream of P1). Most transcripts initiate 
at P2 (Albert et al., 2001; Moberg, Logan, Tyndall, & Hall, 1992).  
In addition to the signals conveyed by the discussed pathways, c-Myc 
transcription is also controlled by a large proximal-promoter. Ongoing transcription 
leads to accumulation of negative supercoiling, necessary for DNA unwinding. The 
2Kbp upstream P1 contain elements capable of sensing this supercoiling and 
detecting the overall transcription rate. A series of non B-DNA sequences, including 
Z-DNA and G-triplex/quadruplex affect the local properties of the DNA polymer 
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and tunes c-Myc transcription by reacting to DNA coiling changes (Brooks & 
Hurley, 2009). 
There are three sites in a Z-DNA shape nearby c-Myc TSSs, two of them are 
positioned upstream of P1 and one occurs on the junction between the first intron 
and the second exon. Z-DNA is a left-handed double helix formed by alternated 
purine–pyrimidine nucleotides, stiffer than B-DNA. The conversion of one turn of 
B-DNA into one turn of Z-DNA, possible at the Z-B-DNA junction, absorbs two 
negative supercoils and therefore could be a way to counteract the spreading of 
coiling stresses due to transcription (Wittig, Wölfl, Dorbic, Vahrson, & Rich, 1992). 
Another highly evolutionarily conserved element, also located nearby the P1 
core promoter, is the NHE element. It is placed 142–115 bp upstream of P1 and 
contains four imperfect repeats of the motif CCCTCCCCA. This sequence was 
shown in vitro to form G-triplex and quadruplex on the purine (G) rich strand and 
I-motif on the pyrimidine (C) rich strand (Mathad, Hatzakis, Dai, & Yang, 2011). 
The I-motif similarly to the G-quadruplex, is a four-stranded intra-molecular DNA 
secondary structure. DNaseI hypersensitivity assays showed that the NHE is a 
particularly accessible DNA, suggesting that it is usually in a nucleosome-free state 
(González & Hurley, 2010). Regarding its functions, there are a few hypotheses 
proposed so far. One, related to the function of the Z-DNA, is that G-quadruplex 
may counteract the propagation of supercoiling to the upstream promoter elements 
(like for the FUSE element) (Brutzer, Luzzietti, Klaue, & Seidel, 2010; Wada & 
Netz, 2009). Another possibility, probably the most important, is that NHE may 
affect c-Myc transcription through the several proteins and complexes it binds. A few 
examples are given by the hnRNP A1, A2, B and K and NUCLEOLIN (Brooks & 
Hurley, 2009; González, Guo, Hurley, & Sun, 2009; González & Hurley, 2010).  
The Far Upstream Sequence Element (FUSE) element, located 1.7 Kbp 
upstream of the P1 promoter, was also shown to be involved in c-Myc regulation. 
Because of its AT rich sequence composition (characterized by a low melting 
temperature), it can open in the presence of negative supercoils accumulated during 
transcription. In the presence of basal transcription, it partially opens and binds the 
FUSE Binding Protein (FBP). FBP recruits the general transcription factor TFIIH, 
involved in transcription initiation and promoter escape, thereby increasing c-Myc 
transcription (Juhong Liu et al., 2001, 2006). This leads to further accumulation of 
negative supercoils and further opening of the FUSE element. At this stage, the 
FUSE Interacting Repressor (FIR) is recruited by FBP, and binds the ssDNA of the 
FUSE through a RNA Recognition Motif. FIR also interacts with the TFIIH and 
somehow reduces c-Myc transcription, with a consequent reduction of negative 
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supercoiling. As a result, the FUSE ssDNA re-annealing ejects both FIR and FBP, 
restoring c-Myc basal transcription (Cukier et al., 2010). 
In conclusion, c-Myc proximal promoter, which is not sufficient to drive c-Myc 
expression in transgenic assays, is equipped with DNA sequences that can undergo 
structural changes (Lavenu, Pournin, Babinet, & Morello, 1994). These sequences 
seem to be important for c-Myc auto-regulation, ensuring that its expression levels do 
not exceed the physiological thresholds. This system may be particularly important 
in case growth-factor responding REs (located outside c-Myc proximal promoter) 
over-stimulate c-Myc transcription (Lavenu et al., 1994). 
2.2.2.2 Long-Range Regulation of c-Myc 
2.2.2.2.1 Genome Wide Association Studies 
c-Myc gene lies in a gene-poor (or gene-desert) region of ~ 3Mbp, in the 
chromosome 8 in humans and in the chromosome 15 in mouse. In mouse c-Myc 
locus extends from the gene Trib1 at the centromeric side, to the end of the Gsdmc 
gene-cluster at the telomeric side. In the whole gene-desert there are few annotated 
transcripts, c-Myc, Fam84b, A1bg and Pvt1. Fam84b and A1bg may be protein-
coding genes, while Pvt1 is a non-coding gene (Hsu et al., 2015). In addition to the 
annotated coding and non-coding genes, c-Myc locus has several evolutionarily 
conserved regions, scattered throughout the gene-desert. Their synteny is preserved 
in mammals as well as in chicken and zebrafish, in a few instances (figure 5). It is 
remarkable that despite the fact that some organisms are hundreds of millions of 
years apart on the phylogenetic tree, they have preserved the relative disposition of 
transcribed regions and conserved elements. 
Genome wide association studies (GWAS) showed that throughout c-Myc locus 
in human, there are several linkage disequilibrium blocks of single nucleotide 
polymorphisms (SNP), with high susceptibility for genetic disorders, and different 
types of cancer (Amundadottir et al., 2006; Easton et al., 2007; Ghoussaini et al., 
2008; Gudmundsson et al., 2007; Haiman et al., 2007; Kiemeney et al., 2008; 
Sebastiani, Timofeev, Dworkis, Perls, & Steinberg, 2009; Tomlinson et al., 2008; 
Zanke et al., 2007).  
From the same GWAS, it was reported that in about 40% of cases there was no 
overlap between transcribed regions and linkage disequilibrium blocks, indicating 
that non-coding polymorphisms may account for a considerable portion of genetic 
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diseases. One possible explanation could be that the observed polymorphisms 
occurred in regulatory elements, thereby affecting functional long-range regulation 
(reviewed in Visel, Rubin, & Pennacchio, 2009). According to this view, some of the 
linkage disequilibrium blocks in c-Myc locus, found hundreds of Kbp away from c-
Myc promoter, could contain regulatory elements whose activity may differ between 
individuals due to polymorphisms (Wasserman, Aneas, & Nobrega, 2010). 
GWAS studies in human showed that in the telomeric side of c-Myc locus, the 
8q24.21 region delineates a linkage disequilibrium block of SNPs associated with the 
genetic disease cleft lip/cleft palate (CLP) (figure 6) (Amundadottir et al., 2006; 
Easton et al., 2007; Ghoussaini et al., 2008; Gudmundsson et al., 2007; Haiman et 
al., 2007; Kiemeney et al., 2008; Sebastiani et al., 2009; Tomlinson et al., 2008; 
Zanke et al., 2007). CLP is one of the most common genetic diseases in humans, 
observed in one out of seven hundred people. It is a multifactorial disorder, with 
many loci involved, including Irf6, Vax1 and many others, in addition to 8q24.21. 
8q24.21 however, was shown in one study to be the major susceptibility locus for 
CLP, with attributable risk of 0.41. It corresponds to a region of 640Kbp 
(chr8:129,700,000-130,340,000, NCBI36/hg18 assembly) containing multiple SNPs 
statistically associated with the disease, among which is ”rs987525” (the one with the 
lowest p-value) (Birnbaum et al., 2009). This 640Kbp window has a corresponding 
ortholog in mouse, located on the telomeric side of c-Myc locus (chr15:62610410-
63188813, NCBI37/mm9 assembly). 
In another study, putative enhancers important during face morphogenesis were 
identified by p300 ChIP-seq on E11.5 mouse facial mesenchyme. Four enriched 
regions were included in the mouse ortholog of the 8q24.21 CLP susceptibility 
region, about 1.1Mbp telomeric to c-Myc. Two of these sequences (hs1877 and 
 
Figure 5 | c-Myc locus evolutionary conservation. Data available at: http://genome-
euro.ucsc.edu/cgi-bin/hgTracks. The middle panel shows the degree of conservation in 
mammals. The lower panel shows the alignment of homolog sequences in other species. 
The figure indicates the presence of several homolog coding and non-coding sequences, 
conserved from mouse to zebrafish, and scattered throughout the locus. 
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mm458) were tested for enhancer activity by reporter assays and were shown to drive 
reporter expression in the facial mesenchyme and maxillary process respectively 
(Attanasio et al., 2014). 
GWAS in human also showed that a region 440Kbp upstream of c-Myc 
contains five blocks of linkage disequilibrium associated with prostate cancer. In one 
study the whole region was analyzed for carrying prostate-specific regulatory 
elements (Wasserman, Aneas, & Nobrega, 2010). The authors tagged three 
overlapping human BAC clones with a LacZ reporter under the control of the core 
promoter of the β-globin gene. They injected the construct in fertilized mouse 
oocytes and evaluated the LacZ staining at different stages after birth. Two clones 
showed reporter expression in the prostate. They further restricted the region driving 
reporter expression to a 5Kbp sequence carrying the key polymorphism rs6983267-
G. The staining pattern observed in the prostate was similar to the one of the 
endogenous c-Myc, as seen by RNA in situ hybridization. The sequence containing 
this susceptibility allele for prostate cancer, occurring about 400Kbp upstream of c-
Myc promoter was proposed to be a prostate enhancer, perhaps acting on c-Myc in a 
long-range manner (Wasserman et al., 2010b). 
2.2.2.2.2 Cancer Studies 
A few data, obtained from cancer cell-lines suggest that not only long-range 
interactions are important for the endogenous promoter–enhancers communication, 
but also that if altered, for example by viral integration into the genome or by 
 
Figure 6 | Human genetic variation in c-Myc locus. Adapted from (Wasserman et al., 
2010b). The picture shows a portion of the c-Myc locus (genomics coordinates: 
chr8:126800000-131000000, hg19 assembly). Each point in the heatmap represents the 
degree of linkage disequilibrium between two given SNPs. The colored rectangles 
emphasize the association of linkage-disequilibrium blocks with different pathologies. 
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chromosomal rearrangements (often seen in cancer), they can lead to ectopic gene 
expression. 
One early example showing long-range regulatory behavior in c-Myc locus comes 
from the study of several T-cells lymphomas. A screening of rat thymic lymphoma 
obtained by infection of T-cells with the retrovirus Moloney murine leukemia virus 
(MoMuLV), produced several cell lines with the characteristics of T-cell lymphomas 
(Lazo, Klein-Szanto, & Tsichlis, 1990). The mapping of the integration site of 
MoMuLV in several leukemia lines thereby obtained, revealed that the majority of 
the integrations occurred in c-Myc locus at various distances from c-Myc promoter, 
the furthest located 270Kbp away (Clark, 1997; Lazo, Lee, & Tsichlis, 1990; 
Palumbo et al., 1990). These insertions were shown to increase c-Myc expression by 
long-range effect, thereby causing T-cell leukemias. 
Human papillomaviruses (HPV16 and HPV18) are the major cause of cervical 
cancers seen worldwide (World Health Organization data). Even though the 
involvement of HPV in interfering with the endogenous gene expression has never 
been described, in the HeLa cell lines (cervical cancer) the HPV18 integrated in the 
genome in multiple places, two of which in c-Myc locus (8q23 and 8q24) (Ambros & 
Karlic, 1987; Joos, Haluska, et al., 1992; Popescu, DiPaolo, & Amsbaugh, 1987). 
Burkitt’s lymphomas provide an example of c-Myc misexpression due to 
interfering long-range activity. Often these cancers arise because of chromosomal 
translocations that fuse c-Myc locus with the Immunoglobulin heavy chain (IgH) locus. 
The mapping of the translocation breakpoints revealed a quite heterogeneous 
distribution in c-Myc locus, ranging from 14 to 340Kbp upstream of c-Myc promoter. 
In the IgH locus, the breakpoints occur within a small window, located close to the 
enhancer of the IgH gene. In this case it was proposed that the IgH enhancer 
interfered with c-Myc regulation, specifically in B-cells, causing c-Myc misexpression 
and consequently, leukemia (Joos, Falk, et al., 1992; Joos, Haluska, et al., 1992). 
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3 Aim of the Project 
Eukaryotic transcription is a process regulated at different levels that can be 
summarized in three major categories: genetic, chromatin and topology. In the last 
decade, especially thanks to the development of next-generation-sequencing (NGS) 
technology, there has been a remarkable increase in the knowledge of each of these 
areas. From a genetic perspective, the improvement in annotation of transcripts and 
non-coding elements such as repetitive sequences, CpG islands, endogenous retro-
transposons, regulatory elements, evolutionarily conserved regions and many others, 
have fueled genomics studies. In the chromatin field, binding sites of several 
transcription factors, as well as chromatin modifications, have been mapped into the 
genomes in many cell lines and tissues, showing that many histone modifications 
have different degrees of correlations with transcription. More recently it has been 
shown that chromosomes and loci are folded in a controlled fashion, and that 
probably, their topological organization helps sorting the regulatory elements that 
act on certain promoters.  
Despite the vast amount of data suggesting that DNA sequence, chromatin and 
topology play an important role in transcriptional regulation, it is still not clear how 
all these components functionally integrate in order to carry out this process. The 
aim of this project is to understand basic mechanisms organizing promoter–
regulatory elements communication. We plan to achieve this by dissecting the 
contribution of chromatin and DNA topology individually, on a model locus. 
c-Myc locus represents an ideal system for this project because of the amount of 
information available regarding the genetic component. Veli Uslu showed that long-
range enhancer(s) boost c-Myc expression selectively on facial tissues during mouse 
embryonic development, and are important to form the upper lip and the primary 
palate. Moreover, the analysis of the regulatory landscape of c-Myc locus in mouse 
embryos, also performed by Veli Uslu, suggests the presence of other enhancer(s) 
active on the liver. These enhancer(s) seem to exert their action from c-Myc itself to 
the end of Pvt1 transcribed region. Importantly, their location does not overlap with 
the facial enhancer(s). The presence of two (sets of) remote enhancers in c-Myc locus, 
active during mouse development on two tissues, give us the possibility to tackle our 
question from two independent systems. In addition, the presence of several tissues 
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where c-Myc expression is kept to the basal level, provides us with important internal 
controls. 
Regarding the experimental setup, our approach is based on combining 
chromatin analysis with targeted genetic engineering and functional assays. The 
advantage of this approach compared to genome-wide studies, which provide clues 
only from a correlative point of view, is that the genetic engineering allows us to 
experimentally test the current models regarding topological and regulatory domains, 
providing functional evidence rather than descriptive correlations. 
We performed the chromatin analysis using the ChIP-seq method. We focused 
on two main goals with this approach. Firstly, map and identify important regulatory 
elements, using antibodies recognizing chromatin signatures for gene promoters, 
enhancers and architectural proteins. Secondly, map broad chromatin domains, 
along the locus, to describe its overall organization in different tissues and compare it 
with the different features of the regulatory landscapes that have been described by 
Veli Uslu. For the second purpose, we took advantage of what was reported by Filion 
and colleagues, namely that despite the vast number of chromatin proteins, histone 
and DNA modifications described in the literature, there are just few major types of 
chromatin. They also reported that there are a few key histone modifications that 
can be used as markers of each chromatin type (Filion et al., 2010).  
The contribution of the topological organization of the locus to c-Myc regulation 
was assessed by three balanced chromosomal inversions. The advantage of inversions 
over duplications and deletions is that they provide a “clean” way to reshuffle the 
genetic elements like promoters, regulatory elements and boundaries without 
changing them in number. The inversions breakpoints were chosen in order to 
perturb the TAD arrangements in specific ways. Finally, functional assays such as 
LacZ reporter assay and transcript detection by qPCR were used as readouts to 
assess the effects of the topological perturbations introduced. 
Because of the role of CTCF and Cohesin to mediate DNA-DNA interactions 
and in the maintenance of the chromosome topology, we decided to test to what 
extent their binding to the genome is influenced by the locus architecture. For this 
question, the mouse lines carrying chromosomal inversions were particularly useful 
because of the reshuffling of the genetic elements that they introduce. We firstly 
investigated the occupancy of CTCF in c-Myc locus in our tissues of interest, namely 
embryonic face and liver. We then assessed, on the same tissues, the effect of the 
genetic reshuffling due to the inversion on CTCF binding. 
Finally, the telomeric end of the locus was reported by Veli Uslu to contain an 
imprinting control region (ICR), responsible for the silencing of some regions of the 
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locus in the maternal allele. We used the inversion mouse lines to test the effect of 
the genetic reshuffling on the imprinted regions. For the sake of clarity, the data 
concerning this phenomenon are presented at the end of the results chapter, and are 
discussed separately from the rest of the work. The material presented and discussed 
in the sections not treating the imprinting, for example the material relative to the 
reporter assays, refer to the paternal allele, which is not imprinted. 
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4 Materials and Methods 
4.1 Materials 
4.1.1 Equipment 
4.1.1.1 Thermomixers 
Product Manufacturer Description 
Eppendorf 
thermomixer® 
compact 
Eppendorf Heating 
Eppendorf 
thermomixer® 
comfort 
Eppendorf Heating, programmable 
Eppendorf 
thermostatTMplus 
Eppendorf Heating and cooling 
4.1.1.2 Shakers 
Product Manufacturer Description 
Maxq 416 / 430 hp 
tabletop digital 
orbital benchtop 
shakers 
Thermo fischer Benchtop orbital shaker  
Polymax 1040 Heidolph Swinging benchtop shacker 
SB3 Stuart Speed and angle adjustable rotator 
4.1.1.3 Incubators 
Product Manufacturer Description 
HyBaid Thermo fischer Oven with rotating system integrated. 
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shacke’n’stack Speed and temperature adjustable. 
Hibridization oven Binder Temperature adjustable 
TW8 Julabo Water bath 
4.1.1.4 Pipettes 
Gilson Pipetman classicTM, p2, p10, p20, p200, p1000. 
4.1.1.5 Vortexes 
Product Manufacturer Description 
Vortex Genie 2 Scientific 
Industries Inc 
Speed adjustable vortex with plate/tube 
adapters 
MS 3 basic Lab 
Shaker 
Laboratory 
mixers 
Speed adjustable vortex 
4.1.1.6 Sonicators 
Product Manufacturer Description 
Bioruptor® Plus 
sonication device 
Diagenode Fully adjustable in power, cycles and duty 
cycles. Including 1.5ml tubes adapter. 
S220  Covaris Focused-ultrasonicator (500KHz). 
4.1.1.7 Bioanalyzer 
Product Manufacturer Description 
2100 Agilent 
technologies 
Including chip-priming station, chip 
vortexer and 2100 Expert software 
4.1.1.8 Qubit 
Product Manufacturer Description 
Qubit™ 3.0 
Fluorometer 
 
Life 
technologies 
Target specific fluorescence nucleic acids 
quantitation. 
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4.1.1.9 Centrifuges 
Product Manufacturer Description 
Microcentrifuge5424 Eppendorf Benchtop centrifuge 
Microcentrifuge 5415 
R 
Eppendorf Benchtop cooling centrifuge 
MultiFuge 2SRT Thermo fischer Cooling centrifuge for falcons and plates 
Megafuge2.0R Heraeus Centrifuge for falcons 
4.1.1.10 Microscopes 
Product Manufacturer Description 
Leica M80 Leica Dissection stereo microscope 
Leica M16 Leica Dissection stereo microscope 
Leica M16F Leica Dissection stereo microscope with camera 
4.1.1.11 Balances 
Product Manufacturer Description 
TE3135-DS Sartorius Accuracy: 1mg 
TE601 Sartorius Accuracy: 10mg 
4.1.1.12 Thermocyclers 
Product Manufacturer Description 
C1000 Thermal 
Cycler 
Bio-Rad Two independent blocks of 48 wells 
C1000 Touch 
Thermocycler 
Bio-Rad One 96 wells block 
S1000 
Thermocycler 
Bio-Rad Four machine connected as “tetrablock”, 
maximal capability 2 x 96 wells blocks and 
4 x 48 wells blocks 
ABI7500 Light 
cycler  
Applied 
biosystems 
RT-qPCR 
BioMark Fluidigm Microfluidic RT-qPCR 
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4.1.1.13 Nanodrops 
Product Manufacturer Description 
Nanodrop8000 Thermo fischer Eight channels spectrophotometer 
ND-1000 NanoDrop One channel spectrophotometer 
4.1.1.14 Magnets 
Product Manufacturer Description 
DynaMagTM2 Invitrogen Magnets for ChIP 
DynaMagTM5 Invitrogen Magnets for ChIP 
4.1.1.15 DNA electrophoresis 
Product Manufacturer Description 
PerfectBlue Maxi 
Gel System L 
Peqlab Small size electrophoresis chamber 
PerfectBlue Maxi 
Gel System M 
Peqlab Medium size electrophoresis chamber 
PerfectBlue Maxi 
Gel System S Plus 
Peqlab Large size electrophoresis chamber 
4.1.1.16 Power supplies 
Product Manufacturer Description 
EPS301 GE healthcare Power supply 
4.1.1.17 Computing 
Minimal resources: 6 cores, 30Gbytes RAM. 
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4.1.2 Reagents 
4.1.2.1 Primers 
ID Name Sequence Application 
426 SB-L3 
AAGTAGATGTCCTAACTG
ACTTGC 
Standard 
genotyping 
429 SB-R3 
TCCTAACTGACCTAAGAC
AGG 
Standard 
genotyping 
3180 196231 L  
CCTGGAATCTCCTTTTGT
TCAGG 
Standard and 
inversion 
genotyping 
3589 196231 R 
ATCCAACACCCCCTTTCT
GC 
Standard and 
inversion 
genotyping 
3033 194578 L  
CAGGAGTTTGCCAATCAA
CAGTG 
Standard and 
inversion 
genotyping 
3034 194578 R 
GAAAGCAAGTGGGGAAG
TCAGAG 
Standard and 
inversion 
genotyping 
790 SB-179039 R 
GTTCCTCCCAAGGTTCAT
GCTC 
Standard and 
inversion 
genotyping 
2432 
c-Myc nonRepeat(L) 
179039 
GGTTCTCTCTCATGGAGT
GTATCAGG 
Standard and 
inversion 
genotyping 
3 SB_Rir1 
GTTTTGGCAAGTCAGTTA
GGACATC 
Inversion 
genotyping 
6 SB_Lir1 
TTTCATCACATTCCCAGT
GGGTC 
Inversion 
genotyping 
5534 Sdha_MRNA_F 
TTGCAGCACAGGGAGGT
ATC 
Fluidigm RT-
qPCR 
5535 Sdha_MRNA_R 
ATGCCATCTCCAGTTGTC
CTC 
Fluidigm RT-
qPCR 
5536 Trib1_MRNA_F 
CGAGGAGAGAACCCAGC
TTAGA 
Fluidigm RT-
qPCR 
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5537 Trib1_MRNA_R 
ATCTGACAGCGCATCATC
TTC 
Fluidigm RT-
qPCR 
5538 Asap1_MRNA_F 
ATGTGACGGCTGAGACAT
GAG 
Fluidigm RT-
qPCR 
5539 Asap1_MRNA_R 
TCTGGTCCGGCATCCGAT
T 
Fluidigm RT-
qPCR 
5543 Fam49b_MRNA_F GCCGCTCGCGAACCT 
Fluidigm RT-
qPCR 
5544 Fam49b_MRNA_R 
TGTCCTTCTATCTGGCGG
C 
Fluidigm RT-
qPCR 
5545 Tbp_MRNA_F 
TGGCGGTTTGGCTAGGTT
TC 
Fluidigm RT-
qPCR 
5546 Tbp_MRNA_R 
GAAATAGTGATGCTGGG
CACT 
Fluidigm RT-
qPCR 
5547 Fam84b_MRNA_F 
TCCGCGCAGGTGGCTTTA
G 
Fluidigm RT-
qPCR 
5548 Fam84b_MRNA_R 
TTACGCTGTGGACTCTCG
TTC 
Fluidigm RT-
qPCR 
1317 
Fwd_SYBR_MmGus
b-qPCR 
CTCTGGTGGCCTTACCTG
AT 
Fluidigm RT-
qPCR 
1318 
Rev_SYBR_MmGus
b-qPCR 
CAGTTGTTGTCACCTTCA
CCTC 
Fluidigm RT-
qPCR 
3006 
cc-Myc(1) qPCR -
Fwd 
CCCTAGTGCTGCATGAGG
AGACAC 
Fluidigm RT-
qPCR 
3007 
 cc-Myc(1) qPCR -
Rev 
CCACAGACACCACATCAA
TTTCTTCC 
Fluidigm RT-
qPCR 
3012 Pvt1 qPCR -Fwd  
CTGAGGTGGAGGAAGTT
GCCCTTG 
Fluidigm RT-
qPCR 
3013 Pvt1 qPCR -Rev  
GGCCACCTCAATCAGGCA
GTGTC 
Fluidigm RT-
qPCR 
5571 Hprt_mRNA_F 
CTTCCTCCTCAGACCGCT
TTT 
Fluidigm RT-
qPCR 
5572 Hprt_mRNA_R 
CATCATCGCTAATCACGA
CGC 
Fluidigm RT-
qPCR 
5559 Nsmce2_MRNA_F 
GGGAGCTGAAGAAGCAA
TATGGTA 
Fluidigm RT-
qPCR 
5560 Nsmce2_MRNA_R ATTGGTTTGGCTCTGGGT Fluidigm RT-
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CA qPCR 
5561 
E430025E21Rik_MR
NA_F 
GTGTTCCTGCTGAAAGAC
CG 
Fluidigm RT-
qPCR 
5562 
E430025E21Rik_MR
NA_R 
CCAGAACTCTGGACCCTT
AAAGT 
Fluidigm RT-
qPCR 
5590 
chr15-60988828-
60989797_F 
TCCGATTCCGATGCAGTT
CC Fluidigm ChIP 
5591 
chr15-60988828-
60989797_R 
TTAGAAGGCCACCATGCT
TGT Fluidigm ChIP 
5592 
chr15-63602886-
63603631_F 
CTTGCTGCTGGACAATGC
TG Fluidigm ChIP 
5593 
chr15-63602886-
63603631_R  
TGGCAGGATTGTGTGGT
GAA Fluidigm ChIP 
5594 
chr15-60591260-
60592101_F 
TATGCCACATGAGGGTCA
GG Fluidigm ChIP 
5595 
chr15-60591260-
60592101_R 
AGCTCTGCTCTCTGCTCT
CT Fluidigm ChIP 
5596 
chr15-63483813-
63484536_F 
GTCCTCCACACCCAAATG
GA Fluidigm ChIP 
5597 
chr15-63483813-
63484536_R 
CGGCTAAGAGGAGGAAA
CAACT  Fluidigm ChIP 
5598 
chr15-63572139-
63572734_F 
ACGGACTACAAGACCAG
GCA Fluidigm ChIP 
5599 
chr15-63572139-
63572734_R 
GGGCCCATAGACTTTCAC
CTC  Fluidigm ChIP 
5600 
chr15-61814519-
61815473_F 
GGATGACCGGAAGCTTG
TCT Fluidigm ChIP 
5601 
chr15-61814519-
61815473_R 
CTGCAGGGTTTCCAGGTT
CT  Fluidigm ChIP 
5602 
chr15-63553022-
63553963_F 
AGACCTCCAGGTGGGAA
GAT Fluidigm ChIP 
5603 
chr15-63553022-
63553963_R 
TTCAGAGTTGGTGGTTGG
CA  Fluidigm ChIP 
5604 
chr15-60933612-
60934521_F 
GGCTCTAACTGTGGGCAT
TCA Fluidigm ChIP 
5605 
chr15-60933612-
60934521_R 
CACCTCCCCCACCCATCT
A Fluidigm ChIP 
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5606 
chr15-63171736-
63172525_F 
GAGGCACATTGTGGAGG
GAG Fluidigm ChIP 
5607 
chr15-63171736-
63172525_R 
CACTGTTCTCTGGGAGAG
CC Fluidigm ChIP 
5608 
chr15-61816690-
61817501_F 
AAGAGCCGTGTGTGCAG
AG Fluidigm ChIP 
5609 
chr15-61816690-
61817501_R 
CTCACTCCAGAGCTGCCT
TC Fluidigm ChIP 
5610 
chr15-63432906-
63433773_F 
GTGACAGGGTATTGCCCA
GC Fluidigm ChIP 
5611 
chr15-63432906-
63433773_R 
ATGGCAAGCTCAGTCCAA
CT Fluidigm ChIP 
5612 
chr15-63660558-
63660911_F 
ACATTCTGAACGCTAGGG
GAC Fluidigm ChIP 
5613 
chr15-63660558-
63660911_R 
TCCCTGTTGGTTCCCTTC
CA Fluidigm ChIP 
5614 
chr15-59928547-
59929378_F 
CGAGAACCCGCATGGTG
AT Fluidigm ChIP 
5615 
chr15-59928547-
59929378_R 
CATCATCACCCTGGCAGA
CA Fluidigm ChIP 
5616 
chr15-62159709-
62160443_F 
TGGAATGCCACCGAAAAG
GA Fluidigm ChIP 
5617 
chr15-62159709-
62160443_R 
AAAGCCCCGAGGATTGT
GAG Fluidigm ChIP 
5618 
chr8-
47020195_Pos1_F 
CTTCCCGACCTCAAATCC
CC Fluidigm ChIP 
5619 
chr8-
47020195_Pos1_R 
AAATAGGGGTGAAGGCG
GC Fluidigm ChIP 
5620 
chr1-
183819016_Pos2_F 
CCGTGTCCACCCATCAAC
AT Fluidigm ChIP 
5621 
chr1-
183819016_Pos2_R  
GCCCTCTGCTGGCTAATG
TC Fluidigm ChIP 
5622 
chr12-
82889780_Pos3_F 
CTGGCACAGCAAGACCAT
GA Fluidigm ChIP 
5623 
chr12-
82889780_Pos3_R 
AACCCCAGAGAGGTGCC
ATA Fluidigm ChIP 
5624 chr17- CCTTGGCTACATGGTGAG Fluidigm ChIP 
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29508031_Pos4_F GT 
5625 
chr17-
29508031_Pos4_R 
AGCCAAGAGCAGGCATA
CAG Fluidigm ChIP 
5626 
chr1-
84730497_Mid1_F 
ACCTTGTTATTTTGCTCT
CCACTC  Fluidigm ChIP 
5627 
chr1-
84730497_Mid1_R 
GACAACATCTGTAACTGC
GTGTC  Fluidigm ChIP 
5628 
chr3-
36036726_Mid2_F 
CTGACACAGGACACAAGC
ATAAAG  Fluidigm ChIP 
5629 
chr3-
36036726_Mid2_R 
TCCAAACTGATACTGTCT
CACACC Fluidigm ChIP 
5630 
chr5-
65394338_Mid3_F 
AAAGTCCCAGTGGCTCTG
TTAT Fluidigm ChIP 
5631 
chr5-
65394338_Mid3_R 
GCCACTTCCAAAGCTTGA
CTTAG Fluidigm ChIP 
5632 
chr10-
100659186_Neg1_F 
TAGCCAGCATTTCTGTTT
CTAGG Fluidigm ChIP 
5633 
chr10-
100659186_Neg1_R 
CAAACACCAGACATACTG
CTTCAT  Fluidigm ChIP 
5634 
chr5-
59680664_Neg2_F 
TGCCGGGCATACAATGCT
TA  Fluidigm ChIP 
5635 
chr5-
59680664_Neg2_R 
GGTGAGTGAGACCAGCG
AAA Fluidigm ChIP 
5636 
chr14-
81658234_Neg3_F 
TGTCAATTTTTGACCACT
CCCAC Fluidigm ChIP 
5637 
chr14-
81658234_Neg3_R 
TCATACTTGGAAACACAG
GAGGT Fluidigm ChIP 
5638 
chr16-
53987613_Neg4_F 
TGCCACCCTAGATGAGAG
ACTAA Fluidigm ChIP 
5639 
chr16-
53987613_Neg4_R 
ACAACTTATCATGAGCCA
CACTATG Fluidigm ChIP 
4.1.2.2 Chemicals 
All the chemical reagents were purchased from Merck or Sigma-Aldrich except for 
the listed ones. 
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Product Supplier Description 
Phenol non stabilized: Chloroform: 
Isoamyl Alcohol 25 : 24 : 1 
Applichem Phenol-chloroform used for 
ChIP DNA purification 
cOmplete Protease Inhibitor Cocktail 
Tablets 
Roche Protease inhibitor small 
molecules, used during ChIP 
4.1.2.3 Enzymes 
Product Supplier Description 
Taq DNA 
polymerase 
Home made Taq polymerase used for the standard 
genotyping 
4.1.2.4 Commercial Kits 
Product Supplier Description 
Qubit® dsDNA HS 
Assay Kit 
Invitrogen Quantifies DNA in the range 0.2-100ng/µl 
Power SYBR® Green 
Master Mix 
Applied 
biosystems 
Master mix including enzyme for RT-
qPCR 
E-Gel® 48 Agarose 
Gels, 2% 
Invitrogen Gel electrophoresis for DNA size selection 
for ChIP-seq library preparation 
High Sensitivity DNA 
Analysis Kits 
Agilent 
technologies 
Reagents for bioanalyzer. Compatible with 
DNA in the range of concentration 
100pg/µl-50ng/µl. 
NEBNext® ChIP-Seq 
Library Prep Master 
Mix Set for Illumina® 
New 
England 
biolabs 
Library preparation kit for ChIP-seq 
NEBNext® Multiplex 
Oligos for 
Illumina® (Index 
Primers Set 1) 
New 
England 
biolabs 
Multiplexing oligonucleotides, compatible 
with  NEBNext® ChIP-Seq Library Prep 
Master Mix Set for Illumina® 
ProtoScript® II First 
Strand cDNA Synthesis 
Kit 
New 
England 
biolabs 
cDNA synthesis kit, compatible with 
Applied biosystems and Fluidigm 
Expand Long Template 
PCR System 
Roche Long-range PCR, used for inversion 
genotyping 
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4.1.2.5 ChIP Antibodies 
4.1.2.6 Magnetic Beads 
Product Supplier Description 
Dynabeads® Protein 
A for 
Immunoprecipitation 
Invitrogen Magnetic beads for ChIP 
SPRIselect reagent kit Beckman 
Coulter 
Magnetic beads for ChIP-seq library 
adaptor cleanup  
4.1.3 Consumables 
4.1.3.1 Purification kits 
Product Supplier Description 
Quiaquick PCR 
purification kit 
Quiagen Column DNA purification 
Minelute PCR 
purification kit 
Quiagen Column DNA purification. Used for 
ChIP-seq library preparation 
RNeasy Plus Mini Kit Quiagen Whole RNA extraction kit (column based). 
Product Vendor Description 
ab8895 Abcam Anti-Histone H3 (mono methyl K4) 
antibody - ChIP Grade  
ab4729 Abcam Anti-Histone H3 (acetyl K27) antibody - 
ChIP Grade  
ab6002 Abcam Anti-Histone H3 (tri methyl K27) 
antibody [mAbcam 6002] - ChIP Grade  
ab4174 Abcam Anti-Histone H2A.Z antibody - ChIP 
Grade  
ab8898 Abcam Anti-Histone H3 (tri methyl K9) antibody 
- ChIP Grade  
07-729 Millipore Anti-CTCF Antibody 
ab992 Abcam Anti-RAD21 antibody - ChIP Grade  
sc-899 Santa Cruz Pol II Antibody (N-20): sc-899 
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4.1.3.2 Cell Culture 
Product Supplier Description 
Nunc™ Cell 
Culture/Petri 
Dishes 
Nunc 56.7 and 150 cm² 
DMEM  Gibco® Cell 
Culture Media 
Low glucose medium 
BW12-492F Lonza bio 
whittacker 
Fetal Serum Bovine (FBS) 
Trypsin-EDTA 
(0.25%), phenol red 
Gibco Trypsin 
4.1.3.3 Embryo Dissection 
Product Supplier Description 
Greiner petri dish Greiner 60 x 15 mm, 94 x 16mm petri dishes 
#5 Dunmont SA Dissection forceps 
4.1.3.4 Tubes 
Product Supplier Description 
Flex Tubes® Eppendorf Standard centrifuge tube. 0,5, 1,5, 2 ml 
Eppendorf Safe-
Lock Tubes 
Eppendorf Centrifuge tube suitable for nitrogen 
freezing. 1,5 ml 
DNA LoBind 
Tubes 
Eppendorf Centrifuge tube for ChIP and low 
concentration samples. 1,5 and 2 ml 
Greiner centrifuge 
tubes 
Greiner Falcon tubes. 15 and 50ml 
4.1.3.5 Fluidigm Chips 
Product Supplier Description 
Flex Six IFC Fluidigm 6 compartments of 12 samples x 12 
primers. 
96.96 IFC Fluidigm 96 samples x 96 primers 
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4.1.3.6 Bioanalyzer Chips 
Product Supplier Description 
Agilent DNA 1000 
Kit  
Agilent 
technologies 
 
4.1.3.7 PCR Plates 
Product Supplier Description 
MicroAmpTM Fast 
Optical 48-Well 
Reaction Plate  
Applied 
Biosystems 
100µl 96 wells plate. Used for ChIP quality 
control. 
Natural 96 well 
non-skirted PCR 
plate  
Greiner 200µl 96 wells plate. Used for standard 
genotyping. 
4.2 Methods 
4.2.1 Genome Regulatory Organization Mapping With 
Integrated Transposons (GROMIT) System 
GROMIT is a reporter system based on a LacZ gene under the control of the β-
globin core promoter. It is equipped with a LoxP site (upstream of the β-
globin:::LacZ cassette) that can be used for genetic engineering purposes. The whole 
construct is inserted into a “sleeping beauty” (SB) transposon (Tc-1 like fish 
transposon). Because of this feature, GROMIT can be remobilized to new genomic 
positions using the specific transposase HSB16. This transposase was obtained by 
genetic engineering and has higher remobilization efficiency than the original SB 
transposase. It was shown in mammals to effectively mediate the transposition in a 
cut and paste manner (Luo, Ivics, Izsvák, & Bradley, 1998). The expression of the 
HSB16 transposase is controlled by the Protamine1 (Prm1) promoter (active only 
during spermatogenesis), and for this reason, the remobilization occurs only on the 
male germline. Male mice carrying both GROMIT SB-transposon and the 
Prm1:::HSB16 transgene produce spermatocytes carrying the SB-transposon in new 
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locations. These new insertions can be obtained as lines, and fixed very simply, by 
crossing these males with Wt females. The HSB16 has the tendency to remobilize 
the SB transposon to locations close to the parental insertion (“local hopping” (Keng 
et al., 2005)). This feature is useful because it allows the fine mapping of a given locus 
once a starting insertion is obtained. 
4.2.2 Balanced Chromosomal Inversions 
The chromosomal inversions are performed using the Cre-LoxP system, according 
to the STRING method (described by Spitz, Herkenne, Morris, & Duboule, 2005). 
The two LoxP required must be in the same chromosome and in opposite 
orientation. In this configuration the Cre enzyme recombines the DNA at the LoxP 
inverting the sequence in between. The LoxP are obtained from GROMIT 
insertions and must span the region of interest to be inverted. Their arrangements 
are listed in the table below. 
Inversion 
name 
Centromeric 
insertion 
breakpoint 
Telomeric 
insertion 
breakpoint 
mm9 coordinates 
(chr15) 
Veli Uslu’s 
defined 
coordinates 
Inversion 1 196231 (+) 194578 (-) 60133316-62168343 c16–3a 
Inversion 2 196231 (+) 179039 (-) 60133316-63550550 c16–17a 
Inversion 3 194578 (-) 192857 (+) 62168343-63550550 3a–17a 
The whole process takes four generations. In order to have both GROMIT 
insertions in the same chromosome, it is necessary to first generate an animal having 
the two insertions in the sister chromosomes. In case a meiotic-crossingover happens 
in the region in between, the two insertions are brought into the same chromosome. 
Once this animal is obtained, it is bred with an animal carrying a constitutively 
expressed Cre recombinase (Hprt:::Cre), in order to obtain pups carrying both alleles 
(it is more convenient, for the following breeding, to screen for a male double 
positive, rather than a female). At this stage the CRE enzyme recombines the DNA, 
and according to the efficiency of the process, a different percentage of the gametes 
will be recombined. The double positive male is bred against Wt C57BL/6J females, 
from this breeding, mice positive for the inversion and negative for the Cre 
recombinase are sought. Because of the fact that the sperm is considerably smaller 
than the oocyte, it likely carries little amount of CRE enzyme, and therefore will not 
interfere later on, at somatic level. The inversion leaves the primary sequences of 
GROMIT insertions (inversion’s breakpoints) unaltered. 
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4.2.3 GROMIT Removal From Inversion Lines 
The inversion lines carry both sleeping beauty transposons at the breakpoint. The 
removal of either of the two is done using the transposase HSB16. HSB16 is placed 
under the control of the Protamine1 promoter (Prm1) that guarantees the transposase 
expression only during spermatogenesis. In the first generation, a male double 
positive for the inversion allele and the HSB16 transposase must be created. 
According to the remobilization efficiency (different for each GROMIT insertion), 
this male has a certain percentage of spermatocytes where one of the two transposons 
is remobilized to a new location or is just removed without being reintegrated. The 
double positive male is bred with Wt C57BL/6J females and the pups are screened 
for the lack either of the two transposons. At this stage, whether the missing 
transposon has reintegrated or not in the genome can be determined by either 
qPCR, determining the number of total transposons, or by further breeding with Wt 
animals. In the last case the presence in the litter of pups positive for GROMIT, but 
negative for the remaining parental insertion, indicates that the transposon missing 
from the inversion breakpoint, reintegrated somewhere else. However in the case no 
unmapped transposon is found in the litter, the lack of reintegration, or the 
reintegration in the same chromosome cannot be distinguished. Because of the fact 
that the HSB16 has the tendency of remobilizing the sleeping beauty transposon to 
locations close to the original one, the eventuality of a remobilization within the 
chromosome must not be neglected. For these reasons the qPCR method is chosen 
whenever possible. 
4.2.4 DNA Extraction From Mouse Tails 
The sliced fragments of tails are lysed over night (ON), at 55°C, 1000 rpm shacking, 
in 200µl of Tail-lysis-buffer for southern-blot (100mM Tris pH 8.5, 5mM EDTA, 
20% SDS 0.2%, 200mM NaCl, in H2O), plus 100µg/ml Proteinase K (PK). The 
tubes are spun for 1 minute and the supernatant is transferred to a new tube. An 
equal volume of isopropanol and 30µl of NaCl 5M are added in each tube. The 
tubes are shacked, incubated at 4°C for 10 minutes and spun for 10 minutes > 
13000rpm on a benchtop centrifuge. The supernatant is discarded and washed with 
70% ethanol by spinning for 10 minutes > 13000 rpm on a benchtop centrifuge. The 
pellet is resuspended in 300µl H2O, warmed for 30 minutes at 37°C with mild 
shacking and stored at -20°C. 
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4.2.5 DNA Extraction From Extraembryonic Membranes 
E11.5 yolk sacs are lysed in 200µl of Quick-tail-lysis-buffer (50mM KCl, 10mM 
Tris pH 8.00, 2mM MgCl2, 0.01% Gelatin, 0.0045% Igepal, 0.0045% Tween-20, in 
H2O) plus 100µg/ml PK ON, at 55°C, 1000rpm shacking. The PK is inactivated by 
10 minutes incubation in 95°C, 1000rpm shacking. The solution is diluted 5 times in 
H2O, spun 2 minutes >13000rpm on a benchtop centrifuge to clear it from the 
debris, and stored at -20°C. 
4.2.6 Standard Genotyping 
Each reaction is carried out in a total volume of 20µl with 0.4µl of home made Taq-
DNA-polymerase, 0.2mM dNTPs (PeqGOLD dNTP set from Peqlab), PCR 
buffer (50mM Tris, pH 9.5, 15mM (NH4)2SO4, 1,17mM MgCl2, in H2O), 250µM 
primers and 2µl DNA solution, typically around 100µg/µl concentrated. The 
reaction is performed with the following conditions. 
Temperature (°C) Duration 
(seconds) 
Description 
95 180 Step1, initial denaturation 
95 20 Step2, denaturation 
60 20 Step3, annealing 
72 72 Step4, extension 
  Step5, go to step 2, 34 additional times 
72 300 Step6, dA adition (not necessary) 
16 ∞ Step7, hold 
The primers combinations for the genotyping of each allele are listed in the 
table below. Every sleeping beauty allele is genotyped from both sides, left and right 
(L and R). In both cases one primer anneals in the sleeping beauty (always #426 for 
the left and #429 for the right), while the other one on the genomic DNA. 
Allele Forward (database ID) Reverse (database ID) 
SB-196231 (L) 426 3180 
SB-194578 (L) 2033 426 
SB-192857 (L) 426 790 
SB-179039 (L) 2432 426 
SB-196231 (R) 3589 429 
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SB-194578 (R) 429 3034 
SB-192857 (R) 2432 429 
SB-179039 (R) 429 790 
4.2.7 Genotyping for Inversions 
The genotyping for inversion is performed using the commercially available kit 
Expand long range template from Roche, according to the manufacturer’s 
specifications. 
Temperature (°C) Duration 
(seconds) 
Description 
92 120 Step 1, initial denaturation 
92 10 Step 2, denaturation 
60 15 Step 3, annealing 
68 300 Step 4, extension 
  Step 5, go to step 2, 9 additional times 
92 10 Step 6, denaturation 
60 15 Step 7, annealing 
68 320 Step 8, extension 
  Step 9, go to step 6, 24 additional times 
68 420 Step10, dA adition (not necessary) 
16 ∞ Step 11, hold 
The primers combinations are listed in the table below. 
Allele Breakpoint Forward 
(database ID) 
Reverse 
(database ID) 
Inversion 1  Centromeric 3180 3034 
Inversion 2 Centromeric 3180 2432 
Inversion 3 Centromeric 3033 2432 
Inversion 1  Telomeric 3033 3589 
Inversion 2 Telomeric 3589 790 
Inversion 3 Telomeric 3034 790 
SB-196231 Wt  3180 3589 
SB-194578 Wt  3033 3034 
SB-192857 and SB-  790 2432 
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179039 Wt 
Transposon (positive 
control) 
 3 6 
The genotyping is performed on GROMIT positive, Hprt:::Cre negative pups. 
PCR for both breakpoints, from the genomic sequences encompassing the 
GROMIT transposon are done. The centromeric (genomic) primer of the 
centromeric breakpoint is used in combination with the centromeric (genomic) 
primer of the telomeric breakpoint. A second PCR is performed for the remaining 
breakpoint, using the telomeric (genomic) primer of the centromeric breakpoint in 
combination with the telomeric (genomic) primer of the telomeric breakpoint. 
Positive animals for long-range PCR on both breakpoints are considered as positive 
for the inversion. In case the LoxP, Hprt:::Cre double positive parent is female, 
additional PCRs spanning the Wt GROMIT insertions, on both breakpoints, must 
be done in order to rule out the possibility of chimerism. This is done because 
despite the Hprt:::Cre negative pups, the mother being positive for this allele can 
produce oocytes containing CRE protein, and therefore, the activity of the enzyme 
during early developmental stages may give rise to chimeras. Animals positive for 
long-range PCR product, for both the Wt and the inverted configuration are 
considered chimeras. 
4.2.8 MEF Culture 
CD1 Wt E13.5 embryos are decapitated and cleared from all the internal organs. 
The remaining carcasses are minced, deepened in 5ml trypsin and incubated 5 
minutes at 37°C in a water bath. The activity of the trypsin is blocked by addition of 
5ml of culture medium (DMEM, 10% FBS). The dissociated cells are spun at 430g 
for 3 minutes at room temperature (RT), resuspended in 12ml of culture medium 
and plated in a 56.7cm2 petry-dish. The cells are split every 2 days with 1:5 dilutions. 
The cells are harvested and processed according to the ChIP procedure until 
sonication. MEF sonicated chromatin can be stored at -80°C indefinitely and is used 
for antibody testing. 
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4.2.9 Embryo Dissection 
Pregnant females are sacrificed by cervical dislocation at 11.5 days of gestation 
(E11.5), the date of the vaginal plug is considered as day–0. The uterus is collected 
and plunged in Phosphate buffered saline (PBS) (137mM NaCl, 2.7mM KCl, 
10mM Na2HPO4, 1.8mM KH2PO4, in H2O). The embryos, together with the 
extra-embryonic membranes, are separated from the uterus. The membranes are 
collected and stored in -20°C, and can be further processed for DNA extraction. The 
embryos are subjected to downstream processing according to the procedure. 
4.2.10 LacZ Staining 
The embryos are collected as described above, with the exception that the CaCl2 and 
MgCl2 are added to the PBS, to a final concentration of 1 and 0.5mM respectively. 
The embryos are fixed for 30 minutes in 4% formaldehyde (w/v) in PBS at 4°C with 
gentle shaking. They are washed in PBS (complemented with CaCl2 and MgCl2) for 
10 minutes one time at 4°C, and one time at RT. Finally, the staining is performed 
by LacZ-staining-solution (0.01% Na Deoxycholate, 0.02% Igepal, 2mM NaCl, 
10mM K4Fe2(CN)6, 10mM K3Fe3(CN)6, 1% spermidine and 2mM X-Gal in 
DMSO, in H2O), in a dark humidified chamber at 37°C, ON. The embryos are 
washed twice in standard PBS at RT, and are stored indefinitely in 2% formaldehyde 
in PBS at 4°C. 
4.2.11 Real Time Quantitative PCR (qPCR) 
qPCRs for all the primer testing and for ChIP quality control, done before library 
preparation, are performed using the StepOneTM kit from Applied Biosystems 
(thermocycler and software, StepOneTM PCR software 2.0). The reaction is done in 
15µl total, 7,5µl Power SYBR® Green Master Mix from Applied Biosystems (2X), 
2µl DNA sample, 250nM primers, with the following cycling phases. 
Temperature 
(°C) 
Duration 
(seconds) 
Description 
95 600 Step 1, initial denaturation 
95 15 Step 2, denaturation 
60 60 Step 3, annealing + extension + fluorescence acquisition 
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  Step 4, go to step 2, 39 additional times 
  Optional (amplicon melting curve calculation) 
95 15 Step 5, denaturation 
60 60 Step 6, annealing + extension 
  Step 7, ramp 0.3°C/s + fluorescence acquisition 
95 15 Step 8, denaturation + fluorescence acquisition 
4.2.12 c-Myc and Neighboring Transcripts Quantification 
4.2.12.1 Experimental Setup 
The experiment is performed on the lines INV1-/-, INV1-/+, INV1+/+, INV2-/-, INV2-
/+, INV2+/+, INV3-/-, INV3-/+ and INV3+/+. The analyzed tissues are E11.5 facial 
mesenchyme (FM), proximal fore limb mesoderm (PFLM), heart and liver. For each 
sample type, three independent biological replicates are analyzed, and are referred 
together as a biological group. 
For INV1 and INV2 (all established on C57BL/6J genetic background) 
heterozygotes males and females are crossed in order to obtain all the genotypes (Wt, 
heterozygotes and homozygotes). Despite the fact that the C57BL/6J line is inbred, 
and has little amount of polymorphisms, we decided to minimize even further the 
difference in genetic background between the comparison groups, this, in order to 
reduce any litter effects as much as possible. This effect may be seen, for example, in 
case all the homozygotes samples come from one litter and all the Wt samples come 
from another one, and as a result, this can confound the analysis. For this reason, we 
decided to balance the litter provenience of the samples between the three genotypes. 
Moreover, the tissue specimens are taken from embryos whose somite count differs 
at most by two (corresponding to about four hours of embryonic development).  
4.2.12.2 RNA Extraction From Embryonic Tissues 
The RNA is purified from embryonic tissues using the RNeasy mini kit from 
Quiagen, according to the manufacturer’s specification and choosing the following 
options. Proximal fore limb mesoderm (PFLM), facial mesenchyme, liver and heart 
tissues are collected from E11.5 mouse embryos, placed in safe lock 1.5ml tubes, 
snap frozen in liquid N2 and stored at -80°C. As an exception from the original 
protocol, regardless of the tissue type and size, the tissues are always resuspended in 
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350µl of RLT buffer. The tissues are homogenized for 45 seconds using an electric 
mortar and pestle. The optional DNase treatment is performed on column, as 
indicated in the manual. The RNA is eluted from the columns with 30µl of RNase 
free water in two subsequent times. The expected total RNA yield varies from tissue 
to tissue, for liver and PFLM is about 4.5µg, for facial mesenchyme 4µg, and for 
heart 1.5µg. DNA contaminations are not detected by qPCR using primers specific 
for genomic DNA. 
4.2.12.3 Reverse Transcription 
The first strand cDNA synthesis is done with the NEB ProtoScript II kit according 
to the manual. The RNA is quantified for all the samples by nanodrop 
spectrophotometer. 200ng are used for the cDNA synthesis. The standard procedure 
suggests including in the experiment a negative control reverse transcription, done by 
replacing the ProtoScript II enzyme with H2O, for each sample. The procedure is 
split into two batches, processing half of the total samples at a time, as an exception, 
the negative control is done only for two randomly chosen samples, for each batch. 
The reaction uses random hexamers as primers, is set in 200µl 8 wells RNase free 
PCR strips and proceeds with the listed cycling phases (the option standard protocol 
is chosen instead of the easy protocol). 
Temperature 
(°C) 
Duration 
(minutes) 
Description 
65 5 Step 1, initial RNA denaturation (with only water, 
RNA and random hexamers) 
  Step 2, spin briefly and put on ice. Add the reaction 
buffer and the ProtoScript II enzyme 
42 5 Step 3, pre-synthesis incubation 
42 60 Step 4, denaturation and cDNA synthesis 
80 5 Step 5, reverse transcriptase inactivation 
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4.2.12.4 Revers Transcription qPCR (RT-qPCR) 
The DNA concentration of the cDNAs does not need to be quantified. The samples 
transferred into 96 wells plates and are handed to the GeneCore facility at EMBL. 
The samples are subjected, without dilution, to the standard Fluidigm sample 
preparation and downstream qPCR. The reactions are set in 2 chips Flex Six IFC, 
using ten independent compartments. Every compartment is loaded with eleven 
samples and one technical negative control (water). The chips are run in a Fluidigm 
Biomark machine using EvaGreen fluorescent dye and the following cycling 
conditions. 
Temperature 
(°C) 
Duration 
(seconds) 
Description 
95 60 Step 1, initial denaturation 
96 5 Step 2, denaturation 
60 20 Step 3, annealing + extension + fluorescence acquisition 
  Step 4, go to step 2, 29 additional times 
60 3 Step 4, ramp start point 
To 95  Step 5, ramp: 1°C / 3s + fluorescence acquisition 
4.2.12.5 RT-qPCR Data Analysis 
The principle of the qPCR analysis is to compare the threshold cycle (Ct) of target 
genes, to the reference one(s). The expression level of the targets is expressed as 
multiple of the expression of the reference(s). The reference genes are selected on the 
basis of being expressed in the analyzed tissues, to have low variability in expression 
levels from sample to sample, and to be unaffected by the experimental treatments 
(in this case genetic engineering) applied to the animals (assumption). In this 
experiment, the target transcripts, object of the analysis are: E430025E21Rik, 
Nsmce2, Trib1, Fam84b, c-Myc, Pvt1, Fam49 and Asap1. The reference transcripts 
are: Gusb, Hprt, Sdha, Tbp. The method applied for the comparison is similar to the 
ΔCt method as described in (Schmittgen & Livak, 2008) (equation 2), with a small 
adaptation. 
Equation 1: ΔCt =CtX −CtR  
Where X represent the target gene and R the reference one. 
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Equation 2: X = 2^ −ΔCt( )  
The method assumes that the primers efficiency is exactly 1 (100% efficient, 
every cycle the number of product doubles) for both targets and references. To avoid 
this inaccuracy, the method used for the quantification in this project is described by 
the equation 3.  
Equation 3:  X = (1+EffR)
^CtR
(1+EffX)^CtX  
Where X represent the target gene, R the reference gene and Eff the efficiency of the 
primers (from 0 to 1). 
However, all the selected primers have efficiency close to 1, and the introduced 
error is negligible. Moreover, as the comparison is done for a given target in different 
genotypes, the error would not lead to any bias, as it is the same in all the compared 
genotypes. Therefore the standard ΔCt method can also be used. 
There are two options regarding how to proceed in case several references are 
used. The first strategy is to average the Ct of all the reference genes and use this 
mean as reference Ct. The second strategy, the one used in this study, is to choose as 
reference, the gene whose expression levels are most stable across samples, and, do 
not differ significantly across different biological groups.  
To quantify expression level of each reference, the equation 3 is used, the 
reference Ct is given in this case by the mean of the other reference genes. The 
coefficient of variation (Cv) is estimated for each reference gene within each 
biological group as described by the equation 5. The reason why equation 5 is chosen 
instead of equation 4, is that for small sample sizes (3–4 in this study) it better 
approximates the Cv. Cv estimates of all biological groups are summed for each 
reference, obtaining a total Cv, equation 6. 
Equation 4: Cv = s
x
 
Where x  represents the estimate of the sample mean and s the estimate of the 
sample standard deviation. 
Equation 5: Cv*= 1+ 1
4n
!
"
#
$
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Where n is the sample size. 
Equation 6: totalCv = Cvi
i
∑  
Where Cvi represents the Cv estimate for the ith biological group. 
To test whether the expression levels of reference genes differ between biological 
groups, and therefore introduce bias in the estimate of the targets, an ANOVA test 
is applied (using functions from the stats package in R). The test works by 
comparing the variance between groups with the variance within groups. The 
ANOVA is applied to each reference gene, setting the significance level threshold to 
0.05. Higher p-values, calculated from the F-distribution, indicate insufficient 
evidence that the expression values in the biological groups differ. 
Once the best-keeper gene is chosen, the enrichment compared to the reference 
gene can be calculated. The hypothesis that Wt and homozygotes inversion samples 
come from the same normal distribution is tested by the standard two-tailed t-test, 
for each combination of line and tissue (stats package in R). The p-values for each 
comparison group (for example INV1-face) are corrected using the Benjamini-
Hochberg method (stats package in R). 
4.2.13 ChIP 
Facial mesenchyme and liver tissues are collected from the embryos at E11.5 and 
fixed in a 1.5ml tube (up to 10 slices of tissues) with 1% formaldehyde in PBS at RT 
for 10 minutes. The formaldehyde is quenched with the addition of glycine to a final 
concentration of 125mM, 5 minutes on ice. The tissues are washed in PBS once and 
can be stored in -80°C. The tissues can be pooled at this stage according to the needs 
(not more than 30 slices per tube, see table below for more precise estimate) and are 
lysed in 1ml of lysis-buffer-A (10mM Hepes, 10mM EDTA, 0.5mM EGTA, 
0.25% Triton X 100, in H2O), for 10 minutes at 4°C. Afterwards, the lysed tissues 
are washed in lysis-buffer-B (10mM Hepes pH8, 200mM NaCl, 1mM EDTA, 
0.5mM EGTA, 0.01% Triton X-100, in H2O) for 10 minutes at 4°C. The pellet is 
resuspended in 300µl of sonication buffer (10mM Tris-HCl pH 8, 1mM EDTA ph 
8, 0.1% SDS, in H2O) complemented with protease inhibitor cocktail from Roche, 
and sonicated in one round on a Bioruptor plus from Diagenode, setting the 
machine on high power, for 24 cycles 30 seconds on and 30 seconds off, constantly 
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at 4°C. If larger volume of sonication buffer is required the sonication is performed 
in multiple rounds each with at most 300µl of sonication buffer. The chromatin is 
pooled (if sonicated in multiple rounds) and spun for 5 minutes at >13000rpm on a 
benchtop centrifuge at 4°C, to get rid of the cell debris. The supernatant is collected 
in a new tube and if needed, can be stored indefinitely at -80°C. The chromatin is 
thawed on ice (if frozen), and the volume is estimated with a pipette. The buffer 
composition is equilibrated to RIPA buffer by addition of one ninth of the volume of 
sonication-to-RIPA-buffer (10X) (10mM Tris-HCl pH8, 1mM EDTA, 10% 
Triton X100, 0.1% SDS, 1% NaDeoxycholate, 1.4M NaCl, in H2O). 2% of the total 
material is taken as input chromatin and is stored at 4°C until indicated. The 
remaining chromatin is diluted from 2 to 10 times in RIPA buffer complemented 
with protease inhibitors from Roche. The antibody is added to the chromatin and 
the tubes are incubated ON on a rotator at 4°C. The immunocomplexes are captured 
by the addition of 20µl of magnetic beads conjugated with Protein A, resuspended in 
RIPA buffer. The slurry is left in rotation at 4°C for other 5 hours, in order for the 
beads to capture most of the immunocomplexes. Before the first wash, the beads are 
immobilized on the side of the tube with a magnetic rack and 100µl of flow-through 
chromatin is collected. The beads are washed three times in RIPA buffer, one time 
in RIPA buffer 500mM NaCl, and one time in TE buffer (10mM Tris-HCl pH8, 
1mM EDTA pH 8, in H2O) leaving the tube in rotation at 4°C for a few minutes 
every wash. After the last wash, the tube is changed with a clean one and the 
immunocomplexes are eluted with 95µl of elution buffer (10mM Tris-HCl pH8, 
1mM EDTA pH 8, 150mM NaCl, 0.1% SDS, in H2O). The input chromatin 
samples are also equilibrated in 95µl of elution buffer and from this step on, together 
with the flow-through fractions, they are subjected to the same treatments as the 
ChIP samples. The crosslinks between DNA and protein are reversed by incubating 
the samples ON at 65°C in a thermomixer with 800rpm shacking. 20µg of PK are 
added to the tubes and incubated for 2 hours at 55°C in a thermomixer, shacking at 
800rpm. Only applied to the ChIP samples: the beads are separated from the 
solution using a magnetic rack and the supernatants are collected into new tubes. 
The prepared DNA is purified by phenol chloroform. One volume of phenol-
choloroform-isoamyl-alcohol (25:24:1) is added to each tube, mixed with a vortex at 
max speed for 30 seconds, and spun for 5 minutes at RT at 15000g. The aqueous 
phases are collected into new tubes. 2.5 volumes of cold 100% ethanol, 20µg of 
glycogen and 0.1 volumes of NaAcetate 3M pH 5 are added to the tubes. They are 
then vortexed for 30 seconds at max speed, incubated for 1h at -20°C and spun for 
10 minutes at >13000rpm on a benchtop centrifuge at 4°C. The DNA pellets are 
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washed with cold 70% ethanol by spinning for 10 minutes at >13000rpm on a 
benchtop centrifuge, at 4°C. The DNA is resuspended in 40µl H2O and can be 
stored at -20°C. 1µg of DNA from the flow through is run on a 1.5% agarose gel. It 
is expected that the majority of the DNA is found in the range 100–400bp. If the 
fragmentation considerably exceeds this range, the DNA cannot be used for 
downstream analysis. The quality of the ChIP is assessed by qPCR. The enrichment 
of the ChIP DNA relative to the input is compared for different genomic locations 
representing known enriched/non-enriched regions. If the signal to noise ratio is 
higher than 30, the samples can be subjected to library preparation and sequencing. 
Epitope Antibody Tissues per ChIP-seq Sonication 
volume (µl) 
Antibody (µg) 
Slices 10^6 cells 
H3K27ac ab4729 10 3 300 1 
H3K4me1 ab8895 10 3 300 0.5 
H2A.Z ab4174 20 6 300 1 
RNA Pol II sc-899 80 24 900 12 
H3K27me3 ab6002 10 3 300 0.5 
H3K9me3 ab8898 20 6 300 0.7 
CTCF 07-729 80 24 900 10 
RAD21 Ab992 80 24 900 3 
4.2.13.1 Library Preparation and Sequencing 
The libraries for ChIP-seq are prepared using the NEB next kits (for libraries and 
multiplexing, listed in the materials section) according to the manufacturer’s 
instructions, applying the following adaptations. DNA purification between every 
reaction is carried out using the Quiaquick PCR purification kit, instead of the 
(recommended) AMPure beads. The size selection is performed before the PCR 
amplification, like described in the protocol, but using 2% E-gels from Invitrogen 
instead of AMPure beads. The quality of the library is assessed by DNA 
electrophoresis on chip, Agilent Bioanalyzer, DNA 1000 kit. It is expected that all 
the samples have a unique fragments distribution centered on 320bp. In case some 
samples carry adaptor dimer contaminants, characterized by a typical peak around 
80bp in the Bioanalyzer chromatogram, the samples are processed using SPRI select 
beads. The samples are all brought to exactly 50µl. 55µl of beads are used for the 
purification. This ratio of aqueous phase and beads efficiently removes DNA with a 
size equal or lower than 80bp. The affected samples are reanalyzed on the 
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Bioanalyzer after the purification. Once all the samples show a single distribution of 
fragments, they are diluted to 10nM and can be pooled (if required). The sequencing 
is done on Illumina HiSeq 2000 machines, choosing the option 50bp single-end 
reads with a dedicated short read for the index. The procedure requires that both 
input and ChIP samples are sequenced to at least 1X coverage. For mammalian 
genomes like mouse this corresponds to approximately 10^7 uniquely mapped reads 
with average genomic fragment size of 250bp. Usually up to 12 samples can be 
pooled in one HiSeq 2000 lane. 
4.2.13.2 ChIP-seq Data Processing 
The reads obtained from the sequencing are aligned to the NCBI37/mm9 reference 
mouse genome using the bowtie2 software (version 2.1.0), using the default settings 
(one mismatch allowed). Alignments are converted from sam to bam-format, They 
are then sorted and indexed using samtools software (version 0.1.19). Peaks are 
called using macs14, also in this case using the default parameters. Coverage tracks 
are done using the GenomicRanges, GenomicAlignments and rtracklayer R 
packages (Bioconductor version: release 3.1). Peaks lift over to all the mouse 
reference genomes coordinates is done using rtracklayer R package. Sequencing 
quality is assessed using ShortRead R package (same Bioconductor release as before). 
4.2.13.3 ChIP-qPCR on c-Myc Inversion Lines 
The occupancy of CTCF and RAD21 on c-Myc locus is analyzed on Wt, INV1, 
INV2 and INV3 lines on 13 selected genomic locations, plus 10 other control 
regions (as listed in the table below).  
Primer name Genomic location Type Figure nomenclature* 
chr15-59928547-59929378 chr15:59928547 Assay F1 
chr15-60591260-60592101 chr15:60591260 Assay F2 
chr15-60933612-60934521 chr15:60933612 Assay FM1 
chr15-60988828-60989797 chr15:60988828 Assay FM2 
chr15-61814519-61815473 chr15:61814519 Assay M1 
chr15-62159709-62160443 chr15:62159709 Assay M2 
chr15-63171736-63172525 chr15:63171736 Assay M3 
chr15-63432906-63433773 chr15:63432906 Assay TEL1 
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chr15-63483813-63484536 chr15:63483813 Assay TEL2 
chr15-63553022-63553963 chr15:63553022 Assay TEL4 
chr15-63572139-63572734 chr15:63572139 Assay TEL5 
chr15-63602886-63603631 chr15:63602886  Assay TEL6 
chr15-63660558-63660911 chr15:63660558 Assay TEL8 
chr8-47020195_Pos1 chr8:47020195 Control Positive 1 
chr1-183819016_Pos2 chr1:183819016 Control Positive 2 
chr12-82889780_Pos3 chr12:82889780 Control Positive 3 
chr1-84730497_Mid1 chr1:84730497 Control Middle 1 
chr3-36036726_Mid2 chr3:36036726 Control Middle 2 
chr5-65394338_Mid3 chr5:65394338 Control Middle 3 
chr10-100659186_Neg1 chr10:100659186 Control Negative 1 
chr5-59680664_Neg2 chr5:59680664 Control Negative 2 
chr14-81658234_Neg3 chr14:81658234 Control Negative 3 
chr16-53987613_Neg4 chr16:53987613 Control Negative 4 
(*) F = Fam84b-TAD; FM = Fam84b-c-Myc-TAD-boundary; M = c-Myc-TAD; 
TEL = Telomeric End of c-Myc locus (the numbers represent the CTCF peaks 
numeration on figure 23A). 
The experiment is done on E11.5 face and liver. For each line at least three 
independent biological replicates are processed. The samples for INV1 are obtained 
from heterozygote-heterozygote breeding, from which only homozygote tissues are 
used. The samples for INV2 and INV3 are generated from homozygote-homozygote 
breeding, while the Wt from C57BL/6J-C57BL/6J breeding. In order to minimize 
litter-based biases, several litters for each line are collected and, tissue slices from 
each litter are randomly subdivided between the replicates (see table below for more 
details). Each sample is processed as described earlier, and the chromatin thereby 
obtained is split into two aliquots, used for CTCF and RAD21 ChIP. The ChIP 
and input DNA (84 samples in total) is subjected to qPCR on a Fluidigm system (96 
primers, 96 samples chip). This setup guarantees at least 4 independent qPCR 
reactions for each sample, using 23 primers. 
Line Tissue Antibodies Biological 
replicates 
Total 
litters 
Slices per 
ChIP 
Wt Liver CTCF, RAD21 3 7 8 
Inversion 1 Liver CTCF, RAD21 3 6 2.5 
Inversion 2 Liver CTCF, RAD21 3 9 10.5 
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Inversion 3 Liver CTCF, RAD21 3 13 7.5 
Wt Face CTCF, RAD21 4 7 6 
Inversion 1 Face CTCF, RAD21 3 6 2.5 
Inversion 2 Face CTCF, RAD21 4 9 7.5 
Inversion 3 Face CTCF, RAD21 4 13 5.5 
4.2.13.4 ChIP-qPCR on c-Myc Inversion Lines Data Processing 
Enrichment compared to input is calculated according to the equation 2, where Ref 
represents the input and X the ChIP. 
To test for difference in enrichment on inversion lines and Wt (control 
genotype) the standard t-test has been used. However, the fact that the variance 
estimated for the technical and biological replicates does not represent the total one, 
may give some inaccuracies. In ChIP-qPCR the variance is modeled according to 
the equation 7. 
Equation 7: σ 2 =σ 2bio logical +σ 2det ection +σ 2residual  
The σ 2det ection represents the variability of the measurement itself (qPCR variability on 
both input and ChIP). The σ 2bio logical can be further subdivided into two components, 
modeled by equation 8. 
Equation 8: σ 2bio logical =σ 2replicate +σ 2genotype  
The biological replicates do not allow estimating the whole biological variance. 
There is another source of biological variability, represented by having different 
lines. One way to overcome this problem could be to perform heterozygotes-
heterozygotes crosses for each line, and compare Wt and homozygotes tissues 
obtained from the same breeding. 
If this breeding setup is not available, like in this case, an analytical correction to 
the σ 2 can be applied. The aim is to find the σ 2genotype  term, whose addition to the 
equation 8 increases the variance, resulting in a slight decrease in statistical power. 
The estimate of σ 2genotype  must be done on the control regions, which are 
assumed to be unaffected by the genetic engineering. The first step in the procedure is to apply a glog transformation to the data, this in order to rule out mean-variance 
relationships (equation 9). Afterwards, the variance components are obtained by 
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fitting linear mixed-effect models (lme4 R package), specifying genotype and 
replicate random-effects. The total variance σ 2 is calculated by summing all the 
variance components in the model. 
Equation 9: g log(x) = ArcSin x( )− log 2( )"# $% / log 2( )  
Finally, p-values are calculated and corrected by Benjamini-Hockberg method. 
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5 Results 
5.1 Genetic Characterization of c-Myc locus, Done By 
Veli Uslu 
5.1.1 Regulatory Landscape of c-Myc locus in Mouse Embryos 
The regulatory potential of c-Myc locus was assessed by a former student in the 
laboratory, Veli Uslu, using the Genome Regulatory Organization Mapping with 
Integrated Transposons (GROMIT) system (Ruf et al., 2011; Uslu et al., 2014). 
GROMIT is based on a LacZ reporter gene under the control of the minimal 
promoter of the β-globin gene. This promoter does not allow the expression of the 
LacZ reporter unless regulatory inputs are conveyed. Therefore, GROMIT can be 
seen as a regulatory sensor that reveals the transcriptional capability of the genome at 
the place where it is inserted, providing a readout of the integrated effects of 
regulatory elements, DNA topology and chromatin environment altogether. 
Veli Uslu started this screening by remobilizing the GROMIT insertion 179039 
(located inside c-Myc locus, established by Sandra Ruf) and obtained more than 50 
new insertions in c-Myc locus, covering mostly the telomeric side.  
From the analysis of the LacZ expression, performed at 11.5 days of gestation 
(E11.5) it was possible to notice that many insertions on the telomeric side of the 
locus showed expression of the LacZ reporter—at least in some tissues—overlapping 
with the endogenous c-Myc expression seen by RNA in-situ hybridization (figure 7). 
Remarkably, some of the insertions that gave LacZ staining patterns reproducing 
most closely the endogenous c-Myc expression, occurred 1.7Mbp away from c-Myc 
promoter, at the telomeric end of the locus (179039 (TRACER database entry ID) or 
17a (Veli Uslu’s nomenclature, expressing the distance from c-Myc promoter in 
hundreds of Kbp), figure 7), the tissues nomenclature is summarized in the 
supplementary figure 1). Tissues such as facial mesenchyme (FM), somites, branchial 
arches (BA), rhombic lip (RL) and proximal limb mesoderm (PLM) appeared 
stained in multiple insertions. Liver staining was observed only for two insertions 
(one of which is 194578 (3a), figure 7), while tissues like tail bud, forebrain, 
midbrain, neural tube and terminal limb mesoderm were never stained.  
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Figure 7 | c-Myc locus regulatory landscape. A) Hi-C interaction heatmap of mouse CH12 
cells (mm9 genomic coordinates chr15:60000000-64000000) available at: 
http://promoter.bx.psu.edu/hi-c/view.php, with annotation of the c-Myc locus regulatory 
domains (RDs) (Rao SS et al., 2014). The resolution is 25Kbp, while the intensity reflects 
the number of sequencing reads for each interaction: ≤1, white; ≥80, red. B) Material 
presented thanks to kind concession of Veli Uslu. This panel shows the LacZ reporter 
staining of E11.5 mouse embryos from selected GROMIT insertions (located on the paternal 
allele) representative of c-Myc and Fam49b RDs. The name of each insertion refers to the 
entry ID in the public database TRACER (http://www.ebi.ac.uk/panda-srv/tracer/). The name 
in brackets refers to the approximate distance from c-Myc promoter, expressed as multiples 
of 10^5bp. 
 
	   77 
Three insertions occurred further away, after the telomeric end of the gene-
desert, in the Fam49b locus. These insertions showed a completely different scenario 
than in c-Myc locus, they had a LacZ staining scattered throughout the embryo, 
being particularly marked on the tail bud, forebrain, midbrain-hindbrain boundary 
and neural tube (192331 (20a), figure 7). Finally, three insertions were obtained at 
the centromeric side of c-Myc locus and were in all the three cases negative. 
 This screening revealed the presence of three distinct regulatory domains (RD) 
on the telomeric side of the locus and on the neighboring loci (Symmons et al., 2014). 
The first one extends from c-Myc to the end of Pvt1 transcribed region, showing 
mainly liver specific transcriptional inputs. The second RD includes the first one and 
extends from c-Myc to the Gsdmc gene cluster. It contains different insertions that 
show LacZ expression in all the tissues with higher c-Myc expression (often in just a 
combination of them), and therefore termed c-Myc-RD. Finally, the third RD lies 
telomeric to the Gsdmc gene cluster, on the Fam49b locus (referred to as Fam49b-
RD), showing completely distinct staining patterns than the ones on c-Myc-RD.  
Importantly, in this region the disposition of RDs extensively overlap with the 
disposition of the topological domains. Hi-C interaction maps of c-Myc locus 
available for mESC, mouse cortex and CH12 cell line show that c-Myc is embedded 
in one TAD extending from just after the gene Fam84b to the Gsdmc cluster, termed 
c-Myc-TAD (figure 8). c-Myc-TAD can be further subdivided into two smaller 
sub-TADs, having c-Myc itself at the border. The c-Myc-RD lies inside the c-Myc-
TAD, overlapping with the telomeric c-Myc-subTAD. At the Gsdmc gene-cluster a 
TAD-boundary separates the c-Myc-TAD from the adjacent and more telomeric 
one. This latter TAD contains the Fam49b gene (Fam49b-TAD) and overlaps with 
the Fam49b-RD. The correlation between TADs and the reporter staining of 
GROMIT insertions suggests that the activity of regulatory elements may be indeed 
confined within the TAD and supports the model proposed by Symmons and 
colleagues describing an extensive overlap between TADs and regulatory domain 
(Symmons et al., 2014). 
A more detailed look reveals that inside c-Myc-TAD not all the insertions led 
to reporter expression in the same tissues. In many cases the staining was present 
only in a subset of the tissues where the endogenous c-Myc expression is higher. In 
addition, some insertions inside c-Myc-TAD gave no reporter expression at all 
(referred to as “cold spots” or “blank spots”, 193970 (10a), figure 7). Focusing on the 
nasal epithelia (NE) the LacZ staining was seen only in insertions located towards 
the telomeric edge of the locus. Others, for example the FM, somites and PLM 
showed LacZ staining of different intensities/strength when comparing GROMIT 
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insertions integrated in different parts of the c-Myc-TAD. Finally in the case of the 
liver, the reporter staining was captured only within ~ 300Kbp to c-Myc, on the 
telomeric side of the locus.  
In conclusion, the fact that the regulatory landscape varies from tissue to tissue 
indicates that the locus could have tissue-specific properties. In addition, the fact that 
not all the insertions occurring intra-TAD gave the same reporter staining, shows 
that not all the positions inside the TAD are equally likely to receive the same 
regulatory inputs. One possible explanation for this may be that in c-Myc locus 
different intra-TAD sub-topologies or chromatin features vary from tissue to tissue. 
 
Figure 8 | c-Myc and neighboring loci topological organization. A) Hi-C interaction 
heatmap of mouse CH12 cells (mm9 genomic coordinates: chr15:58000000-65500000), 
available at: http://promoter.bx.psu.edu/hi-c/view.php (Rao SS et al., 2014). Each point 
shows the interaction between two 25Kbp bins while the intensity refers to the number of 
reads for each interaction, from ≤1 (white) to ≥80 (red). B) The extension of c-Myc locus 
features is represented by green arrows, the TAD structures by blue arrows, TAD-
boundaries by red arrows and the balanced chromosomal inversions (INV1, INV2 and INV3) 
by grey arrows. 
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5.1.2 Identification of Important Regions for c-Myc 
Expression in Facial Tissues 
In human, GWAS showed that the 8q24.21 is the locus with the highest attributable 
risk for non-syndromic cleft-lip and palate (Birnbaum et al., 2009). In mouse, the 
ortholog of the human 8q24.21 lies in the chromosome 15 and corresponds to a 
575Kbp portion of the telomeric side of c-Myc locus. In this region (as well as in the 
neighboring ones), GROMIT captured transcriptional inputs acting on the MFM 
and supports the idea that the region contains long-range regulatory elements 
important for c-Myc expression in the developing face. 
This tissue in mouse and human is the one forming the anterior structures of the 
oral cavity, i.e. the upper lip and the primary palate. The FM can be further 
subdivided in two components: the medial facial mesenchyme (MFM) and the 
lateral facial mesenchyme (LFM), separated by the nasal pits. The two MFN 
processes fuse with the maxillary process and form the upper lip and primary palate, 
whereas the LFM give rise to the nasal alae. In mouse, this event occurs between 10 
and 15 days of gestation. Growth defects of the MFM at this stage, lead to 
incomplete merging with the maxillary process and can cause the disease cleft lip 
and/or cleft palate (CLP) (reviewed in M. J. Dixon, Marazita, Beaty, & Murray, 
2011; Mossey, Little, Munger, Dixon, & Shaw, 2009). 
Veli Uslu hypothesized that the reduced tissue proliferation causing the 
incomplete merge of the MFM⎯observed in the CLP disease⎯was due to a 
decrement of c-Myc expression, caused in turn by polymorphisms on remote 
enhancers.  
Veli Uslu tested this hypothesis in mouse embryos, and also, restricted the 
position of the putative regulatory element(s) to smaller windows. He created a panel 
of chromosomal deletions spanning different parts of the telomeric side of c-Myc 
locus. He did this using the Targeted Meiotic Recombination (TAMERE) method 
(based on the Cre-LoxP system) taking advantage of the LoxP site present inside 
each GROMIT insertion (Hérault, Rassoulzadegan, Cuzin, & Duboule, 1998). The 
analysis of the LacZ reporter expression from E11.5 mouse embryos carrying the 
deletions showed that MFM and NE reporter activity relied on two independent but 
close regions. The NE critical region was restricted to about 100Kbp, from ~ 
1.4Mbp to ~ 1.5Mbp telomeric to c-Myc promoter (Del(14–15), figure 9D), while 
the one for the MFM was restricted to about 600Kbp, ranging from ~ 800Kbp, to ~ 
1.4Mbp telomeric to c-Myc promoter (Del(8–14), figure 9D, supplementary figure 3, 
mm9 genomic coordinates: chr15:62561825-63135562) (Uslu et al., 2014).  
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Importantly, in the same study it was reported that the deletion of both critical 
regions, that caused loss of reporter expression in all facial tissues (MFM, LFM and 
NE, Del(8–17), figure 9D), did not only affect the reporter expression. It also 
affected the endogenous c-Myc expression, specifically in the facial tissues and to a 
lower extent in the fore limbs (FL), but not in other tissues such as heart and liver. 
Therefore, the deleted region contained regulatory elements with enhancer feature, 
affecting selectively c-Myc in the face and FL. Their absence sporadically led to cleft 
lip and palate, and also significantly affected the proportions of craniofacial bones in 
adult mice, suggesting that these regulatory elements are important for the correct 
facial morphogenesis (Uslu et al., 2014). 
 
 
Figure 9 | Identification of facial enhancers in c-Myc locus. Adapted from (Uslu et al., 
2014). A) Panel representing the disposition of deletions in c-Myc and neighboring loci, the 
position of GROMIT insertions, and, the approximate position of the facial regulatory 
elements identified (blue and yellow ellipses, for facial mesenchyme and nasal epithelia 
respectively). B) Frontal view of the head of E11.5 mouse embryos from different GROMIT 
lines subjected to LacZ staining procedure. The staining on medial face mesenchyme 
(MFM) and nasal epithelia (NE) is indicated by blue and yellow arrows respectively. MNP, 
medionasal process; MX, maxillary process; MD mandibular process; LNP, lateral nasal 
process; NP nasal epithelium. C) Vibrotome sections of the face of an E11.5 embryo 
positive for the 17a GROMIT line. The LacZ staining in the MFM and NE is shown by a blue 
and a yellow arrow respectively. D) Frontal view of the head from E11.5 mouse embryos 
carrying selected chromosomal deletions, and subjected to the LacZ staining protocol. The 
deletions Del(8–14) and Del(14–15) allowed the identification of important regions 
responsible for the LacZ reporter expression in the MFM and NE respectively. 
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5.2 Chromatin Composition of c-Myc locus in Wt 
Embryonic Tissues 
5.2.1 Enhancer Associated Chromatin 
5.2.1.1 Setup 
The collocation of the MFM enhancer(s) in a region of 600Kbp needed to be 
refined. For this reason, in order to restrict their position even further we performed 
ChIP-seq for the histone modifications enriched at enhancer sites, namely H3K27ac 
and H3K4me1. These chromatin marks do not provide the exact same readout. 
H3K4me1 is found at active and inactive/poised enhancers, while H3K27ac 
comprises mostly active ones (Creyghton et al., 2010b; Xu et al., 2009).  
We did these experiments on E11.5 Wt specimens of face, liver, and for 
H3K27ac, also the fore brain (FB).  
The way we dissected the face—common to all the experimental procedures 
described thereafter, e.g. cDNA qPCR and bisulfite-sequencing—included both the 
FM and the NE tissues (the latter is embedded inside the FM). However, the fact 
that the FM is much more represented than the NE (in terms of number of cells, 
data not shown), make us support the idea that the experimental evidences 
concerning the face specimens are more attributable to the FM than to the NE. 
However, in order to avoid inaccuracies we will refer to this sample as face.  
Regarding the liver, the reason why we included it in this analysis, is that this 
tissue represents an additional system (to the face) to study c-Myc promoter–
regulatory elements communication. Despite the fact that no chromosomal deletion 
was done in order to prove the presence of liver enhancers in the locus, the liver is one 
of the tissues where c-Myc expression is higher at this stage, as seen by in situ 
hybridization (figure 7). Two GROMIT insertions, mapped by Veli Uslu, located in 
the non-coding transcript Pvt1, revealed LacZ reporter expression in this tissue. 
Although GROMIT per se does not indicate the position of enhancers, it clearly 
indicates that in the liver there are regulatory inputs reaching the 194578 (3a) 
insertion (inside Pvt1) as well as c-Myc promoter (as seen by in situ hybridization) 
(figure 7). The fact that the deletion of 900Kbp (Del(8–17), figure 9D), which 
includes the facial enhancers (for MFM and NE), is responsible for c-Myc 
downregulation in the face (and to a lower extent in the FL), but not in the liver, 
indicates that different sets of regulatory elements coordinate c-Myc expression in 
these two tissues. As the liver enhancers are most likely located centromeric to the 
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deletion breakpoint 8a (Del(8–17)), and, the LacZ expression in the liver is seen only 
for insertions integrated inside Pvt1 transcribed region, it is possible that these 
enhancers lie inside this region. 
Finally, concerning the FB, we know that in this tissue c-Myc expression is kept 
to the basal level. In addition, no GROMIT insertion (integrated in c-Myc locus) 
captured any regulatory input in the FB. For these reasons, we included the FB in 
this analysis as a negative control. 
5.2.1.2 Results 
Focusing on the telomeric side of c-Myc locus, in the face we identified several 
regions with significant enrichment of H3K4me1 compared to the input chromatin 
(also called “peaks”), and are scattered throughout the locus. H3K27ac instead shows 
fewer enriched regions, clustered in three main parts (figure 10A). One encompasses 
the whole Pvt1 transcribed region (about 210Kbp large), another is found at the 
telomeric end of the locus, extending for about 100Kbp around the GROMIT 
insertion 179039 (17a), and the last one corresponds to the ~ 600Kbp region, 
delineated by the deletion Del(8–14), containing the MFM enhancer(s). In 
particular, three out of four H3K27ac peaks of this cluster fall inside this critical 
region (figure 10C). Interestingly, one of these peaks overlaps with the mouse 
ortholog of the sequence hs1877, shown by transgenic assays to drive reporter 
expression in the MFM, as well as in few other tissues (figure 10D and F) (Attanasio 
et al., 2013). Another peak, also located inside the MFM enhancer(s) critical region, 
lies close (~ 2.5Kbp) to the sequence mm458 (figure 10E). This sequence was tested 
by transgenic assay (in the same study as hs1877) and was shown to drive reporter 
expression in the maxillary process (and a few other tissues, but not the FM or NE) 
(figure 10F). Although mm458 and the close H3K27ac peak do not overlap, they 
both map within a broader H3K27ac enriched region, sized about 7Kbp (figure 
10E). However, with our peak calling settings, we call significantly enriched just one 
part of this ~ 7Kbp region, namely, the more centromeric. Importantly, the maxillary 
process, stained in mm458 transgenic assays, is not included in the portion of facial 
tissue that we used for the ChIP-seq experiments (unless as a minor contaminant). 
Therefore it is possible that the H3K27ac peak does not delineate the regulatory 
elements found on the mm458 sequence. 
Regarding the other two clusters of H3K27ac peaks in the face (the one on Pvt1 
transcribed region and the one located at the telomeric end of the locus), their 
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function is unknown. However, chromosomal deletions of both of them show that 
they are dispensable for driving LacZ transcription in the facial tissues (FM and 
NE), as reported by Veli Uslu (figure 9D, Del(c8–7), Del(15–17) and Del(17–21)) 
(Uslu et al., 2014). Therefore, it is possible that MFM enhancer(s) correspond to 
one or more of the three peaks included in the MFM enhancer(s) critical region 
found by Veli Uslu. 
 
 
	   84 
 
Figure 10 | Enhancer associated chromatin. H3K27ac and H3K4me1 ChIP-seq analysis 
of E11.5 Wt (C57BL/6J) face (blue), liver (red) and fore brain (FB, green). The y-axis 
represents the sequencing coverage (different values are due to the slightly different 
sequencing depth of the individual libraries, as well as differences in signal/noise ratios of 
the different antibodies and tissues used). The tracks on the left show the actual ChIP-seq, 
while the ones on the right show the input chromatin control (used to show the biases 
introduced by the procedure and not due to the antibody pull-down). Peaks (called using 
MACS14 software) are shown on a dedicated track underneath each ChIP-seq profile. A) 
Extended view of the c-Myc locus (mm9 coordinates: chr15:60000000-64000000). The 
emphasized regions on the face and liver tracks represent the zoomed regions shown in 
panel B and C respectively. B) Detailed view of liver ChIP-seq coverage profiles on Pvt1 
transcribed region (region potentially containing liver enhancer(s)). C) Detailed view of face 
ChIP-seq experiments, representing part of the telomeric side of c-Myc locus (mm9 
coordinates: chr15:62500000-63500000) which includes the ~ 600Kbp region (Del(8–14)) 
found by Veli Uslu to be critical for c-Myc expression in the MFM (mm9 coordinates: 
chr15:62561825-63135562). The locations of the mouse orthologous of the human 8q24.21 
region (cleft lip and/or palate susceptibility region, including the SNP rs987525) and Del(8–
14) are indicated by magenta and blue lines respectively. D) Detailed view of the region 
overlapping with the mouse ortholog of the (human) sequence hs1877. Attanasio and 
colleagues showed by transgenic assays that this region is capable of driving reporter 
expression in the MFM and other tissues, in mouse embryos. Input chromatin controls and 
peak calling tracks are shown below each ChIP-seq coverage track (same as for panel E). 
E) View of the region surrounding the sequence mm458, found by Attanasio and colleagues 
to drive reporter expression in the maxillary process and a few other tissues in mouse 
embryos. F) Adapted from (Attanasio et al., 2013). Panel showing LacZ staining of E11.5 
mouse embryos tested by transgenic enhancer reporter assays (sequences hs1877 an 
mm458). The numbers indicate the fraction of stained embryos out of the total ones, tested 
for each sequence. 
In the liver, for both H3K4me1 and H3K27ac most of the peaks lie inside the 
Pvt1 transcribed region (figure 10B). For both modifications there are few peaks 
occurring around the insertion 179039 (17a). These data support the idea mentioned 
above, that the liver enhancer(s) are located inside Pvt1 transcribed region. 
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Nevertheless, due to the lack of chromosomal deletions showing any effect on the 
endogenous c-Myc expression, or the abolishment of reporter transcription in the 
liver, we cannot prove the presence of liver enhancer(s) in this region (there is a 
deletion that completely removes c-Myc and Pvt1 (figure 9D, Del(c8–7), however, 
none of the breakpoints show staining in the liver, and therefore, it cannot show any 
reduction of LacZ expression in this tissue). 
In the FB, according to the observations that this tissue has basal c-Myc 
expression, and no regulatory inputs are captured by GROMIT in any location of 
the locus (figure 7B), inside c-Myc locus, except for Fam48b and c-Myc promoters, we 
find no H3K27ac enriched regions (figure 10A and supplementary figure 4). 
The presence of H3K27ac at certain parts of the locus, support the observations 
drawn by Veli Uslu regarding the position of the facial and liver enhancers. In the 
face, our ChIP-seq datasets show the presence of three regions, sized about 1Kbp 
that may include the MFM enhancer(s). In the liver, the 21 H3K27ac peaks found 
in the Pvt1 transcribed region make it more difficult to de-convolute the subset of 
regulatory elements (if any in this region) important for c-Myc expression in this 
tissue. 
5.2.2 Transcriptionally Active Chromatin 
It was recently shown that transcription by RNA Pol II often occurs at enhancer 
sites other than at protein coding genes (Andersson et al., 2014; Core et al., 2014). 
Despite the fact that it is not known how universal this mechanism may be, and, 
what fraction of enhancers undergo active transcription, we decided to take 
advantage of this feature and analyze the transcriptionally active chromatin inside c-
Myc locus, with the purpose of refining even further the position of the tissue-specific 
enhancers. 
We considered a few points before performing this analysis. Firstly, there are 
histone modifications that can be pooled-down (on ChIP-seq experiments) in order 
to identify actively transcribed genes, or active promoters. However, except for the 
H3K27ac (already discussed), these marks do not usually cover enhancer sites. 
Secondly, since the RNA molecules transcribed at enhancer sites are reported to be 
unstable, being degraded soon after they are produced (probably degraded co-
transcriptionally, by the exosome complex), standard transcriptomics methods do not 
usually allow their identification (Core et al., 2014).  
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We opted for a RNA Pol II ChIP-seq approach. We performed this experiment 
on E11.5 face and liver, using an antibody that recognizes the RNA Pol II regardless 
of any post-translational modification (PTM) (for example the phosphorylation of 
the serine 2 of the RNA Pol II CTD, present only during elongation). 
Inside c-Myc locus we observed RNA Pol II occupancy uniquely at annotated 
transcripts in both face and liver (figure 11A, B and C).  
 
Figure 11 | Transcriptionally active chromatin. RNA Pol II ChIP-seq analysis of E11.5 Wt 
(C57BL/6J) face (blue) and liver (red). The y-axis represents the sequencing coverage 
(different values are due to the slightly different sequencing depth of the individual libraries 
as well as differences in signal/noise ratios characteristics of the different tissues). The 
tracks on the left show the actual ChIP-seq, the ones on the right, the input chromatin 
control (used to show the biases introduced by the procedure and not due to the antibody 
pull-down). A) View of c-Myc and surrounding loci (mm9 coordinates: chr15:59000000-
64000000). B) Detailed view of Fam84b (mm9 coordinates: chr15:60530000-60820000). C) 
Detailed view of c-Myc (mm9 coordinates: chr15:61800000-61855000). D) View of an 
intergenic region showing RNA Pol II enrichment (mm9 coordinates: chr15:55000000-
55250000). 
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In the liver, we saw some enrichment of RNA Pol II on Pvt1 transcribed region. 
Since the liver enhancer(s) are likely located inside this region, we cannot tell 
whether the enrichment we found is the result of the Pvt1 transcription or enhancer 
site transcription. 
On a genome-wide scale, our data shows some intergenic RNA Pol II 
occupancy (figure 11D). However, the literature does not provide extensive 
description regarding the function of non-coding transcription in general. Some 
reports propose that non-coding transcription may account for a significant portion 
of gene expression regulation, with a wide spectrum of influence at several layers, 
including chromatin architecture/epigenetics, RNA splicing, editing and turnover 
(reviewed by Mattick & Makunin, 2006). Regarding its role on chromatin, it was 
shown that intergenic transcription can alter nucleosome density and play a role in 
protein–DNA interactions (Hainer, Pruneski, Mitchell, Monteverde, & Martens, 
2011). Since non-coding transcription may have different potential functions, we 
cannot tell whether the intergenic RNA Pol II occupancy we saw on a few genomic 
locations underlies enhancer RNAs or other types of non-coding transcription. 
In addition, because of the fact that we know from deletion experiments that the 
telomeric side of the locus contains facial enhancers (important for c-Myc expression 
on the FM and NE), but we did not see any intergenic RNA Pol II occupancy, we 
conclude from this analysis that either the experimental setup we used for this 
experiment is not suited to identify enhancer RNAs transcription, or that this 
phenomenon is not a universal feature of the enhancers. 
5.2.3 Repressive Chromatin: Heterochromatin and Polycomb 
Chromatin 
The identification of the facial and liver enhancers regions by GROMIT, 
chromosomal deletions and ChIP-seq allowed us to question why the effect of the 
enhancer was not reaching any position in the locus, but only some parts (as seen by 
GROMIT remobilization, figure 7). There were a few possibilities that could be 
tested. The first is that some regions are embedded in repressive chromatin; the 
second is that the topology of the locus allows only certain segments to physically 
contact the enhancers. We started tackling the question from a chromatin 
perspective, and for this reason we performed ChIP-seq for two well known 
repressive histone modifications: H3K9me3, marker of heterochromatin, and 
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H3K27me3, marker of Polycomb repression. Moreover there is evidence that genes 
marked by H3K27me3 interact with each other inside nuclear territories with active 
transcription. The contacts occur both intra and inter-chromosome and form 
repressive microenvironments inside active territories (Vieux-Rochas, Fabre, Leleu, 
Duboule, & Noordermeer, 2015). According to this view, Polycomb may also play a 
role in the 3D chromosomal organization of the genome, which makes the histone 
modification H3K27me3 particularly relevant for this project.  
We performed H3K9me3 and H3K27me3 ChIP-seq experiments using facial 
and liver tissues from Wt embryos, at the stage E11.5. 
In c-Myc locus, we observed in both face and liver one H3K9me3 enriched 
region, occurring about 90Kbp upstream of the GROMIT insertion 179039 (17a) 
(figure 12). In the liver, we saw an additional peak, located at the beginning of the 
Gsdmc gene cluster. Remarkably, the insertion 179039 (17a), as well as the ones 
integrated up to 300Kbp more centromeric, had reporter expression at least in the 
FM.  
Regarding H3K27me3, also in this case the data looked very similar for both of 
the tissues analyzed. In the whole locus we saw a single peak, located on the promoter 
of Pvt1 (figure 12). This result is consistent with the fact that this gene is expressed 
to an almost undetectable level in both embryonic and adult tissues. 
From these data, we conclude that the histone modifications we analyzed do not 
play a major role in repressing specific parts of the locus, and cannot explain the 
regulatory landscape seen by GROMIT, described by Veli Uslu.  
 
Figure 12 | Repressive chromatin. H3K9me3 and H3K27me3 histone modifications ChIP-
seq on E11.5 Wt (C57BL/6J) embryos; face (blue), liver (red). View showing c-Myc and 
neighboring loci (mm9 coordinates: chr15:60000000-64000000). Lefthand tracks represent 
ChIP-seq experiments, while the righthand ones the input chromatin control. Peak-calling 
results are shown underneath each ChIP-seq track. 
	   89 
Regarding the proposed role of Polycomb to mediate long-range interactions, 
our data suggest that this is not likely the case of c-Myc locus. Inside the locus the only 
H3K27me3 enriched region is separated from the closest ones, on the Fam49b-
Asap1 locus, by a known boundary region (probably overlapping with the c-Myc–
Fam49b–TAD-boundary and the Gsdmcl-ps gene). GROMIT insertions integrated 
telomeric to this boundary element, show a very distinct LacZ staining pattern than 
the one observed in c-Myc locus. For these reasons, we rule out the possibility that 
remote H3K27me3 enriched regions are involved in the topological organization of 
c-Myc locus. 
Despite the scarce presence of heterochromatin and Polycomb mark in c-Myc 
locus, compared to the rest of the genome, it is possible that another kind of 
repressive chromatin helps shaping the observed RDs. It is reported that the histone 
H1 positive chromatin covers almost half of the Drosophila genome and is the most 
represented chromatin type in this model, particularly common at gene poor regions 
such as c-Myc locus (Filion et al., 2010). Whether this kind of repressive chromatin 
covers some parts of the locus, remains to be proven, however, we cannot completely 
exclude the role of repressive chromatin to shape the regulatory landscape of the 
locus. 
5.3 Binding of Architectural Proteins in c-Myc locus in 
Wt Embryonic Tissues 
5.3.1 CTCF 
The role of CTCF in mediating long-range interactions has been demonstrated in a 
few cases, the H19-Igf2 and Hbb loci (figure 2) (Kurukuti et al., 2006; Splinter et al., 
2006). Other than these few locus based cases, its general role in maintaining 
chromosomal architecture has been shown by genome-wide studies (Seitan et al., 
2013; Sofueva et al., 2013; Solovei et al., 2013). Therefore, we hypothesized that 
CTCF may be important for promoter–enhancer long-range interactions in c-Myc 
locus. 
We performed CTCF ChIP-seq on E11.5 face, liver, and FB as a control tissue. 
In these three tissues, we observed few qualitative changes in CTCF binding.  
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Starting from the common features, we saw an enrichment of CTCF at the four 
TAD-boundaries of the locus (figure 13), extending from the one overlapping with 
Trib1, to the one overlapping with Gsdmcl-ps (figure 8). We saw at the Trib1–TAD-
boundary four distinct CTCF peaks; at the Fam84b–c-Myc–TAD-boundary, two; 
and at c-Myc–subTAD-boundary, three. Regarding the last TAD-boundary, 
overlapping with the Gsdmcl-ps gene—despite that we saw no CTCF enrichment—
we saw a cluster of 10 binding sites at its flanking region, namely, the telomeric end 
of c-Myc locus (figure 13 A and C).  
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Figure 13 | Architectural proteins occupancy. H2AZ and CTCF ChIP-seq on E11.5 Wt 
(C57BL/6J) face (blue), liver (red) and fore brain (FB, green). y-axis shows the sequencing 
coverage (slightly different for each library). ChIP-seq experiments are shown on the left, the 
input controls, on the right. Peaks are shown underneath ChIP-seq tracks. A) View of c-Myc 
and neighboring loci (mm9 coordinates: chr15:60000000-64000000) showing enrichment of 
CTCF at the TAD-boundaries (Fam48b–c-Myc–TAD-boundary, c-Myc–subTAD-boundary) 
and at the telomeric end of c-Myc locus (Hi-C data is shown at the top of the figure (Rao et 
al., 2014)). Hi-C data is shown at the top of the panel (available at: 
http://promoter.bx.psu.edu/hi-c/view.php) (Rao SS et al., 2014). Similarly to CTCF, H2AZ 
shows enrichment on all the mentioned regions, except for the telomeric end of the locus in 
the FB (tissue with basal c-Myc expression). B) Detailed view of part of the telomeric c-Myc-
TAD (chr15:62000000-63200000) showing only CTCF ChIP-seq tracks. The region contains 
both tissue-specific and tissue-invariant CTCF peaks. C) Detailed view of the surroundings 
of c-Myc–Fam49b–TAD-boundary (chr15:63300000-63850000) and telomeric end of c-Myc 
locus (mm9 coordinates: chr15:634200000-637500000). This region contains 10 CTCF 
binding sites shared in the three tissues analyzed. In the face and liver H2AZ is enriched at 
some of these CTCF sites. In the same tissues H2AZ displays a broader enrichment, 
spanning the entire end of c-Myc locus, and not necessarily localized into defined peaks. 
These data obtained in vivo confirm what was observed on cell lines, proposing 
an enrichment of CTCF at TAD-boundaries (often occurring as clusters of binding 
sites), and suggest that CTCF occupancy at these regions (in c-Myc locus) is fairly 
constant across the three tissues analyzed (Zuin et al., 2013). 
We detected a few differences on CTCF occupancy in the three tissues. The 
whole gene-desert contains two TADs, the more centromeric, including Fam84b (or 
Fam84b-TAD) and c-Myc-TAD. In both cases we observed CTCF binding sites 
occurring intra-TAD. Focusing on c-Myc-TAD, precisely on the centromeric 
subTAD, face, liver and FB shared two out of the six peaks present in the area 
(figure 13A). In the telomeric c-Myc-subTAD, with exception of the telomeric end 
of the locus, there were no CTCF peaks in the FB (figure 13A and B). Here, in the 
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other two tissues, face and liver, we saw altogether seven peaks, but only two of them 
were shared (figure 13A and B). Two out of the three liver specific CTCF peaks 
were located inside the Pvt1 transcribed region (figure 13A). The two face specific 
peaks, lay more on the telomeric side of the subTAD, 400Kbp centromeric to the 
cluster of CTCF binding sites at the telomeric end of the locus.  
We speculate that these few differences in intra-TAD CTCF binding could, in 
principle, be functional and reflect the fact that the MFM and liver coordinate c-Myc 
expression via different regulatory elements, and perhaps achieve so by 
implementing distinct intra-TAD sub-topologies. 
5.3.2 Histone Variant H2AZ 
H2AZ is a histone variant of the histone H2A. It is found preferentially in 
nucleosomes containing another histone variant, H3.3 (a variant replacing the 
histone H3). The nucleosomes containing this couple of histone variants are 
reported to be particularly unstable, and enriched at gene promoters, regulatory 
regions, transcription factor binding sites, as well as at CTCF binding sites (Jin & 
Felsenfeld, 2007; Jin et al., 2009; Yukawa et al., 2014). Despite the fact that for 
technical reasons it is not possible to perform H3.3 ChIP-seq with the standard 
procedure, the analysis of H2AZ alone is relevant to identify these unstable regions.  
ChIP-seq experiments on E11.5 face, liver and FB revealed the presence of 
several tissue-invariant peaks located at both gene promoters and intergenic regions.  
The same experiment also showed an important difference between the three 
tissues: the telomeric end of c-Myc locus was enriched for this histone variant in the 
face and liver, but not in the FB (figure 13C). All the other TAD-boundaries 
flanking regions in the locus showed similar H2AZ occupancy amongst the three 
tissues. Consistent with this observation, at the telomeric end of the locus we 
detected enrichment of the acetylation mark H3K27ac only in the face and liver, but 
not in the FB (figure 10A). Importantly, this part of the locus, which contains a 
tissue-invariant cluster of CTCF peaks, is also a TAD-boundary flanking sequence. 
The tissue-specific differences in enrichment of both H2AZ and H3K27ac that we 
observed could underlie different properties of this region in tissues where c-Myc 
expression is high, compared to the tissues where c-Myc expression is kept at a basal 
level. 
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5.4 Balanced Chromosomal Inversions in c-Myc locus 
5.4.1 Inversion 1 
One of the main purposes of the project is to gain insights into the influence the 
locus topology has on transcription. The reason why we decided to tackle this 
question by making three balanced chromosomal inversions is that these 
rearrangements provide us a way to reshuffle the genetic elements in c-Myc locus, 
without perturbing qualitatively and quantitatively the genetic context. On the basis 
of the position of the tissue specific enhancers relative to c-Myc promoter, as well as 
considering the TADs present in the locus, each inversion is designed to affect the 
locus topology in a specific way. 
The inversion 1 (INV1) extends from Fam84b-TAD (GROMIT insertion 
196231 (-17a or c17a)) to the end of Pvt1 transcribed region (GROMIT insertion 
194578 (3a)). Considering the effect of this perturbation in the MFM, we know that 
the enhancer(s) active in this tissue are located outside the inverted region, precisely 
on the telomeric side. The inversion brings c-Myc and Pvt1 on the centromeric end 
of the locus, further from the facial enhancers compared to the Wt situation. In the 
liver, as we believe that the relevant enhancer(s) lie inside Pvt1 transcribed region, 
the relationship between c-Myc promoter and these enhancer(s) should remain 
unaltered upon inversion. Concerning the topological organization, the two 
breakpoints of the inversion are in two different TADs: the centromeric one in 
Fam84b-TAD, and the telomeric one, in c-Myc-TAD. INV1 therefore mixes the 
two TADs together, and more importantly, it introduces a TAD-boundary 
(Fam84b–c-Myc–TAD-boundary) between c-Myc promoter and the telomeric side 
of the locus (figure 8). This configuration is particularly interesting for the facial 
tissues as in this case c-Myc promoter and the enhancers, other than being further 
away than in the Wt, are also separated by such a boundary. 
The analysis of the LacZ reporter expression showed that the centromeric 
breakpoint 196231 (-17a) remained unresponsive to any transcriptional input even 
after inversion. Regarding the telomeric breakpoint, insertion 194578 (3a), the 
staining on the liver and the weak one on MFM, somites and PLM disappeared 
once this region was moved on the centromeric end of the locus (figure 14B). This is 
somehow expected for MFM, PLM and somites, as we know that the relevant 
enhancers are located telomeric to the insertion 194578 (3a). After inversion, the 
communication between LacZ promoter and enhancers may be affected by what is 
discussed above, namely a greater distance that separates them and/or the 
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interposition of a TAD-boundary in between. The case of the liver is less clear. 
According to our model, for which the liver enhancer(s) may be found inside Pvt1 
transcribed region, nothing changes between the insertion 194578 (3a) and these 
enhancer(s). What changes instead is the context in which these sequences operate. 
We believe that this context is crucial for any regulatory element to function 
correctly. 
 
 
Figure 14 | INV1 regulatory activity at the inversion breakpoints. A) LacZ reporter 
staining in E11.5 196231 (-17a, or c17) and 194578 (3a) GROMIT lines (paternal allele). 
The approximate location of the tissue-specific enhancers is depicted by ellipses, red for the 
liver, blue for the medial face mesenchyme (MFM) and yellow for the nasal epithelia (NE). 
The telomeric end of the locus, which contains a cluster of CTCF binding sites is 
represented by a green ellipse (same color coding as for the panel B). B) LacZ reporter 
staining on an INV1 E11.5 embryo, carrying LacZ reporter at both inversion breakpoints 
(paternal allele). INV1 causes the complete loss of reporter activity on liver, MFM, limbs and 
somites (very weak on the last three tissues) from the 194578 (3a) breakpoint. 
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Figure 15 | Context dependency of promoter–long-range enhancers communication. 
Material shown thanks to kind concession of Veli Uslu, representing LacZ reporter staining 
in E11.5 embryos from Wt (GROMIT insertions 179039 (17a), 193970 (10a) and 192331 
(20a)), Dup(10a–20a) and Del(10a–20a). In the Wt, facial, nasal epithelia, limbs and somites 
enhancer(s) (just shown the facial and liver enhancer(s), as blue and red ellipses 
respectively) reach the GROMIT insertion 179039 (17a), but do not act on the blank spot 
193970 (10a). Outside of c-Myc locus, on the insertion 192331 (20a), other enhancer(s) 
(Fam49b-Asap1 enhancer(s), depicted as a brown ellipse) give a widespread reporter 
expression scattered throughout the embryo. c-Myc and Fam49b-Asap1 enhancers act 
within their regulatory domain likely because of the presence of a boundary element, 
probably located nearby the gene Gsdmcl-ps (inferred from the TAD disposition observed on 
Hi-C data, represented by sand color square-brackets). Upon duplication Dup(10a–20a), the 
LacZ staining acquires the typical pattern of the insertion 179039 (17a), likely because of the 
effect of the enhancers located on the telomeric segment of the duplication. In this instance 
however, the relationship between c-Myc enhancer(s) and the promoter of the reporter is 
identical to the Wt scenario for the insertion 193970 (10a), which gives no staining in any 
tissue. It is possible that the duplication altered the overall genetic context, changing the 
enhancer(s) range of action. Another possibility is that the duplication displaced the LacZ 
reporter from a hypothetical repressor, located centromeric to the insertion 193970 (10a). 
However, the deletion Del(10a–20a) gives a LacZ staining pattern comparable to the one of 
the insertion 192331 (20a) and rules out this possibility. 
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Veli Uslu observed a similar case before. In this instance, the GROMIT 
insertion 193970 (10a), integrated in the middle of the telomeric side of c-Myc locus, 
did not respond to any enhancer (figure 15) (it is one of the few blank spots inside 
the telomeric side of the locus). Veli Uslu made a chromosomal duplication between 
this insertion and 192331 (20a), occurring inside the Fam49b transcribed region 
(telomeric to the Gsdmcl-ps boundary). After the duplication, the remaining 
GROMIT insertion captured transcriptional inputs recapitulating the characteristic 
c-Myc pattern seen at the insertion 179039 (giving the typical staining in FM, NE, 
PLM, BA, and somites). In this duplication the enhancers were also duplicated, 
having the LacZ reporter in the middle. However, in this configuration the 
enhancers located on the centromeric segment of the duplication were separated 
from the LacZ reporter by the c-Myc–Fam49b–TAD-boundary, and therefore, it is 
likely that the transcriptional inputs reaching the reporter came uniquely from the 
enhancers on the telomeric segment of the duplication. Importantly, the sequence in 
between the LacZ reporter and the enhancers present in this telomeric segment 
remained exactly the same. Also in this case, what changed was the context 
surrounding them. Veli Uslu hypothesized that it was the different context that 
allowed the blank spot 193970 (10a) to reach the enhancers and acquire reporter 
expression in FM, NE, PLM, BA and somites upon duplication. 
We analyzed the expression changes of the transcripts inside the locus: c-Myc, 
Pvt1 and Fam84b, as well as the ones at the neighboring loci E430025E21Rik, 
Nsmce2, Trib1, Fam49b and Asap1. We used E11.5 face, liver, proximal fore limb 
mesoderm (PFLM) and heart as control tissue (tissue where c-Myc is expressed at 
basal level). We only observed significant changes in expression of c-Myc and 
Fam84b. c-Myc expression in INV1 homozygote face and PFLM was reduced to 
approximately the basal c-Myc transcription, being ~ 20% of the Wt level (equivalent 
to the deletion of the facial enhancers, seen on Del(8–17)) (figure 16A and B). This 
data supports the hypothesis of c-Myc promoter being separated from the facial (and 
limb) enhancers by the introduction of a TAD-boundary in between them. The 
disappearance of the LacZ reporter expression from the insertion 194578 (3a) upon 
INV1 is consistent with this observation. On the other hand we observed in the face, 
a concomitant upregulation of Fam84b of 2.3 times the Wt level in INV1 
homozygotes (figure 16A). The PFLM had a similar trend although it was not 
statistically significant (figure 16B). We believe that this effect was consequent to the 
hijacking of the facial (and probably also the FL) enhancer(s), usually acting on c-
Myc, by Fam84b.  
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Figure 16 | INV1 c-Myc and neighboring transcripts expression. cDNA-qPCR on E11.5 
INV1-/-, INV1+/-, INV1+/+ facial mesenchyme, proximal fore limb mesoderm, liver and heart 
(sample size n = 3, 46–48 somite pairs stage, genotypes balanced for litter provenience 
within comparison groups). A–D) Individual panels representing the four tissues analyzed. 
The transcripts Ct are referred to the housekeeper gene Gusb and divided by the median Wt 
value (y-axis). Significance codes: p-value > 0.1 ns; 0.05 ≤ p-value < 0.1 “ . ”; 0.01 ≤ p-value 
< 0.5 “ * ”; 0.001 ≤ p-value < 0.01 “ ** ”; p-value < 0.001 “ *** ”. E) Benjamini-Hochberg 
corrected p-values. 
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In INV1, Fam84b is brought closer to the facial enhancers compared to the Wt, 
and with this arrangement, it is no longer affected by the presence of a TAD-
boundary between them. Heart and liver had minor and not significant changes in c-
Myc expression (figure 16C, D and E). 
Finally, INV1 is lethal in homozygote animals. We believe the death occurs 
during embryonic development, between 12.5 and 18.5 days of gestation. Although 
INV1 led to both gene upregulation and downregulation (in the tissues we 
analyzed), the death of the embryos limited to homozygote animals led us to 
hypothesize a loss-of-function mutation. We tested this possibility by crossing INV1 
heterozygotes with Del(c17–17) (deletion of the whole c-Myc locus, GROMIT 
insertions 196231 (-17a)–192857 (17a)). Out of the 24 pups we screened, we 
genotyped no double positive animal. We inferred a significant deviation from 
mendelian proportions (p-value 0.046, Pearson's Chi-squared test with Yates' 
continuity correction). The other three genotypes instead appeared with the same 
frequency, confirming the lethality in INV1 homozygotes to be due to a loss-of-
function mutation of c-Myc and/or Pvt1. Although we do not know which tissue(s) 
are dysfunctional in INV1 homozygotes embryos and cause the lethality, we saw 
downregulation of c-Myc in the face and PFLM, and for this reason we speculate 
that the lethality we saw may have to do with a downregulation of c-Myc itself. 
5.4.2 Inversion 2 
Inversion 2 (INV2) was designed to the test the importance of the telomeric end of 
the locus, i.e., the ~ 200Kbp ranging from the insertion 179039 (17a) to the gene 
Gsdmcl-ps (location of the c-Myc–Fam49b–TAD-boundary), termed segment-T 
(segment telomeric to the insertion 179039 (17a), while the region encompassing the 
~ 130Kbp centromeric to this insertion is termed segment-C). We hypothesized 
from chromatin data that the whole telomeric end of the locus may be important for 
c-Myc regulation in tissues where its expression is higher than the basal level. The 
region contains a cluster of 10 CTCF binding sites, present in all the analyzed 
tissues, however it has H3K27ac and H2AZ enrichment only in tissues with high c-
Myc expression (FM and liver). GROMIT insertions integrated in this region, give 
LacZ staining patterns similar to the one of 179039 (17a), resembling (with 
exception of the liver) the endogenous c-Myc expression pattern (observed by in-situ 
hybridization, figure 7). Hi-C experiments performed on cell lines show that this 
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region contacts other TAD edges inside the locus. Similarly, it is also possible that in 
embryonic tissues the telomeric end of c-Myc locus interacts with other sequences 
inside the locus, including tissue specific enhancers and c-Myc. INV2 uses as the 
centromeric breakpoint the insertion 196231 (-17a or c17a, same as for INV1), 
located at the centromeric side of the locus, inside Fam84b-TAD. 
 
Figure 17 | INV2 regulatory activity at the inversion breakpoints. A) LacZ reporter 
staining of E11.5 196231 (-17a, or c17) and 179039 (17a) GROMIT lines (paternal allele). 
The approximate location of the main cis-acting DNA elements of the locus is depicted on 
the gene model: red, liver enhancer(s); blue, facial enhancer(s); yellow, nasal epithelia 
enhancer(s); green, telomeric end of the locus (represented also on the B panel). B) LacZ 
reporter staining on an INV2 E11.5 embryo, carrying a single LacZ reporter at either of the 
inversion breakpoints (paternal allele). This analysis shows no changes in LacZ staining at 
the breakpoint 196231 (-16a, or c16), silent in both Wt and INV2. The breakpoint 179039 
(17a) shows a reduction of LacZ staining, compared to the Wt, in medial face mesenchyme, 
lateral face mesenchyme, nasal epithelia, proximal fore/hind limb mesoderm, somites, 
rhombic lip and branchial arches. 
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Figure 18 | INV2 c-Myc and neighboring transcripts expression. cDNA-qPCR on E11.5 
INV2-/-, INV2+/-, INV2+/+ facial mesenchyme, proximal fore limb mesoderm, liver and heart 
(sample size n = 3, 46–48 somite pairs stage, genotypes balanced for litter provenience 
within comparison groups). A–D) Individual panels representing the four tissues analyzed. 
The transcripts Ct are referred to the housekeeper gene Gusb and divided by the median Wt 
value (y-axis). Significance codes: p-value > 0.1 ns; 0.05 ≤ p-value < 0.1 “ . ”; 0.01 ≤ p-value 
< 0.5 “ * ”; 0.001 ≤ p-value < 0.01 “ ** ”; p-value < 0.001 “ *** ”. E) Benjamini-Hochberg 
corrected p-values. 
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As for the telomeric breakpoint, INV2 uses the insertion 179039 (17a), located 
between the third and fourth CTCF binding site of the cluster (for both face and 
liver). INV2 splits the telomeric end of the c-Myc-TAD in two parts, segment-C 
and segment-T. Except for the segment-T, which is not included in the inversion, 
INV2 leaves c-Myc-TAD primary sequence almost unaltered. On the other hand, 
this inversion may have some effect on the Fam84b-TAD, as it breaks it into two 
parts, fusing the centromeric one with c-Myc-TAD; except for this one, INV2 does 
not introduce other perturbations. In contrast to INV1, INV2 does not reshuffle the 
position of promoters and enhancers relative to each other, and therefore, it preserves 
their arrangement inside the locus.  
We analyzed the LacZ reporter expression coming from both breakpoints of the 
inversion. Similarly to the Wt, the insertion 196231 (-17a) gave no LacZ staining 
upon inversion (figure 17B). The insertion 179039 (17a) instead, showed a marked 
reduction of reporter expression in all the responsive tissues typical of 17a (FM, NE, 
PLM, BA, RL and somites). Conversely to the case of INV1, where the general 
genetic context affected the activity of the liver enhancer(s) on the LacZ reporter, in 
INV2, the widespread reduction of LacZ staining from the insertion 179039 (17a), 
suggests that the segment-T, which remains at the telomeric end of c-Myc-TAD, in 
particular, is important for the tissue specific enhancers to reach the LacZ promoter. 
RT-qPCR assay showed a significant reduction of c-Myc expression in the face 
to 60% of the Wt level (figure 18A). We observed no other significant changes of 
expression of other transcripts in c-Myc and neighboring loci in the tissues analyzed 
(face, PFLM, liver and heart, figure 18B, C, D and E). We conclude from this 
experiment that the segment-T is important for the facial enhancers to act 
throughout the locus, on the 17a position and on c-Myc. 
5.4.3 Inversion 3 
Inversion 3 (INV3) uses as the telomeric breakpoint the insertion 192857 (17a), 
occurring at the same genomic position as 179039 (17a), and in this respect, it has 
some similarities with INV2. As for INV2, INV3 was designed to separate the first 
three CTCF binding sites (on the segment-C) from the rest of the cluster, 
remaining at the telomeric end of the locus. However, the centromeric breakpoint is 
the insertion 194578 (3a), situated at the end of Pvt1 transcribed region, and 
therefore, conversely to INV2, this inversion occurs intra-TAD.  
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LacZ staining assay in INV3 revealed a weakening of reporter transcription 
from the insertion 192857 (17a) in FM, NE, BA, RL, somites and PLM, and an 
increment in the liver (figure 19B). Similar to INV2, we interpret the weakening of 
the staining pattern of the insertion 179039/192857 (17a) as the effect of the 
separation of the reporter from the segment-T, not included in the inversion. 
 
Figure 19 | INV3 regulatory activity at the inversion breakpoints. A) LacZ reporter 
staining of E11.5 194578 (3a) and 192857 (17a) GROMIT lines (paternal allele). Cis-acting 
DNA elements (approximate location): red, liver enhancer(s); blue, facial enhancer(s); 
yellow, NE enhancer(s); green, telomeric end of the locus (represented also on the B panel). 
B) LacZ reporter staining on an INV3 E11.5 embryo, carrying a single LacZ reporter at either 
of the inversion breakpoints, 194578 (3a) and 192857 (17a), on the paternal chromosome. 
The GROMIT insertion 192857 (17a) upon INV3 shows an increment of LacZ staining in the 
liver, as well as a marked reduction in all the 192857 (17a) characteristic tissues, 
medial/lateral face mesenchyme, nasal epithelia, proximal fore/hind limb mesoderm, 
somites, rhombic lip and branchial arches. The insertion 194578 (3a) shows a gain of LacZ 
staining in medial/lateral face mesenchyme, nasal epithelia, proximal fore/hind limb 
mesoderm, somites and branchial arches and a complete loss of staining in the liver. 
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Figure 20 | INV3 c-Myc and neighboring transcripts expression. cDNA-qPCR on E11.5 
INV3-/-, INV3+/-, INV3+/+ medial/lateral face, proximal fore limb mesoderm (PFLM), liver and 
heart (sample size n = 3 for PFLM, liver and heart, n ≥ 4 for lateral face and n ≥ 5 for medial 
face, 46–48 somite pairs stage, genotypes balanced for litter provenience within comparison 
groups for PFLM, heart and liver, unbalanced for lateral face and medial face). A–E) 
Individual panels representing the five tissues analyzed. The transcripts Ct are referred to 
the housekeeper gene Gusb and divided by the median Wt value (y-axis). Significance 
codes: p-value > 0.1 ns; 0.05 ≤ p-value < 0.1 “ . ”; 0.01 ≤ p-value < 0.5 “ * ”; 0.001 ≤ p-value 
< 0.01 “ ** ”; p-value < 0.001 “ *** ”. F) Benjamini-Hochberg corrected p-values. 
In this case, the activity of the segment-C does not seem to be sufficient to 
compensate for the function of the whole telomeric end of the locus. On the other 
hand, the increment of reporter activity in the liver may be explained by an increased 
proximity to the liver enhancer(s). However, this increment did not reach the level of 
the Wt insertion 194578 (3a).  
Regarding the insertion 194578 (3a), after inversion the reporter gained 
expression in all the typical tissues of 179039/192857 (17a), and lost the expression 
in the liver (figure 19B) completely. The increment in FM, PLM, BA and somites, 
despite not reaching the level of 179039/192857 (17a), confirms the general 
importance of the segment-T to direct enhancers to the LacZ reporter inserted at 
the native 17a position. 
We analyzed the expression levels of the transcripts inside c-Myc locus and in the 
neighboring loci, in face, PFLM, liver and heart. We saw no significant changes, 
except for an upregulation to 1.4 times the Wt level of Asap1 in the liver (figure 
20D). We saw similar trends, although not reaching statistical significance, for 
E43000E21Rik, Nsmce2, Trib1 and Fam49b in this tissue, but not in the face, PFLM 
or heart. This suggests that upon INV3, the effect of liver enhancer(s) may leak to 
other genes, on both centromeric and telomeric sides. The fact that this effect is 
limited to the liver, supports the idea that the communication between promoters 
and enhancers may vary from tissue to tissue.  
Regarding the face, we performed this experiment twice (subdividing the face 
into medial face and lateral face (the NE is split between these two tissues), in case 
these two tissues have effects not seen as a whole face, figure 20A and B), and we 
observed a reproducible, although non-significant, downregulation of c-Myc to 75% 
of the Wt level in both tissues. We think that this result may confirm the 
observation drawn from INV2, that the telomeric end of the locus—even if not 
equipped with enhancers—plays a role in establishing c-Myc promoter–enhancers 
communication. Moreover it suggests that genetic reshuffling occurring intra-TAD 
may lead to small changes in gene expression, probably due to perturbations in long-
range interactions. 
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5.5 Redistribution of Architectural Proteins in 
Inversion Lines 
After analyzing the functional effects of the chromosomal inversion on c-Myc locus, 
we wanted to test whether the effects we observed were accompanied by changes in 
the occupancy of architectural proteins inside the locus. This experiment performed 
on both Wt and inversion lines, aimed to question the importance of the architecture 
of c-Myc locus to determine the binding of architectural proteins. 
As we knew from the ChIP-seq experiments the location of CTCF binding 
sites in face and liver, we opted for a targeted approach, ChIP-qPCR, that offered us 
several technical advantages compared to the ChIP-seq. We assessed 13 main 
CTCF and RAD21 (Cohesin subunit) binding sites of the locus. We performed the 
experiment in face and liver from Wt (C57BL/6J), INV1, INV2 and INV3 
homozygotes E11.5 embryos. For each line we performed at least three biological 
replicates and at least four qPCR replicates. 
We saw significant changes in CTCF occupancy only on the M3 binding site in 
the face INV3, with a reduction to 74% of the Wt level (figure 21A). We also 
detected a reduction to 70% of the Wt level of RAD21 binding on the site F1 in 
INV2 face (figure 21C).  
For this kind of procedure, similar changes are commonly seen also on the 
control regions (designed in order to be unaffected (in theory) by the experimental 
treatments applied). This effect probably reflects a natural variability between 
different lines (supplementary figure 2). Other than the mentioned cases, we 
observed no other significant changes. Therefore, we conclude from this experiment 
that the occupancy of CTCF and the Cohesin subunit do not show major changes 
upon genetic engineering. 
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Figure 21 | Architectural proteins occupancy in inversion lines. A–D) CTCF and RAD21 
(cohesin subunit) occupancy at selected regions of the locus (see panel E for details) in Wt, 
INV1+/+, INV2+/+, INV3+/+  E11.5 face and liver (sample size n ≥ 3). The y-axis represents the 
fold enrichment of ChIP samples to the input chromatin control (background = 1). 
Significance codes: p-value > 0.1 ns; 0.05 ≤ p-value < 0.1 “ . ”; 0.01 ≤ p-value < 0.5 “ * ”; 
0.001 ≤ p-value < 0.01 “ ** ”; p-value < 0.001 “ *** ”. The p-values are corrected for family-
wise error rate using the Benjamini-Hochberg method. F = Fam84b-TAD; FM = Fam84b–c-
Myc–TAD-boundary; M = c-Myc-TAD; TEL = Telomeric end of c-Myc locus (the numbers 
represent the CTCF peak number of figure 23A). E) Gene model showing in red the location 
of the individual PCR amplicons (inside c-Myc locus) and the peaks of CTCF and cohesin 
ChIP-seq experiments. The analyzed regions were selected for containing CTCF and/or 
cohesin binding sites. They represent the closest peaks to the inversions breakpoints, TAD-
boundaries and most of the tissue invariant peaks at the telomeric end of c-Myc locus. The 
two upper peak calling tracks refer to CTCF ChIP-seq in Wt E11.5 face and liver, while the 
ones labeled with the “ * ” are obtained from the publically available datasets SA1 and SMC1 
ChIP-seq (cohesin subunits) done in mouse embryonic fibroblasts (MEF) (Cuadrado et al., 
2015). 
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5.6 Imprinting in c-Myc locus 
5.6.1 Discovery and Characterization, Performed by Veli Uslu 
Veli Uslu observed that inside c-Myc locus, three close GROMIT insertions 
(including 179039 (17a)) had reporter expression only if inherited from the father 
(figure 22). Therefore, these insertions were maternally imprinted.  
 
Figure 22 | Imprinting in c-Myc locus. Data shown thanks to kind concession of Veli Uslu. 
LacZ reporter staining on E11.5 mouse embryos carrying paternally or maternally inherited 
GROMIT insertions The picture shows that the LacZ reporter gene from the insertion 
179039 (17a) (as well as two other close ones) is silent if inherited from the mother, but is 
expressed if it is inherited from the father, suggesting a maternal imprinting effect (the 
imprinting at the insertion 194578 (3a) was determined later on by myself). The insertions 
194578 (3a) and 179039 (17a) are marked with “ * ” to indicate that the pictures were taken 
in a different batch from the others. For these two lines, the embryos carrying GROMIT 
insertions in the maternal allele were obtained from a cross where the mother was positive 
for the indicated GROMIT insertion (in c-Myc locus), and the father had a GROMIT insertion 
located in an unrelated locus. This second insertion is not under imprinting effect and gives 
LacZ staining in tissues (terminal limb) not overlapping with any stained tissue for any 
insertion located inside c-Myc locus; this insertion was used as an internal positive control. 
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Figure 23 | Identification of the imprinting control region in c-Myc locus. A) CTCF 
ChIP-seq in mouse E11.5 face, fore brain and liver showing the 10 CTCF binding sites 
clustered at the telomeric end of c-Myc locus (their numeration is shown below the face 
CTCF dataset). Peak-calling and input controls tracks are shown underneath each ChIP-seq 
track. B) Material shown thanks to Veli Uslu’s concession. In this experiment, four 
chromosomal deletions, covering the complete CTCF cluster, were created in order to 
identify the imprinting control region (ICR) of the locus. Upon Del(17a–17d), the LacZ 
staining reappeared on the maternal allele (on nasal epithelia and branchial arches, E11.5 
embryos), being comparable to the reporter staining on the paternal allele, indicating that the 
imprinting effect was lost. 
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The dissection of the region by small chromosomal deletions showed that the 
ICR lies telomeric to the insertion 179039 (17a) (Del(17a–17d), figure 23).  
The analysis of other GROMIT insertions (8a, 14c and 15a) revealed that 
already 200Kbp centromeric to the affected region, the reporter expression from the 
maternal allele was restored, being indistinguishable from the paternal allele (figure 
22, the imprinting on the insertion 194578 (3a) was determined later by myself, and 
is treated in the discussion). For this reason, the imprinting effect was reported to be 
local, limited to 50Kbp around 179039 (17a). Remarkably, the reporter expression 
observed from the maternal allele for the insertions located outside the imprinted 
region, rules out the possibility that the imprinting inactivates the facial enhancers.  
Bisulfite assays on both face and heart tissues (stage E11.5) from 179039 (17a) 
GROMIT positive embryos, showed that the promoter of the LacZ had DNA 
methylation only if it was maternally inherited (figure 24).  
In order to test whether the imprinting was affecting the activity of the facial 
enhancers on c-Myc, a mouse line carrying their deletion (Del(8–17)) was used. 
E11.5 embryonic facial tissues from animals carrying the deletion on the maternal or 
paternal chromosome were compared. This experiment showed that the paternal and 
maternal enhancers contribute to 50% and 30% of the total c-Myc expression 
respectively, suggesting that the imprinting was responsible for a mild reduction of 
the enhancers’ activity on c-Myc promoter in the maternal allele. 
 
Figure 24 | Methylation status of the 179039 (17a) LacZ promoter. Data shown thanks to 
kind concession of Veli Uslu representing bisulfite sequencing assays on E11.5 facial 
mesenchyme and heart from mouse embryos carrying the 179039 (17a) insertions on the 
paternal or maternal chromosome. Each panel shows different CpG di-nucleotides present 
in the LacZ promoter (columns), and different sequencing clones (rows). 
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5.6.2 Effects of Chromosomal Inversion on the Imprinted 
Regions 
The inversion mouse lines were useful to confirm the results obtained by Veli Uslu 
and also to test whether the extent of the imprinted region may be affected by the 
genetic reshuffling. We addressed these points by analyzing the LacZ reporter 
staining at the inversions breakpoints. 
In INV1, the lack of reporter staining on the paternal allele, from both 
breakpoints, does not allow us to infer whether or not the imprinting in the maternal 
allele is still reaching the telomeric breakpoint (insertion 196231 (-17a) upon INV1) 
(figure 25A).  
In INV2, the insertion 179039 (17a) in the maternal allele gave a LacZ staining 
pattern comparable to the one observed on the paternal allele (figure 25B). The lack 
of LacZ staining from the Wt 179039 (17a) on the maternal allele shows that at this 
site the imprinting is lost upon INV2. Regarding the insertion 196231 (-17a), as it is 
silenced on both paternal and maternal alleles in both Wt and INV2, we cannot tell 
if it is still under imprinting effect upon inversion (figure 25B).  
In INV3, GROMIT insertions located at both inversion breakpoints gave LacZ 
staining from the paternal allele (although with different patterns, figure 25C). In 
the maternal allele, the same locations are completely silenced, as in the Wt scenario, 
showing that the imprinting still reaches the insertions 179039 (17a) and 194578 
(3a) (figure 25C). This experiment supports the idea that the function of the ICR is 
unaffected by the genetic reshuffling introduced by INV3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   115 
 
 
 
 
 
 
 
 
 
 
	   116 
 
 
 
 
	   117 
 
Figure 25 | Effect of the chromosomal inversions on the imprinted regions. LacZ 
staining of E11.5 mouse embryos carrying GROMIT on the maternal and (only for the 
inversion lines) on the paternal allele. The pictures refer to insertions located at the 
inversions breakpoints. In order to prove that the lack of LacZ staining in the Wt controls was 
not due to a technical failure of the staining procedure, the Wt controls embryos shown here 
were obtained from a cross where the paternal genome contained a GROMIT insertion 
located in an unrelated locus, giving a staining pattern (on the terminal limbs) not 
overlapping with the analyzed c-Myc locus insertions. Wt controls are shown at the top of 
each panel. Engineered lines are shown at the bottom. Tissue-specific enhancers are 
represented on the gene models: blue, MFM; yellow, NE; red, liver. The telomeric end of the 
locus is depicted in green. A) In INV1 the imprinting at the telomeric breakpoint 194578 (3a) 
cannot be verified because of the lack of reporter staining also on the paternal allele. B) In 
INV2 the presence of LacZ staining in several tissues from the insertion 179039 (17a) 
(comparable to the LacZ staining from the paternal allele) shows that the imprinting is lost 
upon INV2. C) In INV3 both inversion breakpoints, silent in the Wt, remain silent also upon 
inversion, showing that the imprinting effect is still present at these regions. 
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6 Discussion 
6.1 Roles of Chromatin in c-Myc locus 
The identification of different regulatory domains in c-Myc locus and adjacent loci, as 
well as the observation that even inside the same regulatory domain there can be 
significant differences in transcriptional capability of the individual regions analyzed, 
led us to question whether the chromatin composition of the locus has some 
correlation with this phenomenon. Moreover, the characterization of different 
regions containing tissue-specific enhancers, sized in the range of hundreds of Kbp, 
offered us an important guideline to restrict their position even further, by 
investigating the enhancer-associated chromatin. For these reasons we performed 
different ChIP-seq analysis in Wt animals, focusing on our model tissues, i.e. face 
and liver, at the embryonic stage E11.5. 
ChIP-seq for histone marks enriched at enhancer sites confirmed previous 
information regarding the position of facial and liver enhancers acting on c-Myc 
during mouse embryonic development, and helped us to refine their possible 
genomic locations. Concerning the H3K27ac ChIP-seq on the facial tissue, we saw 
three peaks located inside the ~ 600Kbp critical region previously shown to contain 
important MFM enhancer(s) (figure 10C) (Uslu et al., 2014). One of these peaks in 
particular, overlapped with the mouse ortholog of the sequence hs1877, shown by 
transgenic assays to promote reporter expression in the MFM and support the idea 
that the small regions identified by this approach may contain facial enhancers 
(figure10D and F) (Attanasio et al., 2013). In the liver, the analysis is complicated by 
the fact that inside the candidate region for containing the liver enhancers, we saw 
21 distinct H3K27ac peaks. It is therefore not possible to know at this stage (and 
without further experiments) which region(s) could contain the liver enhancer(s). 
We also assessed the distribution of two kinds of repressive chromatin, with the 
aim of finding clues possibly explaining the regulatory landscape of the locus. We 
investigated two well-known chromatin types, namely the heterochromatin, positive 
for the H3K9me3 histone mark, and the Polycomb chromatin, positive for the 
H3K27me3 histone mark. We found just sporadic representation of these histone 
modifications in c-Myc locus. The only enriched region for H3K9me3 shared 
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between the face and liver lay close to the telomeric end of the locus. Importantly, the 
closest GROMIT insertion to this peak (insertion 193315 (16a)), found just 3.5Kb 
away, is not silenced. Similarly, other close insertions, including 179039 (17a) do 
show LacZ staining. Concerning the H3K27me3 mark, we believe that the 
enrichment at Pvt1 promoter we observed in both face and liver, may be linked to 
the fact that this gene is expressed at an extremely low level in these two tissues. 
Regarding the enhancer-associated mark H3K27ac on the face, the peak 
overlapping with the mouse ortholog of the sequence hs1877 (capable of driving 
reporter expression in the MFM, mentioned above) and included in the facial 
enhancer(s) critical region, occurs 30Kbp away from the GROMIT insertion 193970 
(10a). This insertion, despite being the closest to this H3K27ac peak, is silent in all 
the tissues, and does not respond to any enhancer. On the contrary, insertions 
located much further away from the facial enhancer(s) critical region (the case of 
179039 (17a) is a clear example) do show LacZ expression in the facial tissues. 
According to these observations, our data seems to suggest that the chromatin 
composition of the locus cannot explain the regulatory landscape (and therefore the 
regulatory domains) observed from the GROMIT screening performed by Veli Uslu. 
We therefore tend to favor the idea that the locus topology and long-range 
interactions play a crucial role in c-Myc locus to connect regulatory elements to their 
target regions. 
6.2 Importance of Chromosome Architecture  
6.2.1 Roles of DNA Topology on c-Myc Transcriptional 
Regulation 
In mammalian genomes, regulatory elements and target promoters often occur far 
away from each other, commonly at distances greater than 500Kbp (Martin et al., 
2015). Sometimes these long-range interactions can even skip genes, indicating that 
the proximity is not the only player arranging promoter–regulatory element 
interactions (Marinić, Aktas, Ruf, & Spitz, 2013; Martin et al., 2015). A growing 
body of evidence suggest that metazoan genomes are condensed into the nucleus 
following a determined topology (J. R. Dixon et al., 2012; Rao et al., 2014). It has 
been shown in a few (although increasing number of) cases that the topology of the 
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loci has a functional relevance in gene expression, and if perturbed can lead to 
pathological phenotypes (Lupiáñez et al., 2015; Montavon et al., 2011; Spitz et al., 
2005). In this project we addressed this question using chromosomal inversions in c-
Myc locus to rearrange the relative distribution of enhancers, TAD-boundaries and 
promoters. We probed the resulting effects at the level of expression of c-Myc and 
neighboring genes, as well as by reporter assays.  
With our genetic engineering setup we aimed to alter the genetic context 
between the tissue-specific enhancers and c-Myc promoter. In the case of INV1, we 
saw a significant reduction of c-Myc expression in the face and PFLM, as well as a 
reproducible drop of reporter expression at the inversion breakpoint 194578 (3a).  
 
 
Figure 26 | Perturbations of long-range interactions in INV1. A) Model proposing how 
the facial enhancers (for the FM and NE; here shown only the FM one(s) as a blue ellipse) 
upon INV1 are redirected from c-Myc to Fam84b. TAD-boundaries are represented by sand 
color square-brackets (shown also on panel B). B) In the liver the activity of long-range 
enhancer(s) (probably located inside the Pvt1 transcribed region) on c-Myc promoter, may 
be just mildly affected by the inversion. 
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Figure 27 | CTCF motifs distribution in c-Myc and adjacent loci. The motif positions are 
obtained by BSgenome.Mmusculus.UCSC.mm9 R package (Bioconductor version: Release 
(2.12)), using the JASPAR position weighed matrices (publically available at: 
http://jaspar.genereg.net), using the default parameters (minimum score = 85% identity). 
The CTCF motifs distribution is shown for the Watson and Crick strands separately. The top 
of the figure shows the Hi-C interaction matrix of c-Myc and neighboring loci (Rao et al., 
2014). Cis-acting DNA elements are shown on the gene models: blue, facial enhancer(s); 
yellow, nasal epithelia enhancer(s); red, liver enhancer(s); green, telomeric end of c-Myc 
locus. 
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Along with the downregulation of c-Myc, we observed a concomitant 
upregulation of Fam84b in the same tissues, compatible with a hijacking of the 
enhancers from c-Myc to Fam84b (figure 26A).  
We believe that the marked downregulation of c-Myc observed in the face and 
PFLM could in principle affect also other tissues, and cause the embryonic lethality 
seen on INV1 homozygotes animals.  
One possible explanation for the transcriptional changes observed in the face 
and PFLM could be that INV1 inverts the orientation of important CTCF binding 
sites, compatible with recent evidence obtained in different model loci, proposing an 
orientation dependent CTCF function (reviewed in (Zlotorynski, 2015). In the Pcdh 
locus, the HS51 enhancer lies between Pcdha and Pcdhg gene clusters, interacting only 
with Pcdha promoters in both mouse and human cell lines. Importantly, the HS51 
enhancer contains a CTCF binding site. In this study the whole HS51 enhancer was 
inverted using the CRISPR-Cas9 technology. The inversion caused the HS51 
enhancer to gain interactions with the Pcdhg cluster promoters and lose interactions 
with the Pcdha cluster promoters. Concomitantly, Pcdhg genes expression increased, 
while Pcdha genes expression decreased. Similar data obtained on the β-globin locus 
strengthen the hypothesis that CTCF binding sites orientation contributes to 
organize promoter–enhancer long-range interactions. 
In c-Myc locus, the closest CTCF motifs to c-Myc and Fam84b promoters lie on 
opposite strands. INV1 inverts the orientation of these CTCF motifs, in reference to 
the CTCF motif located on the region containing the facial and limb enhancers (not 
included in the inversion) (figure 27). With INV1 arrangements, CTCF motif 
orientation does correlate with the redirection of the facial and liver enhancers from 
c-Myc to Fam84b. However, looking at the actual CTCF binding on these motifs in 
the Wt, out of the three of them, CTCF binds only the motif at c-Myc promoter. 
Other data (discussed further on) supports the idea that CTCF occupancy does not 
change upon inversions. Moreover, the part of the locus included in INV1, contains 
many other CTCF motifs other than the ones mentioned. The case described for the 
Pcdh locus instead was much simpler, as the inversion involved just one CTCF 
binding site. It is therefore not possible to extrapolate their conclusions to c-Myc 
case. We believe instead that the effect we observed on face and fore limbs was 
mostly due to the interposition of a TAD-boundary between c-Myc and the 
facial/limb enhancers, more than the increased distance separating them or the 
inverted orientation of the CTCF motifs. 
Still with INV1, in the liver we saw a similar trend as in the face and PFLM, 
showing a reduction of c-Myc and Pvt1 expression and an increase of Fam84b (as 
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well as E4300021Rik, Nsmce2, Trib1, Fam49b and Asap1, in all the cases being not 
statistically significant). However, in the liver, this effect was not as pronounced as in 
the face and PFLM, suggesting that the INV1 did not alter the relationship between 
c-Myc and the liver enhancer(s) as much as for the face and PFLM (figure 26B). In 
addition, INV1 caused the disappearance of the liver staining from the insertion 
194578 (3a). Importantly, INV1 preserves the Wt disposition relative to each other 
of the insertion 194578 (3a), c-Myc promoter and the liver enhancer(s) (likely located 
inside Pvt1 transcribed region), suggesting the possibility that the changed context 
in which these sequences operate may be responsible for the effects we observed at 
the level of both reporter expression and endogenous transcript expression. Veli Uslu 
in the past drew similar conclusions using a different genetic engineering model 
(figure 15). In this specific case, we speculate that the effects we saw have to do with 
the importance of the telomeric side of the locus to allow the liver enhancers to reach 
c-Myc promoter and the insertion 194578 (3a). 
6.2.2 Influence of DNA Topology to Determine the Binding 
of Architectural Proteins to the Genome 
According to the current models proposed in the literature, the architectural 
transcription factor CTCF and the Cohesin complex are involved in DNA-DNA 
looping and long-range interactions. Their function led us to question to what extent 
their binding to the genome depends on the DNA sequence itself or on the locus 
architecture.  
We addressed this question by analyzing their binding inside c-Myc locus upon 
inversions. Despite the fact that with our experimental setup we could only probe a 
limited number of regions inside the locus, in INV1 we observed just minor changes 
in CTCF and RAD21 enrichments. As their binding did not seem to have 
rearranged together with the inversion, adapting to the new configuration, we tend 
to think that in this instance, CTCF and the Cohesin complex disposition was not 
significantly constrained by the architecture of the rest of the locus and perhaps more 
influenced by the DNA sequence. 
This experiment also suggests that the changes in c-Myc expression that we saw 
may be more explainable by a rewiring of long-range interactions, occurring at the 
same CTCF and Cohesin binding sites than in the Wt, rather than by changes in 
	   125 
CTCF and Cohesin occupancy inside the locus (provided that architectural proteins 
do play an active role in promoting long-range interactions). 
Similarly to INV1, in INV2 and INV3 the changes in c-Myc expression were 
not accompanied by changes of CTCF and RAD21 occupancy, suggesting that these 
conclusions may not represent a particular case limited to INV1, but could reflect a 
more general scenario, in which the binding to the DNA of these architectural 
proteins may be determined to a large extent by the DNA sequence itself, rather 
than by the surrounding genetic context or the locus architecture, and therefore may 
not be affected (to some extent) by the sequences reshuffling introduced by the 
inversions, or by other kinds of genetic engineering. 
6.3 Roles of the Telomeric End of c-Myc locus 
6.3.1 Long-Range Interactions 
The first evidence showing that the telomeric end of c-Myc locus had some 
remarkable properties comes from the first GROMIT insertion mapped inside c-
Myc locus, namely 179039 (17a), obtained by Sandra Ruf (Ruf et al., 2011). The 
analysis of the LacZ staining pattern given by this insertion revealed that c-Myc and 
the 17a region might respond to the same regulatory elements. At the time it was 
not clear how this was possible, as the two of them were separated by a considerable 
genetic distance, and in addition to this, the insertion 179039 (17a) was closer to 
other genes than it was to c-Myc.  
Now, we know from ChIP-seq experiments that the telomeric end of c-Myc 
locus is enriched for H2AZ and H3K27ac in face and liver, but not in the FB 
(control tissue with basal c-Myc expression). 
Unpublished data, obtained by Veli Uslu and Peter Krijger (from Wouter de 
Laat laboratory) using the 4C method on the embryonic face, showed that this 
region contacted c-Myc promoter as well as the TAD-boundary separating Fam48b-
TAD from c-Myc-TAD. We do not have this kind of data for liver and FB as 
control, therefore we cannot state that the telomeric end of c-Myc locus engages the 
same contacts in tissues where c-Myc transcriptional boost relies on other long-range 
enhancers, or in tissues with basal c-Myc expression. However, some recently 
published Hi-C data showed similar findings to the ones described by Veli Uslu for 
the face, in other cell-types. This study performed with higher sequencing depth and 
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a few technical improvements of the standard protocol, managed to capture in 
human and mouse cells not only the previously described topological domains, but 
also individual loops (Rao et al., 2014). It was proposed that a large fraction of these 
loops occur between TAD edges, namely, the sequences flanking TAD-boundaries. 
In CH12 cells (mouse B-cell lymphoma) c-Myc-TAD also show this behavior, 
namely the 330Kbp at the telomeric end of the locus (corresponding to the telomeric 
end of c-Myc-TAD, mm9 coordinates: ~ chr15:63420000-63750000), extending up 
to the gene Gsdmcl-ps, engage extensive contacts with the centromeric end of c-Myc-
TAD, as well as with c-Myc transcribed region, defining the centromeric edge of the 
telomeric c-Myc-subTAD (figure 8).  
The ChIP-seq data on face, liver and FB (as well as publically available data (T. 
H. Kim et al., 2007)) confirms the presence of multiple CTCF binding sites at each 
of these TAD-edges. In particular, at the telomeric end of c-Myc-TAD, we saw ten 
CTCF peaks. In INV2 and INV3, the telomeric breakpoint lies inside this CTCF 
cluster, splitting it into two blocks and for this reason these lines were useful to ask 
important questions regarding the functions as a contact point of the telomeric end 
of the locus.  
In both cases, we observed a reduction of reporter responsiveness from the 
insertion 17a, upon inversion (on FM, NE, somites, PLM, BA and RL), being more 
pronounced for INV2 (figure 17 and figure 19). These lines show that the 
centromeric (relative to the insertion 17a) segment (segment-C), moved with the 
inversion, is not affected by the enhancer(s) (for the MFM in particular) as much as 
it is in the Wt, likely because of the strengthening action of the other segment (~ 
200Kbp telomeric to the insertion 17a, segment-T) not included in the inversion. 
Supporting this view, in INV3, the insertion 194578 (3a) acquires an expression 
pattern resembling the insertion 192857 (17a) in Wt configuration. Therefore the 
segment-T may have an important role to capture transcriptional input in all the 
characteristic tissues of the insertions 179039 and 192857 (17a).  
In INV2 we saw a reduction of c-Myc expression in the face, while in INV3 this 
effect was reproducible, however not statistically significant (figure 18 and figure 20). 
Remarkably, INV2 preserves the locus structure (with exception of the segment-T), 
therefore, it is likely that the downregulation of c-Myc, may be due to an insufficient 
function of the telomeric end of the locus once it is depleted of the segment-T.  
Also in this case, there is the possibility that changes in the orientation of 
CTCF binding sites are responsible for the effect we observed on c-Myc expression. 
Indeed, 5 out of 8 CTCF motifs are not included in INV2, and therefore their 
orientation, compared to the rest of c-Myc locus, is changed (figure 27). However, the 
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fact that the two parts of the telomeric end of c-Myc locus are separated from each 
other—being at the opposite sides of the locus—with two TAD-boundaries in 
between, supports the idea that this physical separation rather than the changes in 
CTCF motifs orientation are responsible for the insufficient activity of the telomeric 
end of the locus. A good control experiment, in order to rule out the possibility that 
the CTCF motif orientation is important for the topological organization of the 
locus, could be to perform a targeted inversion (using the CRISPR-Cas9 technology) 
of the segment-T. 
Despite the importance of this segment to promote the communication between 
c-Myc promoter and the facial enhancers, in INV3 the relationship between the two 
is unaltered, yet we saw a mild (and non-significant) downregulation of c-Myc in the 
face. There is the possibility that this effect may be due to an improper function of 
the segment-C. However, this segment is brought closer to c-Myc promoter than it 
is in the Wt and moreover it is still present inside the same subTAD. Alternatively, 
it is possible that the mild effect INV3 has on c-Myc expression may be caused by the 
general reshuffling of the sequences inside the subTAD rather than by a single 
sequence in particular. This model does not fully agree with the current ones present 
in the literature, proposing a TAD-centric view of the long-range interactions, 
however, our data support the idea that even inside TADs there may be sub-
topologies whose alteration (for example by genetic engineering), could provoke 
small although perceptible perturbations of gene expression. 
6.3.2 Genomic Imprinting as a Way to Modulate Enhancer 
Functions 
The telomeric end of c-Myc locus was shown by Veli Uslu to be imprinted in the 
maternal allele. Veli Uslu mapped the location of the ICR to be telomeric to the 
insertion 179039 (17a) (figure 23). INV2 was useful to confirm this observation. 
Upon INV2, the imprinting is lost on the breakpoint 179039 (17a). We think that 
in this case, the separation of this insertion from the ICR (with the presence of two 
TAD-boundaries in between) is likely what causes the loss of imprinting (figure 17 
and figure 25B). Interestingly, the small deletions that Veli Uslu used to identify the 
ICR (Del(17a–17d) and Del(17a–19a)) had a very similar staining pattern to the 
INV2 breakpoint 179039 (17a). 
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Veli Uslu reported that the extent of the imprinting was limited to a short 
region around the 17a insertion site. However, in this project we determined that the 
insertion 194578 (3a), which gives LacZ expression in multiple tissues if inherited 
from the father, is silent if inherited from the mother (figure 22). Despite the fact 
that we lack bisulfite-sequencing data regarding the methylation status of the LacZ 
promoter of the insertion 194578 (3a) (a required experiment to undoubtedly prove 
imprinting effects), our data is compatible with the idea that the insertion 194578 
(3a) is imprinted in the maternal allele. This suggests (similarly to the regulatory 
landscape) that the imprinting spreading throughout the locus may be discontinuous. 
Considering the case of the MFM, PLM and somites, the imprinting is present at 
the telomeric end of the locus, close to the ICR, it is absent from the insertion 8a to 
15a, and it reappears more centromeric, on the insertion 194578 (3a). We speculate 
that probably the topology of the telomeric c-Myc-subTAD affects which regions 
contact the ICR, determining the extent of the imprinting. INV3 that includes most 
of the telomeric c-Myc-subTAD was useful to test whether the genetic reshuffling 
that it introduces might have some effect on the distribution of the imprinted 
regions. In INV3, the LacZ reporter at both breakpoints remains silenced upon 
inversion in the maternal allele, indicating that the imprinting is still acting at these 
sites. This data suggests (despite not having information regarding other positions, 
like 8a and 15a, inside the inverted region) that the genetic and topological changes 
did not alter the imprinting distribution. 
One last remark, probably the most important, regards the physiological 
meaning of the imprinting on c-Myc locus. According to the models proposed in the 
literature, the DNA methylation, at least for the case of maternal imprinting, should 
occur at genes promoters, or close by. This, as consequence, leads to the complete 
silencing of some genes and expression of others, with an on/off effect. In c-Myc locus 
the ICR lies 1.7Mbp away from c-Myc promoter. The effect of the DNA 
methylation on the maternal allele does not cause the complete silencing of c-Myc, 
but rather has a milder effect, reducing its expression of ~ 20% (compared to the 
paternal allele). Veli Uslu observed that this difference could be attributed to a 
different use of the enhancers present in the telomeric c-Myc-subTAD. 
In addition, the effect of the imprinting does not seem to affect all the tissues in 
the same manner, for example the GROMIT insertion 16d (figure 22) from the 
maternal allele, gives a mild, although clearly perceptible LacZ staining in the NE, 
although it is imprinted in MFM, PLM and somites. According to the current view, 
in most of the loci, the imprinting does not show tissue-variability.  
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Figure 28 | Tissue-specific imprinted regions in c-Myc locus. Hypothetical model 
showing how the different extent of the imprinting—observed in different tissues—could 
affect the activity of the tissue-specific enhancers. The enhancers are represented by 
ellipses, blue for the facial mesenchyme, yellow for the nasal epithelia and red for the liver. 
The imprinting control region is depicted as a lilac ellipse. The imprinted regions are shown 
as lilac semi-transparent rectangles. The red lines on the gene model show the location of 
the GROMIT insertions on which the imprint has been tested. 
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On the other hand, there are more and more reported cases describing tissue-
specific imprinting that could support our observations obtained in c-Myc locus 
(Babak et al., 2015; J. T. Lee & Bartolomei, 2013; Prickett & Oakey, 2012). In the 
NE (differently from MFM, PLM and somites) the imprinting is not seen at any 
position centromeric to 179039 (17a). Because of the fact that the insertion 194578 
(3a) does not give any staining on the NE, regardless of the parental origin, we 
cannot say whether it is also imprinted on the NE, in addition to MFM, PLM and 
somites. Therefore we cannot tell whether in this tissue the imprinting is local, 
involving only the ICR, or it is discontinuous. 
In conclusion, we observed several differences in c-Myc locus, compared to the 
general models of imprinting described in the literature. These differences include 
that c-Myc is not embedded in a gene-cluster, that the imprinting does not have an 
on/off effect on c-Myc expression, that its extension is discontinuous inside the locus 
and that likely there are differences in the imprinted regions comparing different 
tissues. Therefore, it is possible that the imprinting in c-Myc locus may not be 
established in order to attain mono-allelic expression of c-Myc but rather to modulate 
the activity of the tissue-specific enhancers in different ways for the paternal and 
maternal loci (figure 28). 
Our data suggest that the telomeric end of c-Myc locus, and in particular the 
segment extending from the insertion 179039 (17a) to the gene Gsdmcl-ps may be 
important for the communication between c-Myc and its facial enhancers. As the 
ICR lies on the telomeric end of the locus, we speculate that the imprinting may be a 
way to affect the function of the telomeric end of the locus in the maternal allele, 
which as a consequence, would slightly reduce the effect of the facial enhancers (and 
possibly other ones) on c-Myc. Supporting this view, in INV2 (with which we force a 
reduced function of the telomeric end of the locus), the displacement of the segment 
telomeric to the insertion 179039 (17a) from the rest of the locus, resulted in a 
reduced c-Myc expression in the face. We think it is possible that the imprinting at 
the telomeric end of the locus may cause a relaxation of intra-TAD interactions in 
the maternal locus, causing the reduced effect of the facial enhancers on c-Myc. 
Regarding the mechanisms that could explain this relaxation of interactions, we 
know that the ICR is located somewhere inside a ~ 50Kbp critical region telomeric 
to the insertion 179039 (17a), and that most of the CpG di-nucleotides on the LacZ 
promoter in this insertion are methylated in the maternal chromosome. As the ICR 
critical region contains four tissue-invariant CTCF binding sites (number 4, 5, 6 and 
7, figure 23), out of which, only one (number 6, figure 23) possesses the canonical 
CTCF motif and a CpG dinucleotide. It is possible that if it is methylated in the 
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maternal chromosome, there may be (similarly to the ICR of the Igf2/H19 locus) a 
drop in CTCF binding. If this is the case—and whether it causes a reduction (or just 
a rearrangement) of interactions inside the TAD—must be determined 
experimentally. In order to test CTCF binding on maternal and paternal 
chromosomes, the deletion line Del(17a–17d) used by Veli Uslu to identify the ICR 
critical region can be used. Males and females Del(17a–17d) can be crossed against 
Wt and the allele specific CTCF binding can be tested by ChIP-qPCR. 
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8.2 Abbreviations and Acronym 
Acronym Full name 
(NH4)2SO4 Ammonium sulfate 
3'UTR 3' Untranslated region 
3C Chromatin conformation capture 
4C Circularized chromatin conformation capture 
5C Chromatin conformation capture carbon copy 
A1bg Alpha-1-B glycoprotein 
ANOVA Analysis of variance 
AP1/FOS-JUN V-Jun Avian Sarcoma Virus 17 Oncogene Homolog 
ATP Adenosine triphosphate 
BA Branchial arches 
BEAF Boundary element associated factor 
BET Bromodomain-extraterminal 
BMP Bone morphogenetic protein 
bp Base pairs 
Brd2/3/4 Bromodomain containing 2/3/4 
Brdt Bromodomain testis-specific 
BRE TFIIB recognition element 
c-Myc v-Myc Avian Myelocytomatosis Viral Oncogene Homolog 
CaCl2 Calcium chloride 
Capture-C Hi-C with sequence capture 
ChIP-seq Chromatin immunopreciptation-sequencing 
CLP Cleft lip and/or cleft palate 
CPF-CF Cleavage and polyadenylation factor-cleavage factor 
Cre Cre recombinase 
CREB cAMP response element-binding protein 
Ct Treshold cycle 
CT Chromosome territories 
CTCF CCCTC-binding factor 
CTD Carboxy terminal domain 
DMEM Dulbecco's modified eagle medium 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
dNTPs Deoxynucleotide triphosphate 
DPE Downstream Promoter Element 
E2F(s) Retinoblastoma-Binding Protein 
E430025E21Rik Spastic paraplegia 8 (autosomal dominant) 
EDTA Ethylenediaminetetraacetic acid 
EGF Epithelial growth factor 
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EGTA Tetra(acetoxymethyl Ester) 
EMBL European molecular biology laboratory 
ER Estrogen receptor 
Fam49b Family with sequence similarity 49, member b 
Fam84b Family with sequence similarity 84, member B 
FB Fore brain 
FBP FUSE binding protein 
FBS Fetal serum bovine 
FIR FUSE interacting repressor 
FISH Fluorescence in situ hybridization 
FM Facial mesenchyme 
Ftz Fushi tarazu 
FUSE Far upstream sequence element 
GRO-cap Genomic run-on-5’cap enriched 
GRO-seq Genomic run-on-sequencing 
GROMIT 
Genome regulatory organization mapping with integrated 
transposons 
Gsdmc Gasdermin C 
GTF General transcription factors 
Gusb Glucuronidase beta 
GWAS Genome wide association studies 
H2AK119ub H2A lysine 119 ubiquitination 
H2O Water 
H3K27ac H3 lysine 27 acetylation 
H3K27me3 H3 lysine 27 tri-methylation 
H3K4me1 H3 lysine 4 mono-methylation 
H3K4me3 H3 lysine 4 tri-methylation 
H3K9me3 H3 lysine 9 tri-methylation 
Hbb Hemoglobin subunit beta 
Hi-cap Hi-C with sequence capture of promoter regions 
HMGA1 High mobility group proteins A1 
hnRNP Heterogeneous ribonucleoprotein particle 
HP1 Heterochromatin protein 1 
Hprt Hypoxanthine phosphoribosyltransferase 1 
HS4 Chicken hypersensitivity site 4 
HSB16 Hyperactive SB16 transposase 
ICR Imprinting control regions 
Igf2 Insulin like growth factor 2 
IgH Immunoglobulin heavy chain 
INV1 Inversion1 
INV2 Inversion2 
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INV3 Inversion3 
Irf6 Interferon regulatory factor 6 
K3Fe3(CN)6 Potassium ferrocyanide 
K4Fe2(CN)6 Potassium ferrocyanide 
KCl Potassium chloride 
KH2PO4 Monopotassium phosphate 
LacZ β galactosidase 
LAP Lamin-associated membrane proteins 
LCR Locus control region 
LEF-TCF 
lymphoid enhancer-binding factor - transcription factor 7 (T-cell 
specific, HMG-Box) 
LFM Lateral face mesenchyme 
MAR Matrix attachment regions 
Med12 Mediator complex subunit 12 
mESC Mouse embryonic stem cells 
MFM Medial facial mesenchyme 
MgCl2 Magnesium chloride 
MoMuLV Moloney murine leukemia virus 
MTE Motif Ten Element 
Na2HPO4 Sodium phosphate 
NaCl Sodium chloride 
NaDeoxycholate Sodium deoxycholate 
NE Nasal epithelia 
NFκB 
Nuclear factor of kappa light polypeptide gene enhancer in B-
cells 
NGS Next-generation-sequencing 
Nsmce2 Non-SMC element 2, MMS21 homolog 
ON Over night 
PBS Phosphate-buffered saline 
PCR Polymerase chain reaction 
PDGF Platelet-derived growth factor 
PFLM Proximal fore limb mesoderm 
PIC Pre-initiation complex 
PK Proteinase K 
PLM Proximal limb mesoderm 
Prm1 Protamine gene 
Pvt1 Pvt1 oncogene (non-protein coding) 
qPCR Quantitative PCR 
RD Regulatory domain 
Rfx(s) Regulatory Factor X 
RIPA Radioimmunoprecipitation assay buffer 
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RL Rhombic lip 
RNA Ribonucleic acid 
RNA Pol II RNA polymerase II 
RT Room temperature 
RT-qPCR Reverse transcript qPCR 
SB Sleeping beauty transposon 
SCC1 Sister-chromatid cohesion protein 1 
SCC3/SA Sister-chromatid cohesion protein 3/Stromalin 
Sdha Succinate dehydrogenase complex, subunit A, flavoprotein (Fp) 
SDS Sodium dodecyl sulphate 
Segment-C 
Region of the telomeric end of c-Myc locus covering the ~130Kbp 
centromeric to the GROMIT insertion 179039 (17a) 
Segment-T 
Region of the telomeric end of c-Myc locus extending from the 
GROMIT insertion 179039 (17a) to the gene Gsdmcl-ps 
SINE Short interspersed element 
SMAD(s) Sma-And Mad-related protein(s) 
SMC1 Cohesin subunit1 
SMC3 Cohesin subunit3 
SNP(s) Single nucleotide polymorphism(s) 
Sp1-3 Sp1-3 Transcription Factor 
Src Sarcoma 
ssDNA Single strand DNA 
Stat(s) Signal transducer and activator of transcription 
su(Hw) Protein suppressor of hairy wing 
SWI/SNF Switch/Sucrose non-fermentable 
TAD Topologically associated domans 
Taq Thermus aquaticus 
Tbp TATA box binding protein 
TF Transcription factor 
TGF-β Transforming growth factor β 
Trib1 Tribbles pseudokinase 1 
Tris Tris(hydroxymethyl)aminomethane 
TSS Transcription start site 
USF1 Upstream transcription factor 1 
Vax1 Ventral anterior homeobox 1 
VEZF1 Vascular endothelial zinc finger 1 
WNT Wingless-type MMTV (mouse mammary tumour virus) 
Wt Wild type 
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8.3 Supplementary figures 	  
 
Supplementary figure 1 | c-Myc locus regulatory inputs. Schematic representation of all 
the regulatory inputs captured by GROMIT insertions integrated inside c-Myc locus. 
 
  
Supplementary figure 2 | Architectural proteins binding on control regions, in 
inversion lines. CTCF and RAD21 occupancy at selected control regions in Wt, INV1+/+, 
INV2+/+, INV3+/+  E11.5 facial mesenchyme and liver (sample size n ≥ 3). The y-axis 
represents the fold enrichment of ChIP samples to the input chromatin control (background 
= 1). The control regions were chosen outside c-Myc locus (assumed to be unaffected by 
the chromosomal inversions) and were selected for having different degrees of enrichment 
compared to the input. They are labeled as negative, middle and positive controls. 
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Supplementary figure 3 | Identification of facial enhancers in c-Myc locus. Picture 
obtained from (Uslu et al., 2014) (supplementary figure 2). A) Locations of the deletion lines 
generated to identify the facial regulatory elements. The approximate position of the medial 
face mesenchyme (MFM) and the nasal epithelia (NE) enhancers is depicted by a blue and 
a yellow ellipse respectively. MNE, medionasal enhancer; NEE, nasal epithelial enhancer. 
B–E) Frontal view of the head of E11.5 mouse embryos carrying different chromosomal 
deletions, subjected to LacZ staining procedure. The regions corresponding to the MFM and 
NE are shown by a blue and a yellow arrow respectively. C–E) Vibrotome sections (150µm) 
of the face of E11.5 mouse embryos (from different deletion lines) subjected to LacZ staining 
procedure. C) Panel showing the loss of LacZ staining in the MFM and the preservation of 
the LacZ staining in the NE, upon Del(8–14). D) Pictures showing the LacZ staining present 
in the facial mesenchyme (both medial and lateral) but absent in the NE. E) Pictures 
showing the strong LacZ expression in the MFM and the weak (although still present) one 
on the NE. 
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Supplementary figure 4 | Sequences driving reporter expression in the fore brain. A–
E) Picture showing the LacZ staining pattern of mouse embryos at stage E11.5, subjected to 
reporter assays (Visel, Minovitsky, Dubchak, & Pennacchio, 2007). The genomic locations, 
and the H3K27ac density (ChIP-seq on fore brain tissue of E11.5 Wt embryos) are shown 
on the top of each panel. Peak called regions and input chromatin controls are shown 
underneath the H3K27ac tracks. 
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Cleft lip with or without cleft palate (CL/P) is one of the  
most common congenital malformations observed in humans, 
with 1 occurrence in every 500–1,000 births1,2. A 640-kb 
noncoding interval at 8q24 has been associated with increased 
risk of non-syndromic CL/P in humans3–5, but the genes and 
pathways involved in this genetic susceptibility have remained 
elusive. Using a large series of rearrangements engineered over 
the syntenic mouse region, we show that this interval contains 
very remote cis-acting enhancers that control Myc expression 
in the developing face. Deletion of this interval leads to mild 
alteration of facial morphology in mice and, sporadically,  
to CL/P. At the molecular level, we identify misexpression 
of several downstream genes, highlighting combined impact 
on the craniofacial developmental network and the general 
metabolic capacity of cells contributing to the future  
upper lip. This dual molecular etiology may account for  
the prominent influence of variants in the 8q24 region on 
human facial dysmorphologies.
CL/P is present in a large number of malformation syndromes with 
mendelian inheritance, but most cases correspond to isolated non-
syndromic forms1. The influence of environmental risk factors6 
further complicates definition of the genetic components of CL/P. 
Genome-wide association studies (GWAS) have identified common 
variants contributing to increased risk of CL/P3–5, defining several 
susceptibility loci. Of these, a 640-kb locus at 8q24 showed the 
strongest effect size in different populations, particularly in those 
with European ancestry1,3–5. This large interval corresponds to a gene 
desert (Fig. 1). Such situations are a common outcome of GWAS 
and constitute a challenge in moving from statistical associations to 
functional mechanisms7, particularly for phenotypes that cannot be 
easily reproduced in cell lines.
To obtain insights into the role of the 8q24 noncoding interval 
during craniofacial development and to identify the gene(s) and 
pathway(s) it can influence, we sought to dissect its function in vivo. 
Similarity of craniofacial development in mice and humans8 and con-
served synteny of the 8q24 region (Supplementary Fig. 1) suggested 
that the mouse constitutes a suitable model. To identify regulatory 
activities present in this interval, we exploited a mouse line carrying, 
at the distal end of the locus, an insertion of a LacZ reporter gene 
whose activity reflects endogenous surrounding regulatory activities9. 
As this regulatory sensor lay in a Sleeping Beauty transposon, we 
produced, by repeated in vivo transposition, 38 new insertions in the 
locus (Fig. 1b and Supplementary Table 1). Strikingly, insertions 
within or adjacent to the region orthologous to the CL/P-associated 
interval showed specific LacZ expression in the developing fronto- 
and medionasal process of embryonic day (E) 11.5 mouse embryos, 
when this process fuses with the maxillary process to form the future 
upper lip10 (Fig. 1 and Supplementary Table 1).
To more precisely localize the region(s) responsible for this regulatory 
activity, we used the loxP site present in the transposon to engineer 
a series of rearrangements spanning the entire interval9 (Fig. 1b and 
Supplementary Table 2). We first monitored the effects of the differ-
ent deletions on expression of the reconstituted LacZ sensor (Fig. 1f 
and Supplementary Fig. 2). Confirming our earlier observations9, 
del(8–17) showed no LacZ expression in the developing face. 
All deletions encompassing the 8–14 interval also led to loss of 
LacZ expression in the medionasal process, whereas deletions retaining 
the 10–13 interval had no or minor effects on this expression domain. 
We also analyzed mice carrying different duplications that ‘moved’ 
genomic intervals away from the CL/P-associated interval, linking 
them to a different regulatory domain (Supplementary Fig. 3). We 
observed LacZ expression in the medionasal process in dup(10–20) 
and dup(8–21) but not in dup(13–20) embryos (Supplementary 
Fig. 3), confirming the key role of the 10–13 interval. Altogether, 
the 14 overlapping rearrangements showed that the 280-kb region 
between 10a and 13a contains specific regulatory information 
relevant to CL/P, defining a medionasal enhancer (MNE) region. 
To identify potential regulatory modules constituting the MNE region, 
we carried out chromatin immunoprecipitation (ChIP) on face sam-
ples from E11.5 embryos for enhancer-associated histone modifica-
tions11,12 (Fig. 1g and Supplementary Table 3). The 10–13 interval 
contained several regions enriched for acetylation of histone H3 at 
lysine 27 (H3K27ac) and monomethylation of histone H3 at lysine 4 
(H3K4me1) (Fig. 1g, bottom). These regions are often evolutionarily 
conserved and were not detected in other tissues or cell types13, sug-
gesting that they have a specific function in the face. Supporting 
this hypothesis, it was recently shown that the human sequence 
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corresponding to one of these face-specific H3K27ac and H3K4me1 
peaks showed, in E11.5 transgenic mouse embryos, enhancer activity 
in the face, among other domains14.
Most of the genes surrounding this large region are expressed in the 
developing face (Supplementary Fig. 4), and their promoters show 
active chromatin marks (Supplementary Table 3). To identify MNE 
region–regulated gene(s), we measured by quantitative PCR (qPCR) 
the expression of these genes in dissected tissues from wild-type 
E11.5 embryos and those with deletion of the MNE region (Fig. 2a). 
In the face of del(8–17) embryos, Myc expression was reduced to 15% 
of its normal expression level. None of the other surrounding genes 
tested showed significant (P < 0.05) changes in expression. Notably, 
Myc levels in embryonic heart and liver were unaffected (Fig. 2b), 
showing that the 8–17 interval controls Myc expression only in 
tissues where it has enhancer activity. Whole-mount in situ hybridi-
zation confirmed strong reduction in Myc transcript levels in the 
face but not in the liver of del(8–17) homozygous embryos (Fig. 2c). 
The smaller deletion of the 8–14 interval, which retains the MNE 
region, led to a similar reduction in Myc expression in the developing 
face, whereas deletions that did not include the MNE region (Fig. 2d) 
or simple transposon insertions (Supplementary Fig. 5) had no or 
minor effects. From these experiments, we conclude that the MNE 
region controls Myc expression specifically in the future upper lip. If 
the MNE region regulates Myc expression in trans, both Myc alleles 
should be equally affected. Instead, in compound embryos carrying 
del(8–17) on one chromosome and a GFP-tagged Myc gene15 on the 
other, GFP expression was not diminished (but was instead slightly 
higher), whereas the Myc allele on the same chromosome as del(8–17) 
was downregulated to 30% of wild-type levels, after normalization 
to GFP levels (Fig. 2e). The very different response of the two alleles 
demonstrates that the MNE region acts on Myc in cis across more 
than 1 Mb of DNA. The intermediate effects of heterozygous dele-
tions of the MNE region on Myc expression also supported direct 
regulation in cis.
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Figure 1 Functional characterization of the 8q24 CL/P regulatory landscape. (a) The human 8q24 interval associated with CL/P risk. Genes are shown 
as plain arrows (black, protein-coding genes; gray, annotated noncoding transcripts). The CL/P interval3 and the most significantly associated SNP 
(rs987525) are indicated in blue. (b) Syntenic organization of the mouse locus, depicting transposon insertions (blue triangles) and deletions (red bars) 
used in this study. An expanded list of insertions and alleles is given in Supplementary Table 1. The expression patterns of adjacent insertions (shown 
in c) define a broad ‘medionasal regulatory domain’ indicated by a blue bar whose width represents relative LacZ expression levels. (c) LacZ staining 
of E11.5 embryos with various insertions, with insertion number indicated below. Arrowheads indicate expression in the medionasal process (blue) 
and in the nasal epithelium (orange). Insertions located in the Gsdmc gene cluster did not result in any expression, whereas the more telomeric ones 
around Fam49b resulted in a different expression pattern. (d,e) Magnified view (d) and sections (e) of E11.5 embryos with strong LacZ expression in 
the medionasal process (MNP; blue) and nasal epithelium (NP; orange). MX, maxillary process; MD, mandibulary process; LNP, lateral nasal process. 
Most insertions in the 7a–17a interval also showed LacZ expression in somites and in the limb mesenchyme of E11.5 embryos but not in heart or liver9. 
(f) LacZ staining in the faces of E11.5 embryos carrying the different deletions. The medionasal process and nasal epithelium expression domains 
can be separated by different deletions, highlighting two distinct regulatory regions, the MNE and NEE regions, respectively. See also the description 
of additional lines and sections in Supplementary Figures 2 and 3. Precise genomic positions are given in Supplementary Table 2. (g) Enrichment 
for enhancer-associated marks (blue, H3K4me1; turquoise, H3K27ac) profiled by ChIP sequencing (ChIP-seq) of E11.5 facial tissues highlighted 
several candidate face-specific regulatory regions (dashed boxes; positions and evolutionary conservation are given in Supplementary Table 3). One 
representative profile of two biological replicates is shown for each track. The blue boxed peak corresponds to Vista element hs1877, which showed 
enhancer activity in a number of regions, including the facial mesenchyme14.
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We then investigated the physiological consequences of the deletion 
of the MNE region on facial development. Mice homozygous for 
del(8–17) were born in normal mendelian proportions, with-
out gross abnormalities or the several global skull malforma-
tions observed upon Myc deletion in the neural crest lineage16. 
Homozygous del(8–17) mice usually showed impaired postnatal 
growth, and some died before weaning, suggesting that the 8–17 
interval contains additional elements9 that may regulate Myc 
expression in other organs and tissues. Interestingly, compared to 
their littermates, del(8–17) homozygous mice had a significantly 
smaller snout (P < 0.005) (Fig. 3 and Supplementary Fig. 6a), 
with an abnormal suture of the nasal and frontal bones (Fig. 3b). 
Other craniofacial regions were unaffected (Fig. 3c), and we did not 
observe palatal clefts in any of the pups. Changes in face morphology 
could already be detected in embryos, with a reduction in the width 
of the medionasal process in del(8–17) embryos compared to control 
E11.5 embryos (Fig. 3d). We did not detect any change in apoptosis 
in the developing medionasal prominence at E11.5 (data not shown). 
However, we found a small but significant reduction in the number 
of mitotic cells (P < 0.05) (Fig. 3e and Supplementary Fig. 6b), 
suggesting abnormal cell proliferation. Notably, we recovered a small 
number of E14–E15 embryos heterozygous and homozygous for 
del(8–17) with cleft lip and/or abnormal facial development (Fig. 3f): 
out of 121 embryos produced from heterozygous × heterozygous 
crosses, 4 del(8–17) embryos showed cleft lip and 4 other del(8–17) 
embryos showed cleft palate. The normal rate of spontaneous CL/P 
on the C57BL/6J background, on which our alleles are maintained, 
is extremely low17, and none of the 35 wild-type embryos from these 
crosses had abnormal craniofacial morphology (Fisher’s exact prob-
ability test P = 0.0589). Thus, these sporadic cases further support the 
involvement of this region in susceptibility to CL/P.
To identify genetic pathways that might contribute to the increased 
incidence of CL/P, we compared the mRNA transcriptomes of the medio-
nasal regions in del(8–17) and control embryos at E11.5. We found 100 
genes that showed significant (false discovery rate (FDR) < 0.05), albeit 
mild, differences in expression (Fig. 4a, Supplementary Figs. 7 and 8, 
and Supplementary Table 4). We tested and confirmed differences 
in expression for a subset of these genes using qPCR in del(8–17) and 
del(8–14) homozygous embryos. We also showed that the expression 
of these genes was not altered in del(14–17) embryos, in which the 
deleted interval does not include the MNE region (Fig. 4b). Consistent 
with our qPCR analysis, Myc expression was reduced to 17% of wild-
type levels, and we found no significant changes for the genes located 
in the surrounding 5 Mb of sequence (Supplementary Table 5). Gene 
Ontology (GO) analysis showed that the majority of the genes misex-
pressed in del(8–17) embryos were involved in ribosome assembly and 
translational control (Supplementary Tables 6 and 7). For these genes, 
the fold change in expression was small (20–25%), but all showed 
lower expression levels in del(8–17) embryos and enrichment of the 
associated terms was maintained even when considering only highly 
expressed genes. Interestingly, MYC has already been shown to be a 
direct regulator of ribosome biogenesis in cancer and cellular models18. 
Our results stress the notion that physiological, non-oncogenic 
expression levels of Myc modulate ribosomal and translation- 
associated protein expression. We also found significant yet mild 
misexpression of a number of transcription factors and signaling 
molecules known to be important for facial development 
(Supplementary Table 8). Intriguingly, the altered frontonasal sutures 
in del(8–17) mice resembled the phenotype induced by facial-specific 
knockout of Tfap2a19. Whereas Tfap2a expression seemed unaltered 
in del(8–17) embryos, Nr2f1, whose product, together with TFAP2A, 
binds to a large subset of neural crest cell (NCC) enhancers20, showed 
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Figure 2 Gene expression changes upon  
deletion of the MNE region. (a) Gene  
expression in the face of wild-type (WT)  
and del(8–17) homozygous E11.5  
embryos (normalized to Gusb levels and  
displayed with the wild-type expression  
level set as 1). Fam84b, A1bg, Myc,  
Pvt1, Gsdmc, Fam49b and Asap1 (Ddef1)  
are in the chr. 15: 60,000,000–64,000,000  
region, and Gusb and Pdhb are on chromosomes  
5 and 14, respectively. The primers used for  
Gsdmc cannot distinguish the different isoforms  
of the Gsdmc genes, which are duplicated in tandem. (b) Myc expression in different tissues  
from E11.5 embryos. Values are expressed after normalization to Gusb levels (set as 1 in each tissue). (c) Loss of Myc expression detected by whole-
mount in situ hybridization in the medionasal process (MNP) but not in the liver (L) of del(8–17) homozygous embryos relative to wild-type E11.5 
embryos. Staining in control embryos is highlighted by dashed circles. (d) Myc expression in the face of E11.5 embryos heterozygous for different 
deletions. Values are expressed after normalization to Gusb levels (set as 1 in each tissue). (e) Allele-specific analysis of Myc expression in the faces of 
E11.5 embryos showed that the MNE region acts in cis. The reference allele Myctm1Slek carries an insertion of GFP in the second exon of Myc15, and 
its expression is detected with GFP-specific primers. Expression levels of the other alleles (wild type or del(8–17)) were determined by subtracting GFP 
expression levels from the overall Myc expression levels (the Myc-specific primers used amplified both alleles). Myc expression levels are significantly 
lower in del(8–17) than in wild-type mice (Student’s t test, P < 5.6 × 10−5), whereas GFP expression is instead higher. In all charts, error bars represent 
s.d. ***P < 0.005, Student’s t test; NS, not statistically significant (P > 0.05).
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lower expression levels. TFAP2A also interacts both genetically and 
directly with MYC21,22. These interactions may contribute to propa-
gating the consequences of Myc downregulation in the facial NCC 
gene regulatory network (GRN).
The distinct facial morphology of mice carrying deletion of the MNE 
region and the sporadic CL/P cases observed demonstrate the key func-
tional role of this region in craniofacial morphogenesis. These findings 
support the implication of genetic variation at 8q24 in CL/P3–5 and in 
normal variation in facial shape23,24 in humans. They refine the proposed 
critical interval to a smaller region, distal to the marker most significantly 
associated with CL/P, rs987525 (ref. 3; Supplementary Fig. 9).
At the molecular level, we show that this region is a key tissue- 
specific cis-regulatory enhancer for Myc. Its extremely remote location 
further emphasizes the role of distant regulatory elements in con-
trolling gene activity14,25, not only for tissue-specific developmental 
regulators but also for genes with more general functions26. The MNE 
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Figure 3 Facial dysmorphologies upon 
deletion of the CL/P-associated 8q24 region. 
(a) Comparison of the skulls of del(8–17) 
homozygous mice to those of their wild-type 
littermates. Dorsal views of representative  
skulls from 3-week-old wild-type and mutant 
(del(8–17)) mice, stained with Alcian blue 
(cartilage) and Alizarin red (bone). IOD, 
interorbital distance; NBL, nasal bone  
length. Scale bars, 5 mm. (b) Enlarged views  
of the frontonasal regions showing the  
abnormal suture in del(8–17) mice  
(highlighted by dashed lines). (c) Comparison  
of different bone lengths and skull measures 
(FBL, frontal bone length; PBL, parietal  
bone length) in 3-week-old (del(8–17),  
n = 5; wild type, n = 7) mice. Del(8–17)  
mice showed reduced nasal and frontal bone 
lengths (Student’s t test, P = 0.0033 and 
0.0028, respectively). Box plots show medians 
and first and third quartiles. Whiskers indicate 
minimum and maximum values. (d) Comparison 
of the widths of the lateral and medial parts  
of the developing face in wild-type (n = 3)  
and del(8–17) (n = 4) E11.5 embryos.  
The landmarks (arrows) used to compare the  
lateral and medial widths of the developing 
faces of E11.5 embryos are shown on the left. 
NS = not significant. (e) Quantification of 
proliferation in the faces of wild-type (n = 5)  
and (del(8–17) homozygous (n = 7) E11.5 
embryos. Values represent the proportion of mitotic cells, determined by staining for phosphorylated histone H3, averaged from 10–30 serial sections 
per embryo. In d and e, box plots show medians and first and third quartiles. Whiskers indicate 1.5 times the interquartile ranges of the first and third 
quartiles. *P = 0.011 (Student’s t test). (f) Most E14.5 del(8–17) embryos have normal face morphology (top), but a minority have CL/P (arrow) with 
other craniofacial malformations (bottom). In all panels, statistical significance was determined with Student’s t tests. ***P < 0.005, *P < 0.05.
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Figure 4 Alterations in gene expression  
upon deletion of the CL/P-associated 8q24 
region. (a) Changes in expression measured 
by RNA sequencing in the medial faces of 
del(8–17) homozygous embryos (four replicate 
libraries from four different embryos) compared 
to wild-type controls (four replicate libraries 
from littermates). Genes with significant  
(FDR < 0.05) changes in expression are  
shown in red. See Supplementary Table 4 for  
a list of the misregulated genes and 
Supplementary Figure 7 for heat-map 
representations of the data. RNA sequencing 
analysis also showed downregulation of  
several blood-specific genes; their presence 
arose from the small blood vessels in the 
dissected tissues and suggested an additional 
role of the 8–17 interval in hematopoiesis, in which Myc has an important role49. Notably, the genomic region involved appears to be distinct from the 
MNE region, as the downregulation of Apoe and Csf1 was observed in del(14–17) but not in del(8–14) embryos (Supplementary Fig. 8). (b) Validation 
by qPCR of expression changes for some of the genes identified by RNA sequencing. The levels of Rplp1 and Rps20 are significantly (***P < 0.005, 
**P < 0.01, Student’s t test) decreased to similar extents in the medial faces of del(8–17) (n = 4 to 7) and del(8–14) (n = 3) homozygote E11.5 
embryos but not in del(14–17) (n = 3) homozygote E11.5 embryos. Nr2f1 levels also appeared lower (*P < 0.05, Student’s t test). Error bars, s.d.
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region comprises several adjacent blocks carrying enhancer-associated 
epigenetic marks, which may act collectively to control Myc expres-
sion, as described for other loci27–29. In such situations, deletions of 
individual modules may show only limited or subtle effects14,27 and 
may lead to an underestimation of their collective role. Indeed, it was 
recently proposed that GWAS may identify haplotypes with multiple 
polymorphisms affecting adjacent enhancers instead of a single ‘master’ 
element30. For this reason, larger rearrangements, such as the ones used 
here for 8q24 or earlier to characterize the 9p21 coronary artery dis-
ease (CAD)-associated interval31, may be a useful strategy in following 
up GWAS findings, particularly for intervals with multiple candidate 
enhancer regions32.
The different types of genes found to be misexpressed upon deletion 
of the MNE region give insights into the nature of the risk associated 
with variants in 8q24 (Supplementary Fig. 10). MYC is known for its 
role in NCCs16,33, and our analyses suggest that the altered expression 
levels of downstream genes involved in facial development observed 
with deletion of the MNE region may account for the slight but pen-
etrant concurrent facial dysmorphism. In this context, orofacial clefts 
may constitute the extreme end of a spectrum of normal phenotypic 
variation23,34. In addition to this hypothesis, we suggest that the global 
misexpression of ribosomal subunits and translation factors observed 
in del(8–17) mice may contribute to CL/P incidence through a dis-
tinct process. Heterozygous mutations of ribosomal genes, including 
Rps7 and Rps20, whose expression was downregulated in del(8–17) 
mice, have phenotypic consequences in mice and humans35–37. Of 
note, humans with Diamond-Blackfan anemia, which is caused by 
mutations affecting diverse ribosomal proteins, are also prone to CL/P 
malformations38. Abundance of ribosomal proteins therefore consti-
tutes a limiting factor: even mild, reduced expression of ribosomal 
and translation regulatory genes in del(8–17) mice may affect cellular 
metabolic capacity, leading to a general but spatially restricted sen-
sitivity. This phenomenon may account for the influence of diverse 
metabolic and environmental conditions (for example, tobacco or 
alcohol use, diabetes or folate deficiency) that have been proposed 
to contribute to CL/P etiology6 by transforming broad-spectrum but 
minor growth perturbations into growth defects affecting a specific 
embryonic process. The combination of these different effects might 
explain why this region has such a high population attributable risk3 
and a prominent influence on facial (dys)morphologies.
Interestingly, GWAS for other traits—prominently, susceptibility 
to diverse types of cancer—have identified associations with other 
regions within 8q24 (refs. 39–42), which were proposed to coincide 
with variants in tissue-specific enhancers for Myc or other genes43–47. 
As illustrated recently48, validating or determining the role of these 
variants in vivo will be essential. The series of overlapping deletions 
and rearrangements described here opens up avenues to further 
dissect this important regulatory landscape.
URLs. TRACER, http://tracerdatabase.embl.de/; HTSeq-count, http://
www-huber.embl.de/users/anders/HTSeq/doc/index.html.
METHODS
Methods and any associated references are available in the online 
version of the paper.
Accession codes. ChIP-seq data have been deposited in the Gene 
Expression Omnibus (GEO) under accessions GSM1279691, 
GSM1279692 and GSM1279693. RNA sequencing data have been 
deposited in GEO under accessions GSM1279694–GSM1279701.
Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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ONLINE METHODS
Mouse alleles. Transposon insertion sites were generated and mapped as 
described previously9. Additional information on each insertion can be found 
on the TRACER website50. To distinguish the different Myc alleles, we used 
Myctm1Slek (ref. 15). The reference allele Myctm1Slek carries an insertion of the 
GFP gene in the second exon of Myc, and the encoded fusion protein appeared 
functional15. Yet, we noticed that the GFP-tagged allele was expressed at lower 
levels than the wild-type allele, suggesting that it might be a hypomorph. Myc 
is known to negatively regulate its own transcription through its promoter 
region51, and this feedback can account for overall Myc levels in compound 
mice, on top of the specific effect of del(8–17) in cis.
Mouse alleles were genotyped by PCR of DNA purified from tail biopsies 
(for mice after birth) or yolk sacs (for embryos). Sequences for the primers 
for each insertion are provided in Supplementary Table 9. Deletions and 
duplications were generated by TAMERE52 using the Hprttm1(cre)Mnn line53,54. 
Rearrangements were further verified by long-range PCR (Expand Long-Range 
dNTPack, Roche), using primers flanking the reconstituted transposon. Mouse 
lines were maintained by backcrossing on a C57BL/6J background. Both male 
and female embryos were used for the experiments. Sample sizes were not 
predetermined.
Mouse experiments were conducted in accordance with the principles 
and guidelines in place at EMBL, as defined and overseen by its Institutional 
Animal Care and Use Committee, in accordance with European Convention 
18/3/1986 and Directives 86/609/EEC and 2010/63/EU.
LacZ staining and in situ hybridization. LacZ staining and mRNA whole-
mount in situ hybridization were performed as previously described9. Except 
where indicated, LacZ staining was performed on embryos heterozygous for 
the corresponding insertion, obtained by mating a transgenic male with a 
wild-type female.
Quantitative RT-PCR. Total RNA was purified from the dissected faces, fore-
limbs, hearts and livers of E11.5 embryos (45–48 somites) (RNeasy Mini kit, 
Qiagen) and eluted in 30–50 ?l of nuclease-free water. For each RNA sam-
ple, we first measured concentration and purity with a Nanodrop ND-1000 
spectrophotometer, and we then checked quality with a Bioanalyzer (Agilent 
Technologies) (Supplementary Fig. 11a). Possible DNA contamination was 
checked for by PCR using the 179039L and 179039R primers. Samples that 
did not meet quality control standards were discarded. First-strand cDNA was 
synthesized from 250–750 ng of total RNA using the Protoscript M-MuLV 
kit (NEB) with random hexamers. Quantitative RT-PCR was carried out in 
0.1-ml and 0.2-ml wells of 96-well plates. We included 1 ?l of cDNA, 1 ?M 
primer mix and 10 ?l of SYBR Green PCR Master Mix (Applied Biosystems) 
in a 20-?l final volume. Primers are listed in Supplementary Table 10. PCR 
was carried out on StepOnePlus Real-Time PCR systems (Life Technologies) 
and AB7500 Real-Time PCR systems (Applied Biosystems). Each primer pair 
was tested for efficiency and specificity following recommended procedures55 
(Supplementary Fig. 11b). We included Gusb and Pdhb as references. As Gusb 
expression levels (Ct values) were more in the range of those for the genes of 
interest, we used this gene for normalization, although the same significant 
differences were observed using normalization to Pdhb levels. Gene expres-
sion data were processed using Microsoft Excel and StepOne Real-Time PCR 
Software v2.0. For each group, two to five biological replicates were used (spe-
cific numbers are indicated in the figures), and, for each sample, quantification 
was performed on two to three technical replicates.
Skeletal preparation and analysis. Skulls from postnatal day (P) 19–21 and 
P40 mice were prepared following a standard procedure56 and stained with 
0.3% Alcian blue or 0.1% Alizarin red. For morphological measurements, ten 
landmarks from the top view of the skull and six landmarks from the bottom 
view were used57. Measurements were compared between age-matched groups. 
No mice were excluded from the analyses. Comparisons between the del(8–
17) homozygous mice and wild-type controls were carried out with Student’s 
t tests, and the statistical variance was calculated by f test. Exclusion of any of 
the samples did not have a critical impact on the statistical significance of the 
difference between genotypes.
Cell proliferation assays. Antibody to phosphorylated histone H3 (Ser10; 
06-570, Millipore, rabbit polyclonal) was used at a 1:200 dilution in 10% 
FCS, 0.2% PBS with Tween-20 (PBST) blocking solution on 5-?m paraf-
fin sections prepared from E11.5 embryos. Antigen retrieval was carried 
out in citrate buffer, pH 6.0 (Dako), and an Alexa Fluor 594–conjugated 
anti-rabbit secondary antibody was used at a 1:500 dilution with 
1× 4?,6-diamidino-2-phenylindole (DAPI) in the blocking solution. Images 
were acquired at 10× and 20× magnification with a Zeiss CellObserver HS 
Automated wide-field microscope. Four to 10 images were stitched together 
to obtain a full E11.5 embryonic face section. Image analysis was carried out 
with Fiji software58, using an automated macro to minimize subjective errors 
in counting nuclei positive for phosphorylation of histone H3. In brief, for 
each section, phosphorylated histone H3 signal was captured with the DsRed 
filter, and the signal obtained with the GFP-filtered image was subtracted 
out to remove background autofluorescence. The resulting signal image (S) 
was subjected to background rolling, Gaussian blur and Renyi Entropy dark 
thresholding. To define parameters for the automated counting of particles 
positive for phosphorylated histone H3 in 10× and 20× wide-field images, 
mitosis-phase particles were counted manually on 63× magnification images 
of the two sections that covered the whole face, obtained by stitching images 
recorded with a Spinning-Disk Microscope (PE Ultraview VoX) and using 
Volocity software (PerkinElmer). Particle counting was then performed and 
overlaid on the DAPI image: particle signals that were too elongated or did not 
overlap with DAPI signal were eliminated manually to obtain the final number 
of particles positive for phosphorylated histone H3 (pSc). The average number 
of pSc particles for a wild-type sample was 291. Cell numbers were estimated 
by measuring DAPI area (aD) on each section, as current Fiji plug-ins for 
DAPI signal counting were computationally inefficient for large samples. We 
verified that DAPI area and cell count performed with the Cell Counter plug-in 
(I. Levenfus, TU Dresden) showed a linear correlation of >99.5% in the range 
of 20 to 8,000 cells. Data were collected for sections from seven del(8–17) 
homozygous embryos and five wild-type littermate controls. The proliferation 
rate was defined as pSc/aD for each section. On average, proliferation rate was 
higher in the 130 sections from the 5 wild-type embryos than in the 165 sec-
tions from the 7 del(8–17) homozygous embryos (Student’s t test, P < 1 × 10−5) 
(Supplementary Fig. 6b). The average proliferation rate was also calculated for 
each embryo (as the average of the values measured for all the sections from 
one embryo). Again, the seven del(8–17) homozygous embryos showed lower 
values than the five controls (Student’s t test, P < 0.05) (Fig. 3e).
ChIP-seq experiments. For a given ChIP experiment, 25 facial mesenchyme 
samples were collected from E11.5 embryos, pooled, minced and fixed for 10 min 
in 1% formaldehyde in PBS. Formaldehyde was quenched through incubation 
with 250 mM glycine for 1 min on ice, and cells were lysed in buffer A (10 mM 
HEPES, pH 8.0, 1 mM EDTA, 0.5 mM EGTA, 0.25% Triton X-100 and 1:100 
freshly added PMSF) for 10 min at 4 °C on a rotating wheel. Cells were then 
incubated with buffer B (10 mM HEPES, pH 8.0, 200 mM NaCl, 1 mM EDTA, 
0.5 mM EGTA, 0.01% Triton X-100 and 1:100 freshly added PMSF) for 
10 min at 4 °C on a rotating wheel. Cells were resuspended in 300 ?l of 
sonication buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA, pH 8.0, 0.1% SDS 
and 1:100 freshly added PMSF) and sonicated with a Bioruptor for 24 min, 
with a duty cycle of 0.5 on the high-power setting. An aliquot of 2% of 
chromatin was taken as the input control. Chromatin was then equilibrated 
to 300 ?l of RIPA buffer and immunoprecipitated with 1.2 ?g of antibody 
to H3K27ac (Abcam, ab4729) or 0.75 ?g of antibody to H3K4me1 (Abcam, 
ab8580) with rotation overnight at 4 °C. Protein A Dynabeads (10001D, 
Life Technologies) were added (20 ?l per tube), incubated for 5 h in rota-
tion and washed four times in RIPA buffer and 1 time in Tris-EDTA. 
Immunoprecipitated complexes were eluted in 100 ?l of elution buffer, and 
cross-links were reversed at 65 °C overnight. Afterward, 20 ?g of proteinase K 
was added to each tube, and samples were incubated for 2 h in 55 °C. Finally, 
DNA was purified with QIAquick columns.
Libraries were prepared with NEB Next ChIP-seq Sample Prep Master Mix 
Set I (E6240S, NEB) and NEB Next Multiplex Oligos for Illumina (E7335S, 
NEB) and sequenced with a depth of 100 million reads for the input samples 
and 30 million reads for the ChIP samples.
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RNA sequencing. The facial tissues of four del(8–17) homozygous and four 
wild-type E11.5 littermate embryos were dissected and treated independently 
as biological replicates. Drosophila melanogaster S2 cells (72,000) were spiked 
into each tube to detect any global perturbation in mRNA levels. Total RNA 
was isolated with an RNeasy Mini kit (Qiagen). RNA quality and quantity 
were measured with a 2100 Bioanalyzer (Agilent Technologies). RNA sam-
ples were prepared according to the TruSeq RNA sample preparation guide 
(Illumina). We performed 50-bp, single-end sequencing on an Illumina HiSeq 
instrument. The eight samples were barcoded and run on the same flow cell. 
RNA sequencing data were processed with the iRAP (version 0.2.0; N.A.F., 
R. Petryszak, J.C.M. and A. Brazma, unpublished data) analysis pipeline (with 
default settings). More specifically, reads were mapped to the mouse reference 
genome (GRCm38.72) using TopHat59 (version 1.4.1) with the default number 
of mismatches. Read counts for each gene were estimated by running HTSeq-
count (version 0.5.3.p9) with intersection non-empty mode. Data normaliza-
tion and identification of genes with significantly different expression levels 
were performed using DESeq (version 1.10.1)60. P values were adjusted for 
multiple testing using the Benjamini-Hochberg procedure, with a corrected 
P value of 0.05 being used to identify differentially expressed genes. The ratio 
of reads mapped to the mouse genome and to the Drosophila genome was 
similar for all samples, suggesting the absence, in this context and for this 
range of Myc expression levels, of a global amplifier effect that would change 
the expression levels of most genes61,62.
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